No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4qv0C, 1.0000, 0.00, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2, 4qzzQ, 0.9999, 0.05, 1.000, 240, 240, YCP IN COMPLEX WITH OMURALIDE
3, 4qzzC, 0.9999, 0.05, 1.000, 240, 240, YCP IN COMPLEX WITH OMURALIDE
4, 4qv8Q, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-C52F MUTANT
5, 4qv8C, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-C52F MUTANT
6, 4qv7Q, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A50V MUTANT
7, 4qv7C, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A50V MUTANT
8, 4qv4Q, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45T MUTANT
9, 4qv4C, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45T MUTANT
10, 4qv1Q, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45A MUTANT
11, 4qv1C, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45A MUTANT
12, 4qv0Q, 0.9999, 0.00, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT
13, 4quyQ, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A49S-MUTANT
14, 4quyC, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A49S-MUTANT
15, 6gopQ, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
16, 6gopC, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
17, 5fgaQ, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
18, 5fgaC, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
19, 5czaQ, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT
20, 5czaC, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT
21, 5bxnQ, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
22, 5bxnC, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
23, 5bxlC, 0.9998, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT
24, 4y9yQ, 0.9998, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT
25, 4y9yC, 0.9998, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT
26, 4qwuQ, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
27, 4qwuC, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
28, 4qw1Q, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
29, 4qw1C, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
30, 4qvnQ, 0.9998, 0.07, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
31, 4qvnC, 0.9998, 0.07, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
32, 4qvlQ, 0.9998, 0.06, 1.000, 240, 240, YCP IN COMPLEX WITH BORTEZOMIB
33, 4qvlC, 0.9998, 0.06, 1.000, 240, 240, YCP IN COMPLEX WITH BORTEZOMIB
34, 4qv5Q, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-M45I MUTANT
35, 4qv5C, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-M45I MUTANT
36, 4qv3Q, 0.9998, 0.08, 1.000, 240, 240, YCP BETA5-M45V MUTANT
37, 4qv3C, 0.9998, 0.08, 1.000, 240, 240, YCP BETA5-M45V MUTANT
38, 5fg9Q, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
39, 5fg9C, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
40, 5fg7Q, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T1A MUTANT
41, 5fg7C, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T1A MUTANT
42, 5d0wQ, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT
43, 5d0wC, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT
44, 5cgfQ, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT
45, 5cgfC, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT
46, 5bxlQ, 0.9997, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT
47, 4ya4Q, 0.9997, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT
48, 4ya4C, 0.9997, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT
49, 4ya1Q, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT
50, 4ya1C, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT
51, 4y8rQ, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT
52, 4y8rC, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT
53, 4r00Q, 0.9997, 0.10, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
54, 4r00C, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
55, 4qvyQ, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
56, 4qvyC, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
57, 4qvwQ, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
58, 4qvwC, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
59, 4qvpQ, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
60, 4qvpC, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
61, 4qv9Q, 0.9997, 0.10, 1.000, 240, 240, YCP BETA5-C63F MUTANT
62, 4qv9C, 0.9997, 0.10, 1.000, 240, 240, YCP BETA5-C63F MUTANT
63, 4qv6Q, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49V MUTANT
64, 4qv6C, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49V MUTANT
65, 5cz7Q, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
66, 5cz7C, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
67, 5cz6Q, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
68, 5cz6C, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
69, 4z1lQ, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
70, 4z1lC, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
71, 4y8mQ, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
72, 4y8mC, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
73, 4quxQ, 0.9996, 0.10, 1.000, 240, 240, YCP BETA5-A49T-MUTANT
74, 4quxC, 0.9996, 0.10, 1.000, 240, 240, YCP BETA5-A49T-MUTANT
75, 5l6bQ, 0.9995, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
76, 5l5uQ, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
77, 5l5uC, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
78, 5l5rQ, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
79, 5l5rC, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
80, 5l5bQ, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
81, 5l5bC, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
82, 5dkjQ, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
83, 5dkjC, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
84, 5d0tQ, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
85, 5d0tC, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
86, 4qvqQ, 0.9995, 0.12, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
87, 4qvqC, 0.9995, 0.12, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
88, 5lttQ, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
89, 5lttC, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
90, 5l6bC, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
91, 5l6aQ, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
92, 5l6aC, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
93, 5l65Q, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
94, 5l65C, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
95, 5l5zQ, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
96, 5l5zC, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
97, 5l5xQ, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
98, 5l5xC, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
99, 5l5wQ, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
100, 5l5wC, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
101, 5l5hQ, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
102, 5l5hC, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
103, 5l5fQ, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
104, 5l5fC, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
105, 5l5aQ, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
106, 5l5aC, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
107, 5d0xQ, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
108, 5d0xC, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
109, 4qw0Q, 0.9994, 0.14, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
110, 4qw0C, 0.9994, 0.14, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
111, 5l6cQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
112, 5l6cC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
113, 5l67Q, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
114, 5l67C, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
115, 5l66Q, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
116, 5l66C, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
117, 5l64Q, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
118, 5l64C, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
119, 5l63Q, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
120, 5l63C, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
121, 5l62Q, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
122, 5l62C, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
123, 5l61Q, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
124, 5l61C, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
125, 5l5sQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
126, 5l5sC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
127, 5l5pQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
128, 5l5pC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
129, 5l5eQ, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
130, 5l5eC, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
131, 5l5dQ, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
132, 5l5dC, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
133, 5d0vQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
134, 5d0vC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
135, 5cghQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
136, 5cghC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
137, 4y8uQ, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
138, 4y8uC, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
139, 4y6vQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
140, 4y6vC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
141, 4y69Q, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
142, 4y69C, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
143, 4rurQ, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
144, 4rurC, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
145, 4qz4Q, 0.9993, 0.14, 1.000, 240, 240, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
146, 4qz4C, 0.9993, 0.14, 1.000, 240, 240, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
147, 4qwxQ, 0.9993, 0.15, 1.000, 240, 240, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
148, 4qwxC, 0.9993, 0.15, 1.000, 240, 240, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
149, 4qvmQ, 0.9993, 0.15, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
150, 4qvmC, 0.9993, 0.15, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
151, 5m2bQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
152, 5l5yQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
153, 5l5yC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
154, 5l5tQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
155, 5l5tC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
156, 5l5qQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
157, 5l5qC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
158, 5l5oQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
159, 5l5oC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
160, 5l5iQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
161, 5l5iC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
162, 5jhrQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
163, 5jhrC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
164, 5fghQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
165, 5fghC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
166, 5cggQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
167, 5cggC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
168, 5bouQ, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
169, 5bouC, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
170, 4ya9Q, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
171, 4ya9C, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
172, 4ya7Q, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
173, 4ya7C, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
174, 4y9zQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
175, 4y9zC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
176, 4y8pQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
177, 4y8pC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
178, 4y8nQ, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
179, 4y8nC, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
180, 4y77Q, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
181, 4y77C, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
182, 4y75Q, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
183, 4y75C, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
184, 4qz6Q, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
185, 4qz6C, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
186, 4qz5Q, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
187, 4qz5C, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
188, 4qz3Q, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
189, 4qz3C, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
190, 4qz0Q, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
191, 4qz0C, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
192, 4qwfQ, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
193, 4qwfC, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
194, 4qw6Q, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
195, 4qw6C, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
196, 4qvvQ, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
197, 4qvvC, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
198, 5m2bC, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
199, 5l68Q, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
200, 5l68C, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
201, 5l60Q, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
202, 5l60C, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
203, 5l5vQ, 0.9991, 0.17, 1.000, 240, 240,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
204, 5l5vC, 0.9991, 0.17, 1.000, 240, 240,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
205, 5l5jQ, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
206, 5l5jC, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
207, 5l55Q, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
208, 5l55C, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
209, 5l52Q, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
210, 5l52C, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
211, 5fggQ, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
212, 5fggC, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
213, 5dkiQ, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
214, 5dkiC, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
215, 5cgiQ, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
216, 5cgiC, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
217, 5ahjQ, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
218, 5ahjC, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
219, 4ya5Q, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
220, 4ya5C, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
221, 4y6aQ, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
222, 4y6aC, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
223, 4qwlQ, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
224, 4qwlC, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
225, 4qw7Q, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
226, 4qw7C, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
227, 4qw5Q, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
228, 4qw5C, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
229, 4qw4Q, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH CARFILZOMIB
230, 4qw4C, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH CARFILZOMIB
231, 4nnnQ, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH MG132
232, 4nnnC, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH MG132
233, 5jhsQ, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
234, 5jhsC, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
235, 5d0zQ, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
236, 5d0zC, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
237, 5cz9Q, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
238, 5cz9C, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
239, 5cz4Q, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
240, 5cz4C, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
241, 4y8lC, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
242, 4y8jQ, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
243, 4y8jC, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
244, 4y70C, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
245, 4qzwQ, 0.9990, 0.17, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
246, 4qzwC, 0.9990, 0.17, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
247, 4qz2Q, 0.9990, 0.18, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
248, 4qz2C, 0.9990, 0.18, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
249, 5l69Q, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
250, 5l69C, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
251, 5d0sQ, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
252, 5d0sC, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
253, 4ya3Q, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
254, 4ya3C, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
255, 4y8tQ, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
256, 4y8tC, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
257, 4y8sQ, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
258, 4y8sC, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
259, 4y8lQ, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
260, 4y8kQ, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
261, 4y8kC, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
262, 4y8iQ, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
263, 4y8iC, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
264, 4y82Q, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
265, 4y82C, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
266, 4y7wQ, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
267, 4y7wC, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
268, 4y74Q, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
269, 4y74C, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
270, 4y70Q, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
271, 4r17Q, 0.9989, 0.18, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
272, 4r17C, 0.9989, 0.18, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
273, 4qz7Q, 0.9989, 0.18, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
274, 4qz7C, 0.9989, 0.18, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
275, 5lajQ, 0.9988, 0.19, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
276, 5lajC, 0.9988, 0.19, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
277, 5fgfQ, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
278, 5fgfC, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
279, 5fgeQ, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
280, 5fgeC, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
281, 4ya0Q, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
282, 4ya0C, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
283, 4y8qQ, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
284, 4y8qC, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
285, 4y8oQ, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
286, 4y8oC, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
287, 4y80Q, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
288, 4y80C, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
289, 4y7yQ, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
290, 4y7yC, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
291, 4r18Q, 0.9988, 0.20, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
292, 4r18C, 0.9988, 0.20, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
293, 4qz1Q, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
294, 4qz1C, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
295, 4qxjC, 0.9988, 0.20, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
296, 4qwrQ, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
297, 4qwrC, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
298, 4qwiQ, 0.9988, 0.20, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
299, 4qwiC, 0.9988, 0.20, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
300, 5fhsQ, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
301, 5fhsC, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
302, 5fgiC, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
303, 5fgdQ, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
304, 5fgdC, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
305, 4y81Q, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
306, 4y81C, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
307, 4y7xQ, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
308, 4y7xC, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
309, 4qxjQ, 0.9987, 0.20, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
310, 4qw3Q, 0.9987, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
311, 4qw3C, 0.9987, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
312, 5laiQ, 0.9986, 0.21, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
313, 5laiC, 0.9986, 0.21, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
314, 5fgiQ, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
315, 5cz8Q, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
316, 5cz8C, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
317, 5cz5Q, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
318, 5cz5C, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
319, 4qzxQ, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
320, 4qzxC, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
321, 4qwkQ, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
322, 4qwkC, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
323, 4no8Q, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
324, 4no8C, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
325, 4no1Q, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
326, 4no1C, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
327, 4ya2Q, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
328, 4ya2C, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
329, 4y78Q, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
330, 4y78C, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
331, 4y6zQ, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
332, 4y6zC, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
333, 4qwjQ, 0.9985, 0.22, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
334, 4qwjC, 0.9985, 0.22, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
335, 4qlsC, 0.9984, 0.23, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
336, 4y8gQ, 0.9983, 0.24, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
337, 4y8gC, 0.9983, 0.23, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
338, 4qltQ, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
339, 4qltC, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
340, 4qlsQ, 0.9983, 0.23, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
341, 4qlqQ, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
342, 4qlqC, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
343, 5l54Q, 0.9982, 0.24, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
344, 5l54C, 0.9982, 0.24, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
345, 4no6Q, 0.9982, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
346, 4no6C, 0.9982, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
347, 4y8hQ, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
348, 4y8hC, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
349, 4y84Q, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
350, 4y84C, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
351, 4qwsQ, 0.9981, 0.25, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
352, 4qwsC, 0.9981, 0.25, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
353, 4qlvQ, 0.9978, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
354, 4qlvC, 0.9978, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
355, 4no9C, 0.9978, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
356, 4qwgQ, 0.9977, 0.27, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
357, 4qwgC, 0.9977, 0.27, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
358, 4no9Q, 0.9977, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
359, 4r02Q, 0.9976, 0.28, 1.000, 240, 240, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
360, 4nnwQ, 0.9976, 0.28, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
361, 4nnwC, 0.9976, 0.28, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
362, 4r02C, 0.9975, 0.29, 1.000, 240, 240, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
363, 4qluQ, 0.9975, 0.29, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
364, 4qluC, 0.9975, 0.29, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
365, 4qbyQ, 0.9969, 0.33, 1.000, 240, 240, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
366, 4qbyC, 0.9969, 0.33, 1.000, 240, 240, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
367, 4j70C, 0.9961, 0.36, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
368, 4j70Q, 0.9960, 0.37, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
369, 3sdkC, 0.9960, 0.36, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
370, 3oeuC, 0.9958, 0.38, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
371, 4q1sC, 0.9957, 0.38, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
372, 4ltcC, 0.9957, 0.39, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
373, 3mg4C, 0.9957, 0.38, 1.000, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
374, 4fzcQ, 0.9956, 0.39, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
375, 4fzcC, 0.9956, 0.39, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
376, 3mg8C, 0.9956, 0.39, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
377, 3mg7C, 0.9956, 0.38, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
378, 4hrcC, 0.9955, 0.39, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
379, 4hnpC, 0.9955, 0.39, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
380, 3oevC, 0.9955, 0.39, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
381, 3mg0C, 0.9955, 0.39, 0.996, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
382, 4ltcQ, 0.9954, 0.40, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
383, 4lqiQ, 0.9954, 0.40, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
384, 4lqiC, 0.9954, 0.40, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
385, 4jsuQ, 0.9953, 0.41, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
386, 4jsuC, 0.9953, 0.41, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
387, 4hrdC, 0.9953, 0.41, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
388, 4gk7Q, 0.9953, 0.41, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
389, 4gk7C, 0.9953, 0.40, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
390, 4eu2D, 0.9953, 0.41, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
391, 4fzgC, 0.9952, 0.41, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
392, 3mg6C, 0.9952, 0.40, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
393, 3hyeC, 0.9952, 0.41, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
394, 4jt0Q, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
395, 4jt0C, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
396, 4jsqQ, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
397, 4jsqC, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
398, 4fzgQ, 0.9951, 0.41, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
399, 3un4Q, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
400, 3un4C, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
401, 3tddQ, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
402, 3tddC, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
403, 3shjQ, 0.9951, 0.42, 0.996, 241, 240, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
404, 3shjC, 0.9951, 0.41, 0.996, 241, 240, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
405, 3mg0Q, 0.9951, 0.41, 0.996, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
406, 3hyeQ, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
407, 3gptQ, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
408, 3gptC, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
409, 4hrdQ, 0.9950, 0.42, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
410, 3nzwQ, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
411, 3nzwC, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
412, 3nzjQ, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
413, 3nzjC, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
414, 3gpwQ, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
415, 3gpwC, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
416, 3e47C, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
417, 4intQ, 0.9949, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
418, 4intC, 0.9949, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
419, 4inrC, 0.9949, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
420, 3un8C, 0.9949, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
421, 3nzxQ, 0.9949, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
422, 3nzxC, 0.9949, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
423, 3e47Q, 0.9949, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
424, 2fakQ, 0.9949, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
425, 2fakC, 0.9949, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
426, 4x6zD, 0.9948, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
427, 4inuC, 0.9948, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
428, 3un8Q, 0.9948, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
429, 2f16C, 0.9948, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
430, 4inuQ, 0.9947, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
431, 4inrQ, 0.9947, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
432, 2gplC, 0.9947, 0.43, 0.996, 241, 240, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
433, 2f16Q, 0.9947, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
434, 3okjQ, 0.9946, 0.44, 0.996, 241, 240, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
435, 3okjC, 0.9946, 0.44, 0.996, 241, 240, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
436, 3dy4Q, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
437, 3dy4C, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
438, 3dy3Q, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
439, 3dy3C, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
440, 3d29Q, 0.9946, 0.44, 0.996, 241, 240, PROTEASOME INHIBITION BY FELLUTAMIDE B
441, 3d29C, 0.9946, 0.44, 0.996, 241, 240, PROTEASOME INHIBITION BY FELLUTAMIDE B
442, 2gplQ, 0.9946, 0.44, 0.996, 241, 240, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
443, 4x6zR, 0.9945, 0.44, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
444, 3gpjQ, 0.9943, 0.45, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
445, 3gpjC, 0.9943, 0.45, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
446, 2zcyQ, 0.9943, 0.45, 0.996, 241, 240, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
447, 2zcyC, 0.9943, 0.45, 0.996, 241, 240, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
448, 4q1sQ, 0.9942, 0.47, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
449, 4hrcQ, 0.9942, 0.45, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
450, 5nifR, 0.9941, 0.46, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
451, 4zzgR, 0.9940, 0.46, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
452, 4hnpQ, 0.9940, 0.46, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
453, 3bdmQ, 0.9940, 0.46, 0.996, 241, 240, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
454, 3bdmC, 0.9940, 0.46, 0.996, 241, 240, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
455, 5nifD, 0.9935, 0.48, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
456, 4eu2R, 0.9934, 0.48, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
457, 3oevQ, 0.9932, 0.49, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
458, 4zzgD, 0.9931, 0.49, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
459, 3mg8Q, 0.9931, 0.49, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
460, 3wxrD, 0.9930, 0.50, 1.000, 241, 240, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
461, 3sdkQ, 0.9929, 0.50, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
462, 3mg4Q, 0.9928, 0.51, 1.000, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
463, 1rypD, 0.9924, 0.52, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
464, 1rypR, 0.9921, 0.53, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
465, 3oeuQ, 0.9919, 0.54, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
466, 3mg6Q, 0.9917, 0.55, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
467, 3mg7Q, 0.9904, 0.60, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
468, 3wxrR, 0.9903, 0.68, 1.000, 241, 240, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
469, 1jd2C, 0.9896, 0.61, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
470, 1g65C, 0.9895, 0.64, 0.996, 241, 240, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
471, 1g65Q, 0.9892, 0.65, 0.996, 241, 240, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
472, 1jd2X, 0.9890, 0.63, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
473, 5mp9d, 0.9864, 0.68, 1.000, 240, 240, 26S PROTEASOME IN PRESENCE OF ATP (S1)
474, 3jcpMA, 0.9851, 0.72, 0.996, 241, 240, 
475, 3jcpM, 0.9851, 0.72, 0.996, 241, 240, 
476, 5mpad, 0.9844, 0.72, 0.996, 241, 240, 26S PROTEASOME IN PRESENCE OF ATP (S2)
477, 5mp9D, 0.9820, 0.73, 1.000, 240, 240, 26S PROTEASOME IN PRESENCE OF ATP (S1)
478, 3sdiC, 0.9814, 0.80, 1.000, 240, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
479, 3jcoMA, 0.9801, 0.47, 0.996, 238, 237, 
480, 3jcoM, 0.9801, 0.83, 0.996, 241, 240, 
481, 1g0uC, 0.9797, 0.83, 0.996, 241, 240, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
482, 3sdiQ, 0.9794, 0.83, 0.996, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
483, 1g0uQ, 0.9791, 0.54, 0.996, 238, 237, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
484, 5wvkR, 0.9704, 0.55, 0.996, 238, 237, 
485, 5mpaD, 0.9703, 0.56, 0.996, 238, 237, 26S PROTEASOME IN PRESENCE OF ATP (S2)
486, 5wvkY, 0.9697, 1.02, 1.000, 241, 240, 
487, 4cr2D, 0.9638, 1.09, 1.000, 240, 240, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
488, 5a5bD, 0.9625, 1.05, 1.000, 241, 240, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
489, 4cr3D, 0.9625, 1.15, 1.000, 242, 240, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
490, 4cr4D, 0.9570, 1.17, 1.000, 242, 240, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
491, 1z7qR, 0.9558, 1.17, 1.000, 242, 240, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
492, 1z7qD, 0.9558, 1.34, 1.000, 242, 240, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
493, 3unes, 0.9547, 1.30, 1.000, 241, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
494, 3uneC, 0.9541, 1.30, 1.000, 241, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
495, 3unbs, 0.9539, 1.21, 0.591, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
496, 3unbQ, 0.9539, 1.21, 0.591, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
497, 3unfQ, 0.9536, 1.24, 0.586, 239, 237, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
498, 3unfC, 0.9536, 1.23, 0.586, 239, 237, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
499, 5gjrV, 0.9535, 1.24, 0.595, 238, 237, 
500, 3unhQ, 0.9534, 1.24, 0.595, 238, 237, MOUSE 20S IMMUNOPROTEASOME
501, 3unhC, 0.9534, 1.22, 0.591, 243, 237, MOUSE 20S IMMUNOPROTEASOME
502, 3uneQ, 0.9534, 1.24, 0.595, 238, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
503, 5gjrJA, 0.9531, 1.24, 0.595, 238, 237, 
504, 3unee, 0.9529, 1.22, 0.595, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
505, 4r3oD, 0.9524, 1.23, 0.586, 243, 237, HUMAN CONSTITUTIVE 20S PROTEASOME
506, 4r3oR, 0.9523, 1.23, 0.591, 239, 237, HUMAN CONSTITUTIVE 20S PROTEASOME
507, 3unbC, 0.9523, 1.25, 0.591, 243, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
508, 4r67t, 0.9522, 1.25, 0.591, 243, 237, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
509, 4r67f, 0.9522, 1.26, 0.586, 239, 237, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
510, 4r67D, 0.9522, 1.24, 0.591, 243, 237, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
511, 4r67R, 0.9521, 1.24, 0.591, 243, 237, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
512, 1fntD, 0.9519, 1.24, 0.591, 243, 237, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
513, 1fntR, 0.9518, 1.24, 0.591, 243, 237, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
514, 5lf6Q, 0.9517, 1.17, 1.000, 239, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
515, 3unbe, 0.9516, 1.17, 1.000, 239, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
516, 5lf1Q, 0.9514, 1.19, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
517, 5le5C, 0.9513, 1.28, 0.586, 239, 237, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
518, 5lf3Q, 0.9507, 1.20, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
519, 5lexC, 0.9507, 1.19, 0.597, 236, 236, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
520, 5leyQ, 0.9506, 1.21, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
521, 5lf7Q, 0.9505, 1.20, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
522, 5lezC, 0.9505, 1.22, 0.597, 239, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
523, 5lf4Q, 0.9504, 1.22, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
524, 5lf3C, 0.9503, 1.20, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
525, 5leyC, 0.9502, 1.22, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
526, 5lf7C, 0.9501, 1.21, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
527, 5lf0Q, 0.9501, 1.21, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
528, 5lf6C, 0.9499, 1.21, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
529, 5lf1C, 0.9497, 1.22, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
530, 5lf4C, 0.9495, 1.22, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
531, 5lf0C, 0.9494, 1.22, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
532, 5l4gD, 0.9494, 1.22, 0.597, 236, 236, 
533, 5gjqk, 0.9491, 1.23, 0.597, 236, 236, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
534, 5gjqE, 0.9490, 1.29, 0.574, 243, 237, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
535, 5mpbR, 0.9486, 1.29, 0.591, 243, 237, 
536, 5l4gR, 0.9481, 1.31, 0.591, 243, 237, 
537, 1iruR, 0.9474, 1.43, 1.000, 240, 240, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
538, 1iruD, 0.9474, 1.33, 0.574, 243, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
539, 5mpbD, 0.9469, 1.31, 0.586, 243, 237, 
540, 5vfsD, 0.9384, 1.31, 0.586, 243, 237, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
541, 5vfuU, 0.9374, 1.41, 1.000, 240, 240, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
542, 5vftJ, 0.9374, 1.42, 0.591, 239, 237, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
543, 5vfsCA, 0.9373, 1.87, 0.351, 228, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
544, 5m32Q, 0.9366, 1.43, 0.591, 239, 237, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
545, 5mpcD, 0.9356, 1.43, 0.591, 239, 237, 
546, 6avoI, 0.9348, 1.44, 0.591, 239, 237, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
547, 5m32C, 0.9347, 1.36, 0.591, 235, 235, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
548, 5mpcR, 0.9346, 1.68, 1.000, 240, 237, 
549, 5t0cV, 0.9338, 1.19, 0.595, 232, 232, 
550, 5t0cBB, 0.9338, 1.38, 0.585, 234, 234, 
551, 5le5Q, 0.9334, 1.55, 1.000, 240, 237, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
552, 6avoN, 0.9333, 1.49, 0.591, 239, 237, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
553, 5lexQ, 0.9325, 1.49, 0.591, 239, 237, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
554, 5wviI, 0.9319, 1.16, 0.597, 233, 231, 
555, 5lezQ, 0.9315, 1.22, 0.595, 232, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
556, 5vfuIA, 0.9280, 1.18, 0.597, 233, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
557, 5vftj, 0.9280, 1.63, 1.000, 242, 240, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
558, 5t0gJ, 0.9278, 1.19, 0.597, 234, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
559, 5gjqj, 0.9270, 1.58, 0.591, 239, 237, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
560, 5gjrIA, 0.9268, 1.58, 0.591, 239, 237, 
561, 5gjrU, 0.9267, 1.56, 0.591, 239, 237, 
562, 5gjqD, 0.9262, 2.00, 0.321, 250, 237, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
563, 5leyB, 0.9260, 2.00, 0.321, 250, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
564, 5lf7B, 0.9257, 2.01, 0.321, 250, 237, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
565, 5lf4B, 0.9257, 1.99, 0.316, 250, 237, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
566, 5lf0B, 0.9257, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
567, 5wviAA, 0.9255, 1.99, 0.321, 248, 237, 
568, 5lf1B, 0.9255, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
569, 5le5P, 0.9255, 2.00, 0.321, 248, 237, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
570, 5le5B, 0.9255, 1.71, 1.000, 242, 240, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
571, 5lf6B, 0.9254, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
572, 5lezB, 0.9254, 1.99, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
573, 5l4gQ, 0.9254, 1.99, 0.325, 248, 237, 
574, 5lf3B, 0.9253, 2.00, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
575, 5lexB, 0.9253, 2.01, 0.321, 248, 237, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
576, 5lf7P, 0.9250, 1.97, 0.325, 250, 237, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
577, 5lf1P, 0.9248, 2.00, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
578, 5lezP, 0.9246, 2.01, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
579, 5leyP, 0.9246, 2.02, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
580, 5lexP, 0.9246, 2.02, 0.325, 248, 237, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
581, 5lf6P, 0.9245, 2.04, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
582, 5lf4P, 0.9245, 2.02, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
583, 3uneP, 0.9245, 2.03, 0.325, 247, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
584, 3unbB, 0.9244, 2.02, 0.325, 248, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
585, 4r67s, 0.9243, 2.03, 0.325, 248, 237, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
586, 4r67Q, 0.9243, 2.00, 0.325, 248, 237, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
587, 4r67e, 0.9243, 1.90, 0.322, 248, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
588, 4r67C, 0.9243, 1.91, 0.322, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
589, 3unbP, 0.9243, 1.91, 0.322, 250, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
590, 3unbr, 0.9242, 1.91, 0.322, 250, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
591, 5lf0P, 0.9240, 1.91, 0.322, 250, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
592, 5lf3P, 0.9239, 1.91, 0.322, 248, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
593, 3unbd, 0.9237, 1.91, 0.322, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
594, 4r3oQ, 0.9230, 2.04, 0.325, 248, 237, HUMAN CONSTITUTIVE 20S PROTEASOME
595, 4r3oC, 0.9230, 2.03, 0.325, 248, 237, HUMAN CONSTITUTIVE 20S PROTEASOME
596, 5l4gC, 0.9229, 1.91, 0.322, 248, 236, 
597, 3unhP, 0.9229, 1.93, 0.322, 250, 236, MOUSE 20S IMMUNOPROTEASOME
598, 3unhB, 0.9229, 1.93, 0.322, 250, 236, MOUSE 20S IMMUNOPROTEASOME
599, 1iruQ, 0.9224, 2.00, 0.325, 250, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
600, 1iruC, 0.9223, 2.05, 0.321, 248, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
601, 3unfP, 0.9221, 2.05, 0.321, 248, 237, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
602, 3unfB, 0.9221, 2.05, 0.325, 250, 237, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
603, 3uner, 0.9221, 2.05, 0.325, 250, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
604, 5vfoj, 0.9219, 1.91, 0.322, 248, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
605, 3uned, 0.9209, 1.91, 0.322, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
606, 3uneB, 0.9198, 2.03, 0.325, 248, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
607, 5vfqCA, 0.9195, 1.69, 0.595, 239, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
608, 5vfpBA, 0.9192, 1.94, 0.326, 248, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
609, 5vfrj, 0.9179, 1.81, 0.328, 248, 235, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
610, 5t0hJ, 0.9137, 1.73, 0.591, 239, 237, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
611, 4v7oZA, 0.9136, 1.72, 0.595, 239, 237, 
612, 4v7oR, 0.9136, 1.75, 0.595, 239, 237, 
613, 4v7oLA, 0.9136, 1.75, 0.578, 239, 237, 
614, 4v7oD, 0.9136, 1.11, 0.991, 227, 226, 
615, 5vfsC, 0.9107, 1.11, 0.991, 227, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
616, 5vfsBA, 0.9098, 1.11, 0.991, 227, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
617, 5vfoi, 0.9076, 1.11, 0.991, 227, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
618, 5vfuT, 0.9075, 1.44, 0.591, 239, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
619, 5vftI, 0.9075, 1.98, 0.335, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
620, 4g4sD, 0.9074, 2.04, 0.331, 250, 236, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
621, 5vfqBA, 0.9069, 2.01, 0.335, 250, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
622, 5vfri, 0.9060, 2.00, 0.335, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
623, 5m32P, 0.9060, 2.00, 0.335, 250, 236, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
624, 5vfpAA, 0.9059, 0.71, 0.995, 220, 220, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
625, 5ln3D, 0.9052, 2.01, 0.335, 250, 236, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
626, 6avoZ, 0.9047, 2.04, 0.335, 250, 236, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
627, 6avoO, 0.9047, 2.21, 0.314, 244, 236, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
628, 5vfoI, 0.9045, 2.03, 0.335, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
629, 5vfqC, 0.9044, 1.86, 0.591, 248, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
630, 5vfuHA, 0.9043, 1.86, 0.325, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
631, 5vfti, 0.9043, 1.86, 0.325, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
632, 5vfrI, 0.9043, 1.87, 0.329, 248, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
633, 5t0cU, 0.9041, 1.73, 0.591, 239, 237, 
634, 5t0cAB, 0.9041, 1.87, 0.325, 248, 234, 
635, 5vfoJ, 0.9037, 2.07, 0.326, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
636, 5vfpC, 0.9030, 2.07, 0.326, 250, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
637, 5vfqD, 0.9029, 1.87, 0.325, 248, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
638, 5vfpD, 0.9027, 2.09, 0.326, 250, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
639, 5vfrJ, 0.9022, 2.09, 0.326, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
640, 1g65O, 0.9013, 1.85, 0.573, 239, 234, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
641, 5lf1O, 0.9012, 1.88, 0.329, 248, 234, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
642, 5lexO, 0.9012, 1.72, 0.348, 228, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
643, 1g65A, 0.9010, 1.86, 0.590, 239, 234, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
644, 5lf3O, 0.9009, 1.72, 0.348, 228, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
645, 5lezO, 0.9009, 1.85, 0.590, 239, 234, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
646, 5vfuS, 0.9006, 2.25, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
647, 5vftH, 0.9006, 1.86, 0.590, 239, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
648, 5lf7O, 0.9006, 1.52, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
649, 5lf0O, 0.9006, 1.34, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
650, 3okjO, 0.9006, 1.34, 0.392, 230, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
651, 3okjA, 0.9006, 1.53, 0.367, 250, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
652, 1rypB, 0.9006, 1.35, 0.388, 230, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
653, 5lf6O, 0.9005, 1.35, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
654, 5lezA, 0.9005, 1.43, 0.386, 232, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
655, 5leyO, 0.9005, 1.43, 0.386, 232, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
656, 5lexA, 0.9005, 1.35, 0.388, 230, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
657, 3un8O, 0.9005, 1.36, 0.388, 230, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
658, 1rypP, 0.9005, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
659, 4zzgP, 0.9004, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
660, 2gplA, 0.9004, 1.53, 0.367, 250, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
661, 5nifP, 0.9003, 1.36, 0.388, 230, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
662, 4intA, 0.9003, 1.35, 0.392, 230, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
663, 2gplO, 0.9003, 1.36, 0.388, 230, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
664, 5lf4O, 0.9002, 1.35, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
665, 3uneq, 0.9002, 1.54, 0.367, 250, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
666, 3e47O, 0.9002, 1.53, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
667, 3e47A, 0.9002, 1.54, 0.362, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
668, 5lf1A, 0.9001, 1.53, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
669, 3un8A, 0.9001, 1.54, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
670, 2f16O, 0.9001, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
671, 2f16A, 0.9001, 1.53, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
672, 5le5O, 0.9000, 1.36, 0.388, 230, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
673, 4intO, 0.9000, 1.53, 0.390, 233, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
674, 4inrA, 0.9000, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
675, 4inrO, 0.8999, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
676, 2fakA, 0.8999, 1.36, 0.392, 230, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
677, 4y8kO, 0.8998, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
678, 2fakO, 0.8998, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
679, 5vfsAA, 0.8997, 1.54, 0.367, 250, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
680, 5lf6A, 0.8997, 1.37, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
681, 4zzgB, 0.8997, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
682, 4y8kA, 0.8997, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
683, 4qv3O, 0.8997, 1.54, 0.367, 250, 229, YCP BETA5-M45V MUTANT
684, 4no1O, 0.8997, 1.54, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
685, 4no1A, 0.8997, 1.55, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
686, 4inuA, 0.8997, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
687, 4r67r, 0.8996, 1.46, 0.386, 232, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
688, 4r3oP, 0.8996, 1.37, 0.392, 230, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
689, 4r3oB, 0.8996, 1.55, 0.362, 250, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
690, 4qv5O, 0.8996, 1.55, 0.367, 250, 229, YCP BETA5-M45I MUTANT
691, 4qv5A, 0.8996, 1.55, 0.367, 250, 229, YCP BETA5-M45I MUTANT
692, 4qv3A, 0.8996, 1.55, 0.367, 250, 229, YCP BETA5-M45V MUTANT
693, 4jsqO, 0.8996, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
694, 4jsqA, 0.8996, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
695, 4inuO, 0.8996, 1.39, 0.396, 233, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
696, 3tddO, 0.8996, 1.39, 0.396, 233, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
697, 3tddA, 0.8996, 1.39, 0.396, 233, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
698, 3gptO, 0.8996, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
699, 3gptA, 0.8996, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
700, 5nifB, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
701, 5fgfO, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
702, 5fgfA, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
703, 4qwlO, 0.8995, 1.54, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
704, 4qwlA, 0.8995, 1.54, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
705, 4jt0O, 0.8995, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
706, 4jt0A, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
707, 3oevA, 0.8995, 1.55, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
708, 3nzjA, 0.8995, 1.55, 0.362, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
709, 1jd2V, 0.8995, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
710, 5vfsB, 0.8994, 1.55, 0.367, 250, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
711, 5lf4A, 0.8994, 1.56, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
712, 5lf3A, 0.8994, 1.56, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
713, 5lf0A, 0.8994, 1.55, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
714, 5leyA, 0.8994, 1.55, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
715, 5l55A, 0.8994, 1.55, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
716, 5cghA, 0.8994, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
717, 5cggO, 0.8994, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
718, 5cggA, 0.8994, 2.04, 0.331, 250, 236, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
719, 5ahjO, 0.8994, 1.46, 0.382, 232, 228, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
720, 5ahjA, 0.8994, 1.37, 0.392, 230, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
721, 4r67P, 0.8994, 1.37, 0.392, 230, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
722, 4r00O, 0.8994, 1.38, 0.388, 230, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
723, 4r00A, 0.8994, 1.37, 0.392, 230, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
724, 4qwrO, 0.8994, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
725, 4qwrA, 0.8994, 1.56, 0.362, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
726, 3nzxO, 0.8994, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
727, 3nzxA, 0.8994, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
728, 3nzjO, 0.8994, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
729, 1iruP, 0.8994, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
730, 5l55O, 0.8993, 1.39, 0.396, 233, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
731, 5l52O, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
732, 5l52A, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
733, 5jhrO, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
734, 5jhrA, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
735, 5fgiA, 0.8993, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
736, 5fgeO, 0.8993, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
737, 5fgeA, 0.8993, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
738, 5d0zO, 0.8993, 1.39, 0.392, 233, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
739, 5d0zA, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
740, 5d0sO, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
741, 5d0sA, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
742, 5cz9O, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
743, 5cz9A, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
744, 5cghO, 0.8993, 1.56, 0.367, 249, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
745, 4y8pO, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
746, 4y8pA, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
747, 4r67d, 0.8993, 1.56, 0.367, 250, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
748, 4qzwO, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
749, 4qzwA, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
750, 4qz7O, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
751, 4qz7A, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
752, 4qv7O, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT
753, 4qv7A, 0.8993, 1.56, 0.362, 250, 229, YCP BETA5-A50V MUTANT
754, 4qv4O, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT
755, 4qv4A, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT
756, 4ltcO, 0.8993, 1.39, 0.396, 233, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
757, 3unec, 0.8993, 1.56, 0.367, 250, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
758, 3mg7O, 0.8993, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
759, 5lf7A, 0.8992, 1.56, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
760, 5fhsO, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
761, 5fhsA, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
762, 5fgiO, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
763, 4ya1O, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
764, 4ya1A, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
765, 4y8qO, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
766, 4y8qA, 0.8992, 1.52, 0.395, 233, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
767, 4y8lA, 0.8992, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
768, 4y82O, 0.8992, 1.38, 0.392, 230, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
769, 4y82A, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
770, 4x6zP, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
771, 4r67B, 0.8992, 1.56, 0.367, 249, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
772, 4qv8O, 0.8992, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT
773, 4qv8A, 0.8992, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT
774, 4qlqO, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
775, 4qlqA, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
776, 4qbyO, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
777, 4qbyA, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
778, 4ltcA, 0.8992, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
779, 3uneO, 0.8992, 1.56, 0.367, 249, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
780, 3mg6A, 0.8992, 1.39, 0.396, 233, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
781, 3mg0O, 0.8992, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
782, 3h4pJ, 0.8992, 1.56, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
783, 3dy3A, 0.8992, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
784, 5le5A, 0.8991, 1.56, 0.367, 250, 229, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
785, 5jhsO, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
786, 5jhsA, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
787, 5fggO, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
788, 5fggA, 0.8991, 1.56, 0.395, 233, 228, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
789, 5fgdO, 0.8991, 1.56, 0.362, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
790, 5fgdA, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
791, 5fg7O, 0.8991, 1.66, 0.402, 232, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
792, 5fg7A, 0.8991, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
793, 5cgiO, 0.8991, 1.38, 0.392, 230, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
794, 5cgiA, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
795, 4ya7A, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
796, 4ya2O, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
797, 4ya2A, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
798, 4y8mO, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
799, 4y8lO, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
800, 4y7xO, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
801, 4y7xA, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
802, 4y77O, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
803, 4y77A, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
804, 4qzxO, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
805, 4qzxA, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
806, 4qz3O, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
807, 4qz3A, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
808, 4qwjO, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
809, 4qwjA, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
810, 4qwiO, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
811, 4qwiA, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
812, 4qw7O, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
813, 4qw7A, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
814, 4qw6O, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
815, 4qw6A, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
816, 4qw5O, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
817, 4qw5A, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
818, 4qv1O, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT
819, 4qv1A, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT
820, 4q1sA, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
821, 3un4O, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
822, 3un4A, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
823, 3shjO, 0.8991, 1.56, 0.367, 250, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
824, 3oevO, 0.8991, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
825, 3nzwO, 0.8991, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
826, 3nzwA, 0.8991, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
827, 3mg0A, 0.8991, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
828, 3gpwO, 0.8991, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
829, 3gpwA, 0.8991, 1.56, 0.362, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
830, 3dy3O, 0.8991, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
831, 3d29A, 0.8991, 1.55, 0.367, 250, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
832, 2zcyA, 0.8991, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
833, 6avoP, 0.8990, 1.55, 0.367, 250, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
834, 6avob, 0.8990, 1.56, 0.367, 250, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
835, 5l54A, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
836, 5d0vO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
837, 5d0vA, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
838, 5czaO, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
839, 5czaA, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
840, 5cz5O, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
841, 5cz5A, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
842, 5cgfO, 0.8990, 1.38, 0.388, 230, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
843, 5cgfA, 0.8990, 1.38, 0.388, 230, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
844, 5bxlO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
845, 5bxlA, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
846, 4z1lO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
847, 4ya7O, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
848, 4y9yO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
849, 4y9yA, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
850, 4y8sO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
851, 4y8sA, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
852, 4y8mA, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
853, 4y75A, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
854, 4r02A, 0.8990, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
855, 4qz6O, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
856, 4qz6A, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
857, 4qz0O, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
858, 4qz0A, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
859, 4qwxO, 0.8990, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
860, 4qwxA, 0.8990, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
861, 4jsuO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
862, 4jsuA, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
863, 4fzcO, 0.8990, 1.57, 0.362, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
864, 4fzcA, 0.8990, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
865, 3shjA, 0.8990, 1.56, 0.367, 250, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
866, 3mg7A, 0.8990, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
867, 3h4pA, 0.8990, 1.56, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
868, 3d29O, 0.8990, 1.56, 0.367, 250, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
869, 2zcyO, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
870, 1jd2A, 0.8990, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
871, 5l67O, 0.8989, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
872, 5l64O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
873, 5l61O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
874, 5l61A, 0.8989, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
875, 5l5wO, 0.8989, 1.57, 0.358, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
876, 5l5wA, 0.8989, 1.65, 0.402, 232, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
877, 5l5vO, 0.8989, 1.55, 0.367, 250, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
878, 5l5vA, 0.8989, 1.55, 0.367, 250, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
879, 5l5oO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
880, 5l5oA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
881, 5l5bO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
882, 5l5bA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
883, 5l54O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
884, 5fg9O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
885, 5fg9A, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
886, 5d0wO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
887, 5d0wA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
888, 5cz8O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
889, 5cz8A, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
890, 4z1lA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
891, 4ya9O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
892, 4ya9A, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
893, 4y9zO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
894, 4y9zA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
895, 4y8hO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
896, 4y8hA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
897, 4y80O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
898, 4y80A, 0.8989, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
899, 4y7yO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
900, 4y7yA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
901, 4y7wO, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
902, 4y7wA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
903, 4y75O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
904, 4y70O, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
905, 4y70A, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
906, 4y6zA, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
907, 4qz5O, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
908, 4qz5A, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
909, 4qz4O, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
910, 4qz4A, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
911, 4qwkO, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
912, 4qwkA, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
913, 4qwfO, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
914, 4qwfA, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
915, 4qv0O, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
916, 4quyO, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT
917, 4quyA, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT
918, 4quxO, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT
919, 4quxA, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT
920, 4no8O, 0.8989, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
921, 4no8A, 0.8989, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
922, 3sdkO, 0.8989, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
923, 3mg8A, 0.8989, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
924, 3hyeA, 0.8989, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
925, 5m2bO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
926, 5m2bA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
927, 5lttO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
928, 5lttA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
929, 5lajO, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
930, 5lajA, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
931, 5l6cO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
932, 5l6cA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
933, 5l6bO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
934, 5l6bA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
935, 5l6aO, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
936, 5l6aA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
937, 5l67A, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
938, 5l64A, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
939, 5l62O, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
940, 5l5xO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
941, 5l5xA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
942, 5l5tO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
943, 5l5tA, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
944, 5l5aO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
945, 5l5aA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
946, 5fgaO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
947, 5fgaA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
948, 5cz7O, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
949, 5cz7A, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
950, 4y8uO, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
951, 4y8uA, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
952, 4y8rO, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
953, 4y8rA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
954, 4y8jO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
955, 4y8jA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
956, 4y6zO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
957, 4y6aO, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
958, 4y6aA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
959, 4r18O, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
960, 4r18A, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
961, 4qzzO, 0.8988, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH OMURALIDE
962, 4qzzA, 0.8988, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH OMURALIDE
963, 4qz2O, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
964, 4qz2A, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
965, 4qxjO, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
966, 4qxjA, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
967, 4qv9O, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT
968, 4qv9A, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT
969, 4qv0A, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
970, 4fzgO, 0.8988, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
971, 4fzgA, 0.8988, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
972, 3wxrB, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
973, 3sdkA, 0.8988, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
974, 3oeuO, 0.8988, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
975, 3hyeO, 0.8988, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
976, 3h4pL, 0.8988, 1.56, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
977, 3gpjO, 0.8988, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
978, 3gpjA, 0.8988, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
979, 3bdmA, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
980, 5l68O, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
981, 5l68A, 0.8987, 1.56, 0.367, 249, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
982, 5l66O, 0.8987, 1.57, 0.362, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
983, 5l66A, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
984, 5l63O, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
985, 5l63A, 0.8987, 1.65, 0.402, 232, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
986, 5l62A, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
987, 5l60O, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
988, 5l60A, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
989, 5l5rO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
990, 5l5rA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
991, 5l5qO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
992, 5l5qA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
993, 5l5pO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
994, 5l5pA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
995, 5l5jO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
996, 5l5jA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
997, 5l5hO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
998, 5l5hA, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
999, 5l5fO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1000, 5d0tO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1001, 5d0tA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1002, 5bxnA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1003, 4ya5A, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1004, 4y8nO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1005, 4y8nA, 0.8987, 1.57, 0.362, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1006, 4y8iO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1007, 4y8iA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1008, 4y8gO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1009, 4y8gA, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1010, 4y81O, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1011, 4y81A, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1012, 4y78O, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1013, 4y78A, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1014, 4y74O, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1015, 4y74A, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1016, 4y6vO, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1017, 4y6vA, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1018, 4r17A, 0.8987, 1.56, 0.367, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1019, 4qw4O, 0.8987, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH CARFILZOMIB
1020, 4qw4A, 0.8987, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH CARFILZOMIB
1021, 4qvyO, 0.8987, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1022, 4qvyA, 0.8987, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1023, 4qlvO, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1024, 4qlvA, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1025, 4qltO, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1026, 4qltA, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1027, 4nnnO, 0.8987, 1.57, 0.367, 249, 229, YCP IN COMPLEX WITH MG132
1028, 4nnnA, 0.8987, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH MG132
1029, 4gk7O, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1030, 4gk7A, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1031, 3mg4A, 0.8987, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1032, 3h4pH, 0.8987, 1.57, 0.362, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1033, 3h4pC, 0.8987, 1.57, 0.362, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1034, 3bdmO, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1035, 5l65O, 0.8986, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1036, 5l65A, 0.8986, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1037, 5l5zO, 0.8986, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1038, 5l5zA, 0.8986, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1039, 5l5uO, 0.8986, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1040, 5l5uA, 0.8986, 1.56, 0.362, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1041, 5l5fA, 0.8986, 1.66, 0.402, 232, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1042, 5l5eO, 0.8986, 1.66, 0.402, 232, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1043, 5l5eA, 0.8986, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1044, 5cz6O, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1045, 5cz6A, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1046, 5bxnO, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1047, 4ya5O, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1048, 4ya4O, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1049, 4y8oO, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1050, 4y8oA, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1051, 4y84O, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1052, 4y84A, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1053, 4y69O, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1054, 4y69A, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1055, 4rurO, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1056, 4rurA, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1057, 4r17O, 0.8986, 1.57, 0.367, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1058, 4r02O, 0.8986, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1059, 4qwgA, 0.8986, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1060, 4qvlO, 0.8986, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH BORTEZOMIB
1061, 4qvlA, 0.8986, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH BORTEZOMIB
1062, 3oeuA, 0.8986, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1063, 3mg6O, 0.8986, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1064, 5l5yO, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1065, 5l5yA, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1066, 5l5sO, 0.8985, 1.57, 0.367, 249, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1067, 5l5sA, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1068, 5l5iO, 0.8985, 1.57, 0.362, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1069, 5l5dO, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1070, 5l5dA, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1071, 5d0xO, 0.8985, 1.57, 0.362, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1072, 5d0xA, 0.8985, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1073, 5bouO, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1074, 5bouA, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1075, 4ya4A, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1076, 4y8tO, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1077, 4y8tA, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1078, 4qwsO, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1079, 4qwsA, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1080, 4qwgO, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1081, 4qw0O, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1082, 4qw0A, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1083, 4qvwO, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1084, 4qvwA, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1085, 4qvqO, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1086, 4qvqA, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1087, 4qvpO, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1088, 4qvpA, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1089, 4qluO, 0.8985, 1.57, 0.362, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1090, 4qluA, 0.8985, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1091, 3mg8O, 0.8985, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1092, 5vfpZ, 0.8984, 1.57, 0.367, 250, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1093, 5l5iA, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1094, 5fghO, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1095, 5fghA, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1096, 5dkjO, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1097, 5dkjA, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1098, 5cz4O, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1099, 5cz4A, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1100, 4ya3O, 0.8984, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1101, 4ya3A, 0.8984, 1.51, 0.377, 232, 228, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1102, 4qwuO, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1103, 4qwuA, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1104, 4qw1O, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1105, 4qw1A, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1106, 4qvnO, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1107, 4qvnA, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1108, 4qlsO, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1109, 4qlsA, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1110, 4q1sO, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1111, 4no6O, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1112, 4no6A, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1113, 5laiO, 0.8983, 1.57, 0.367, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1114, 5laiA, 0.8983, 1.57, 0.367, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1115, 4nnwO, 0.8983, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1116, 4nnwA, 0.8983, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1117, 4lqiA, 0.8983, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1118, 3h4pD, 0.8983, 1.57, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1119, 5l69O, 0.8982, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1120, 5l69A, 0.8982, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1121, 4qz1O, 0.8982, 1.57, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1122, 4qz1A, 0.8982, 1.57, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1123, 4qvvO, 0.8982, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1124, 4qvvA, 0.8982, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1125, 4no9O, 0.8982, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1126, 4no9A, 0.8982, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1127, 4lqiO, 0.8982, 1.66, 0.402, 232, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1128, 4hrdO, 0.8982, 1.58, 0.362, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1129, 4hnpO, 0.8982, 1.58, 0.362, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1130, 3h4pN, 0.8982, 1.58, 0.362, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1131, 3h4pK, 0.8982, 1.58, 0.362, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1132, 3dy4A, 0.8982, 1.57, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1133, 4ya0O, 0.8981, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1134, 4ya0A, 0.8981, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1135, 4qvmO, 0.8981, 1.57, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1136, 4qvmA, 0.8981, 1.57, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1137, 3uneA, 0.8981, 1.56, 0.362, 250, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1138, 3h4pG, 0.8981, 1.56, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1139, 3h4pF, 0.8981, 1.67, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1140, 3dy4O, 0.8981, 1.67, 0.402, 232, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1141, 6gopO, 0.8980, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1142, 6gopA, 0.8980, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1143, 4hrdA, 0.8980, 1.57, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1144, 3mg4O, 0.8980, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1145, 3h4pE, 0.8980, 1.57, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1146, 5vfoh, 0.8979, 1.56, 0.395, 233, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1147, 4hnpA, 0.8979, 1.68, 0.402, 232, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1148, 5gjqC, 0.8978, 1.67, 0.402, 232, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1149, 5dkiO, 0.8978, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1150, 5dkiA, 0.8978, 1.58, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1151, 4qw3O, 0.8978, 1.58, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1152, 4qw3A, 0.8978, 1.57, 0.362, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1153, 4j70A, 0.8978, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1154, 3h4pM, 0.8978, 1.69, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1155, 3h4pI, 0.8977, 1.52, 0.377, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1156, 4qv6O, 0.8976, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT
1157, 4qv6A, 0.8976, 1.41, 0.396, 233, 227, YCP BETA5-A49V MUTANT
1158, 3h4pB, 0.8976, 1.58, 0.367, 250, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1159, 4j70O, 0.8975, 1.58, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1160, 4hrcO, 0.8974, 1.58, 0.362, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1161, 1g0uA, 0.8974, 1.58, 0.362, 250, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1162, 5vfqAA, 0.8972, 1.57, 0.367, 250, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1163, 3wxrP, 0.8971, 1.70, 0.402, 232, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1164, 5vfrh, 0.8969, 1.71, 0.402, 232, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1165, 5l4gB, 0.8968, 1.58, 0.367, 250, 229, 
1166, 4hrcA, 0.8967, 1.58, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1167, 3unbO, 0.8967, 1.69, 0.402, 232, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1168, 3unbc, 0.8967, 1.58, 0.367, 250, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1169, 3unbA, 0.8967, 1.57, 0.367, 249, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1170, 5t0gI, 0.8965, 1.52, 0.368, 246, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1171, 1iruB, 0.8964, 1.53, 0.377, 232, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1172, 1g0uO, 0.8964, 1.58, 0.367, 249, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1173, 3unbq, 0.8963, 1.53, 0.377, 232, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1174, 4eu2B, 0.8961, 1.51, 0.396, 233, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1175, 5l4gP, 0.8960, 1.59, 0.367, 249, 229, 
1176, 4eu2P, 0.8959, 1.35, 0.389, 231, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1177, 3sdiA, 0.8955, 1.36, 0.389, 231, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1178, 3sdiO, 0.8954, 1.36, 0.389, 231, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1179, 5gjrT, 0.8951, 2.16, 0.322, 250, 236, 
1180, 5gjrHA, 0.8949, 1.47, 0.392, 233, 227, 
1181, 1j2qB, 0.8949, 1.53, 0.368, 246, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1182, 1j2qA, 0.8948, 1.36, 0.389, 231, 226, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1183, 1j2qF, 0.8947, 1.55, 0.368, 249, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1184, 1j2qE, 0.8947, 1.60, 0.395, 233, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1185, 1j2qD, 0.8947, 1.55, 0.368, 249, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1186, 1j2qC, 0.8946, 1.56, 0.368, 246, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1187, 1j2qG, 0.8945, 1.55, 0.368, 246, 228, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1188, 4x6zB, 0.8940, 1.38, 0.394, 231, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1189, 5t0cZA, 0.8939, 1.39, 0.394, 231, 226, 
1190, 5t0cT, 0.8939, 1.79, 0.435, 237, 230, 
1191, 3unhO, 0.8938, 1.80, 0.435, 237, 230, MOUSE 20S IMMUNOPROTEASOME
1192, 3unhA, 0.8938, 1.80, 0.435, 237, 230, MOUSE 20S IMMUNOPROTEASOME
1193, 4g4sB, 0.8937, 1.80, 0.435, 237, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1194, 3unfO, 0.8935, 1.80, 0.435, 237, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1195, 3unfA, 0.8935, 1.80, 0.435, 237, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1196, 5mp9B, 0.8934, 1.80, 0.435, 237, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1197, 4r02P, 0.8933, 1.58, 0.368, 248, 228, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1198, 5dkjP, 0.8932, 1.54, 0.386, 232, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1199, 5dkjB, 0.8932, 1.54, 0.386, 232, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1200, 5d0tP, 0.8932, 1.33, 0.391, 230, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1201, 4qvqP, 0.8932, 1.33, 0.391, 230, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1202, 4qvqB, 0.8932, 1.57, 0.364, 246, 228, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1203, 3jcpKA, 0.8932, 1.34, 0.391, 230, 225, 
1204, 3jcpK, 0.8932, 1.34, 0.391, 230, 225, 
1205, 1z7qE, 0.8932, 1.63, 0.362, 250, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1206, 5gjqi, 0.8931, 2.05, 0.306, 244, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1207, 5d0tB, 0.8931, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1208, 4qvpP, 0.8931, 2.05, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1209, 4qvmP, 0.8931, 2.05, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1210, 4qvmB, 0.8931, 2.05, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1211, 1z7qS, 0.8931, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1212, 5dkiP, 0.8930, 1.63, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1213, 5dkiB, 0.8930, 1.63, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1214, 5d0xP, 0.8930, 1.63, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1215, 5d0xB, 0.8930, 1.91, 0.342, 245, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1216, 4qw1P, 0.8930, 1.41, 0.394, 231, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1217, 4qw1B, 0.8930, 2.05, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1218, 4qvpB, 0.8930, 2.05, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1219, 3d29R, 0.8930, 2.06, 0.306, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1220, 4y8uP, 0.8929, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1221, 4y8uB, 0.8929, 1.91, 0.342, 245, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1222, 4qwuP, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1223, 4qwuB, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1224, 4qw0B, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1225, 4qvwP, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1226, 4qvwB, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1227, 4qvvP, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1228, 4qvnP, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1229, 4qvnB, 0.8929, 1.94, 0.341, 242, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1230, 4ltcP, 0.8929, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1231, 4intP, 0.8929, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1232, 4hrdB, 0.8929, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1233, 3d29D, 0.8929, 2.05, 0.306, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1234, 2zcyR, 0.8929, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1235, 2zcyD, 0.8929, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1236, 6epfD, 0.8928, 2.06, 0.306, 244, 232, GROUND STATE 26S PROTEASOME (GS1)
1237, 5lajP, 0.8928, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1238, 5lajB, 0.8928, 2.05, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1239, 5fghP, 0.8928, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1240, 5fghB, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1241, 5cz7P, 0.8928, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1242, 5cz7B, 0.8928, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1243, 4z1lP, 0.8928, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1244, 4z1lB, 0.8928, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1245, 4ya0P, 0.8928, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1246, 4ya0B, 0.8928, 2.03, 0.582, 246, 237, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1247, 4y69P, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1248, 4y69B, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1249, 4r02B, 0.8928, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1250, 4r00P, 0.8928, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1251, 4qw0P, 0.8928, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1252, 4qvvB, 0.8928, 2.06, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1253, 4eu2S, 0.8928, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1254, 3dy3R, 0.8928, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1255, 2gplP, 0.8928, 2.06, 0.306, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1256, 2gplB, 0.8928, 2.06, 0.306, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1257, 2fakP, 0.8928, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1258, 2fakB, 0.8928, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1259, 2f16B, 0.8928, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1260, 5l5iP, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1261, 5l5iB, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1262, 5cgfP, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1263, 5cgfB, 0.8927, 1.96, 0.336, 242, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1264, 4ya5P, 0.8927, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1265, 4ya5B, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1266, 4y8lP, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1267, 4y8lB, 0.8927, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1268, 4y8iP, 0.8927, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1269, 4y8iB, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1270, 4rurP, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1271, 4rurB, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1272, 4r00B, 0.8927, 2.05, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1273, 4qz2P, 0.8927, 2.05, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1274, 4qz2B, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1275, 4qz1P, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1276, 4qw3P, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1277, 4qw3B, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1278, 3dy3D, 0.8927, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1279, 3bdmR, 0.8927, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1280, 3bdmD, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1281, 2f16P, 0.8927, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1282, 5l68P, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1283, 5l68B, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1284, 5l5tP, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1285, 5l5tB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1286, 5l5jP, 0.8926, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1287, 5l5jB, 0.8926, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1288, 5l5eP, 0.8926, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1289, 5l5eB, 0.8926, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1290, 5l54P, 0.8926, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1291, 5l54B, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1292, 5fgaP, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1293, 5fgaB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1294, 5cz8P, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1295, 5cz8B, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1296, 5cgiP, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1297, 5cgiB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1298, 4ya3P, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1299, 4ya3B, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1300, 4y8nP, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1301, 4y8nB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1302, 4y6vP, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1303, 4y6vB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1304, 4qzxP, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1305, 4qz1B, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1306, 4qz0P, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1307, 4qz0B, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1308, 4qxjP, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1309, 4qxjB, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1310, 4qw6P, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1311, 4qvyP, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1312, 4qvyB, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1313, 4qvlP, 0.8926, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
1314, 4qvlB, 0.8926, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
1315, 4intB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1316, 4inrB, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1317, 3nzjP, 0.8926, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1318, 3nzjB, 0.8926, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1319, 3hyeP, 0.8926, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1320, 5lttP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1321, 5lttB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1322, 5l65P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1323, 5l65B, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1324, 5l60P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1325, 5l60B, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1326, 5l5xP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1327, 5l5xB, 0.8925, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1328, 5l5sB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1329, 5l5oP, 0.8925, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1330, 5l5fP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1331, 5l5fB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1332, 5l52P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1333, 5l52B, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1334, 5fg9P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1335, 5fg9B, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1336, 5fg7P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1337, 5fg7B, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1338, 5cz4P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1339, 5cz4B, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1340, 5bouP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1341, 5bouB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1342, 5a0qQ, 0.8925, 2.06, 0.306, 244, 232, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1343, 5a0qC, 0.8925, 2.06, 0.306, 244, 232, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1344, 4ya1P, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1345, 4y9yP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1346, 4y9yB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1347, 4y8pP, 0.8925, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1348, 4y8kP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1349, 4y8kB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1350, 4y8jP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1351, 4y8jB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1352, 4y7yP, 0.8925, 1.92, 0.328, 237, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1353, 4y7yB, 0.8925, 1.92, 0.328, 237, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1354, 4y6aP, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1355, 4y6aB, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1356, 4r18P, 0.8925, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1357, 4r18B, 0.8925, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1358, 4qzxB, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1359, 4qz5P, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1360, 4qz5B, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1361, 4qwrP, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1362, 4qwrB, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1363, 4qwiP, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1364, 4qwiB, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1365, 4qw7P, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1366, 4qw6B, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1367, 4qv7P, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT
1368, 4qv7B, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT
1369, 4qv3P, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT
1370, 4quxP, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT
1371, 4quxB, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT
1372, 4hrcB, 0.8925, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1373, 4hnpB, 0.8925, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1374, 3nzwP, 0.8925, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1375, 3mg0P, 0.8925, 2.07, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1376, 3hyeB, 0.8925, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1377, 3e47P, 0.8925, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1378, 1g65B, 0.8925, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1379, 5laiP, 0.8924, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1380, 5laiB, 0.8924, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1381, 5l6bP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1382, 5l6bB, 0.8924, 1.93, 0.307, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1383, 5l67P, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1384, 5l67B, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1385, 5l66P, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1386, 5l5zP, 0.8924, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1387, 5l5zB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1388, 5l5yP, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1389, 5l5yB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1390, 5l5vP, 0.8924, 2.06, 0.306, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1391, 5l5vB, 0.8924, 2.06, 0.306, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1392, 5l5sP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1393, 5l5oB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1394, 5jhsP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1395, 5jhsB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1396, 5d0zP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1397, 5d0zB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1398, 5cz6P, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1399, 5cz6B, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1400, 4ya1B, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1401, 4y9zP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1402, 4y8qP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1403, 4y8qB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1404, 4y8pB, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1405, 4y8oP, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1406, 4y8mP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1407, 4y8mB, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1408, 4y80P, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1409, 4y80B, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1410, 4y78P, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1411, 4y78B, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1412, 4y77P, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1413, 4r17P, 0.8924, 2.07, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1414, 4qz7P, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1415, 4qz7B, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1416, 4qz6P, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1417, 4qz6B, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1418, 4qz4P, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1419, 4qz4B, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1420, 4qwxP, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1421, 4qwxB, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1422, 4qwjP, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1423, 4qwfP, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1424, 4qwfB, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1425, 4qw7B, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1426, 4qw4P, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
1427, 4qw4B, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
1428, 4qv8P, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT
1429, 4qv8B, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT
1430, 4qv3B, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-M45V MUTANT
1431, 4qv0P, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1432, 4qv0B, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1433, 4qltP, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1434, 4qltB, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1435, 4qlsP, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1436, 4qlsB, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1437, 4ltcB, 0.8924, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1438, 4inrP, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1439, 3nzwB, 0.8924, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1440, 3gpjR, 0.8924, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1441, 3gpjD, 0.8924, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1442, 3e47B, 0.8924, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1443, 5l6cP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1444, 5l6cB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1445, 5l69B, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1446, 5l66B, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1447, 5l62P, 0.8923, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1448, 5l62B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1449, 5l61P, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1450, 5l61B, 0.8923, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1451, 5l5qP, 0.8923, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1452, 5l5qB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1453, 5l5pP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1454, 5l5pB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1455, 5fhsP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1456, 5fhsB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1457, 5fgfP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1458, 5fgfB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1459, 5fgdP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1460, 5fgdB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1461, 5d0vP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1462, 5d0vB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1463, 5czaP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1464, 5czaB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1465, 5cz5P, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1466, 5cz5B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1467, 5bxnP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1468, 5bxnB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1469, 5bxlP, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1470, 5bxlB, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1471, 4ya9P, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1472, 4ya9B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1473, 4y9zB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1474, 4y8oB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1475, 4y8hP, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1476, 4y84P, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1477, 4y84B, 0.8923, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1478, 4y82P, 0.8923, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1479, 4y82B, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1480, 4y81P, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1481, 4y81B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1482, 4y7xP, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1483, 4y7xB, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1484, 4y7wP, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1485, 4y7wB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1486, 4y77B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1487, 4y70P, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1488, 4y70B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1489, 4qzwP, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1490, 4qzwB, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1491, 4qz3P, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1492, 4qz3B, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1493, 4qwlP, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1494, 4qwlB, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1495, 4qwkP, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1496, 4qwkB, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1497, 4qwjB, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1498, 4qw5P, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1499, 4qw5B, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1500, 4qv4P, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-M45T MUTANT
1501, 4quyP, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49S-MUTANT
1502, 4quyB, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49S-MUTANT
1503, 4jsuP, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1504, 4jsuB, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1505, 4gk7P, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1506, 4gk7B, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1507, 3okjP, 0.8923, 2.07, 0.306, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1508, 3okjB, 0.8923, 2.07, 0.306, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1509, 3mg0B, 0.8923, 2.07, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1510, 3dy4R, 0.8923, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1511, 1g65P, 0.8923, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1512, 1fntS, 0.8923, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1513, 1fntE, 0.8923, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1514, 5l69P, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1515, 5l64P, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1516, 5l64B, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1517, 5l63P, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1518, 5l63B, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1519, 5l5hP, 0.8922, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1520, 5l5hB, 0.8922, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1521, 5jhrP, 0.8922, 2.21, 0.309, 244, 233, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1522, 5jhrB, 0.8922, 1.90, 0.333, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1523, 5fgiP, 0.8922, 1.90, 0.333, 244, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1524, 5fgiB, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1525, 5d0sP, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1526, 5d0sB, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1527, 5cz9P, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1528, 5cz9B, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1529, 4ya7P, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1530, 4ya7B, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1531, 4y8rP, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1532, 4y8rB, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1533, 4y8hB, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1534, 4y8gP, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1535, 4r17B, 0.8922, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1536, 4qzzP, 0.8922, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH OMURALIDE
1537, 4qzzB, 0.8922, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH OMURALIDE
1538, 4qv4B, 0.8922, 2.07, 0.306, 244, 232, YCP BETA5-M45T MUTANT
1539, 4nnwP, 0.8922, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1540, 4nnwB, 0.8922, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1541, 3dy4D, 0.8922, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1542, 5m2bP, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1543, 5m2bB, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1544, 5l5uP, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1545, 5l5uB, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1546, 5l5dP, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1547, 5l5dB, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1548, 5l5aP, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1549, 5l5aB, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1550, 5l55P, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1551, 5l55B, 0.8921, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1552, 5fgeP, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1553, 5fgeB, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1554, 5d0wP, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1555, 5d0wB, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1556, 4ya4P, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1557, 4ya4B, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1558, 4y8gB, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1559, 4y75P, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1560, 4y75B, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1561, 4y74P, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1562, 4y74B, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1563, 4y6zP, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1564, 4y6zB, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1565, 4qv9P, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT
1566, 4qv5P, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT
1567, 4qv5B, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT
1568, 4qv1P, 0.8921, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT
1569, 4qv1B, 0.8921, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT
1570, 4jsqP, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1571, 4jsqB, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1572, 3gpwP, 0.8921, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1573, 3gpwB, 0.8921, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1574, 5l5wP, 0.8920, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1575, 5l5wB, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1576, 4y8sP, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1577, 4y8sB, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1578, 4qwsP, 0.8920, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1579, 4qwsB, 0.8920, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1580, 4qv9B, 0.8920, 2.07, 0.306, 244, 232, YCP BETA5-C63F MUTANT
1581, 4lqiP, 0.8920, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1582, 4lqiB, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1583, 4inuB, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1584, 3tddP, 0.8920, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1585, 3tddB, 0.8920, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1586, 6gopP, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1587, 5t0hI, 0.8919, 2.06, 0.306, 244, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1588, 5l6aP, 0.8919, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1589, 5l6aB, 0.8919, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1590, 5fggP, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1591, 5fggB, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1592, 5cggP, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1593, 5cggB, 0.8919, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1594, 4nnnP, 0.8919, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH MG132
1595, 4nnnB, 0.8919, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH MG132
1596, 4inuP, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1597, 3un4P, 0.8919, 2.20, 0.322, 250, 236, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1598, 3un4B, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1599, 3nzjR, 0.8919, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1600, 6gopB, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1601, 5cghP, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1602, 5cghB, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1603, 5ahjP, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1604, 5ahjB, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1605, 4qlqP, 0.8918, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1606, 4qlqB, 0.8918, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1607, 4jt0P, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1608, 4jt0B, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1609, 4fzcB, 0.8918, 1.96, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1610, 3nzjD, 0.8918, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1611, 3gptP, 0.8918, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1612, 3gptB, 0.8918, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1613, 5m32O, 0.8917, 2.06, 0.306, 244, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1614, 5m32A, 0.8917, 2.06, 0.306, 244, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1615, 4qwgP, 0.8917, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1616, 4qwgB, 0.8917, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1617, 4qluP, 0.8917, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1618, 4qluB, 0.8917, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1619, 4fzcP, 0.8917, 2.08, 0.306, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1620, 5l5bP, 0.8916, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1621, 5l5bB, 0.8916, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1622, 4ya2P, 0.8916, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1623, 4ya2B, 0.8916, 1.48, 0.392, 230, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1624, 4y8tP, 0.8916, 1.48, 0.392, 230, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1625, 4y8tB, 0.8916, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1626, 4jt0R, 0.8916, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1627, 4hnpR, 0.8916, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1628, 3un8R, 0.8916, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1629, 3mg0R, 0.8916, 2.08, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1630, 5l5rP, 0.8915, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1631, 4qv6P, 0.8915, 2.06, 0.306, 244, 232, YCP BETA5-A49V MUTANT
1632, 4qv6B, 0.8915, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT
1633, 4q1sP, 0.8915, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1634, 4jt0D, 0.8915, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1635, 4hrcP, 0.8915, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1636, 3un4R, 0.8915, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1637, 3un4D, 0.8915, 1.99, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1638, 3tddD, 0.8915, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1639, 3nzxP, 0.8915, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1640, 3nzxB, 0.8915, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1641, 5l5rB, 0.8914, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1642, 4inrR, 0.8914, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1643, 4inrD, 0.8914, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1644, 4fzcR, 0.8914, 1.96, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1645, 4fzcD, 0.8914, 1.95, 0.307, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1646, 3tddR, 0.8914, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1647, 4q1sR, 0.8913, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1648, 4no6P, 0.8913, 1.95, 0.341, 242, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1649, 4no6B, 0.8913, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1650, 4no1P, 0.8913, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1651, 4no1B, 0.8913, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1652, 4inuD, 0.8913, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1653, 4intD, 0.8913, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1654, 4hrdP, 0.8913, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1655, 4hnpP, 0.8913, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1656, 4fzgP, 0.8913, 1.96, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1657, 4fzgB, 0.8913, 1.98, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1658, 3mg4P, 0.8913, 2.09, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1659, 2gplR, 0.8913, 2.08, 0.306, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1660, 2gplD, 0.8913, 2.08, 0.306, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1661, 2fakR, 0.8913, 2.08, 0.306, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1662, 2fakD, 0.8913, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1663, 5nifS, 0.8912, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1664, 4qlvP, 0.8912, 1.95, 0.307, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1665, 4qlvB, 0.8912, 1.95, 0.307, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1666, 3un8P, 0.8912, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1667, 3shjR, 0.8912, 2.08, 0.306, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1668, 3shjD, 0.8912, 2.10, 0.306, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1669, 3nzwR, 0.8912, 1.95, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1670, 4zzgS, 0.8911, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1671, 4jsuR, 0.8911, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1672, 4j70P, 0.8911, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1673, 4j70B, 0.8911, 2.00, 0.341, 236, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1674, 4inuR, 0.8911, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1675, 4intR, 0.8911, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1676, 3un8B, 0.8911, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1677, 3shjP, 0.8911, 1.96, 0.341, 242, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1678, 3shjB, 0.8911, 1.96, 0.341, 242, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1679, 3nzwD, 0.8911, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1680, 5nifQ, 0.8910, 2.00, 0.341, 236, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1681, 4ltcR, 0.8910, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1682, 4jsuD, 0.8910, 2.09, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1683, 3hyeR, 0.8910, 2.08, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1684, 3hyeD, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1685, 3gpwR, 0.8910, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1686, 3gpwD, 0.8910, 2.08, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1687, 3gptR, 0.8910, 2.08, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1688, 2f16R, 0.8910, 2.08, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1689, 2f16D, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1690, 4q1sB, 0.8909, 2.10, 0.306, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1691, 4no9P, 0.8909, 1.98, 0.341, 242, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1692, 4no9B, 0.8909, 1.97, 0.341, 242, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1693, 4jsqR, 0.8909, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1694, 4jsqD, 0.8909, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1695, 3gptD, 0.8909, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1696, 5vfuGA, 0.8908, 1.96, 0.341, 242, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1697, 5vfth, 0.8908, 1.96, 0.341, 242, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1698, 4x6zC, 0.8908, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1699, 4j70R, 0.8908, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1700, 3nzxR, 0.8908, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1701, 3nzxD, 0.8908, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1702, 3d29P, 0.8908, 2.10, 0.306, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1703, 3d29B, 0.8908, 1.97, 0.341, 242, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1704, 1rypQ, 0.8908, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1705, 4no8P, 0.8907, 1.97, 0.341, 242, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1706, 4no8B, 0.8907, 1.59, 0.382, 232, 228, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1707, 3un8D, 0.8907, 1.59, 0.382, 232, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1708, 3e47R, 0.8907, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1709, 3e47D, 0.8907, 1.98, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1710, 4hnpD, 0.8906, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1711, 4fzgR, 0.8906, 1.97, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1712, 4fzgD, 0.8906, 2.09, 0.306, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1713, 4eu2Q, 0.8906, 2.09, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1714, 1rypS, 0.8906, 2.09, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1715, 4qbyP, 0.8905, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1716, 4qbyB, 0.8905, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1717, 3okjR, 0.8905, 1.98, 0.341, 242, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1718, 3okjD, 0.8905, 1.97, 0.341, 242, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1719, 3mg8R, 0.8905, 1.97, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1720, 3mg7R, 0.8905, 2.00, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1721, 3mg6R, 0.8905, 1.97, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1722, 3mg4B, 0.8905, 1.97, 0.341, 242, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1723, 3mg0D, 0.8905, 1.97, 0.307, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1724, 4lqiR, 0.8904, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1725, 5t0gH, 0.8903, 2.08, 0.306, 244, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1726, 4lqiD, 0.8903, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1727, 4j70D, 0.8903, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1728, 4eu2C, 0.8903, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1729, 3wxrS, 0.8903, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1730, 1rypE, 0.8903, 2.02, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1731, 3mg4R, 0.8902, 2.01, 0.341, 242, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1732, 3dy3B, 0.8902, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1733, 1rypC, 0.8902, 1.98, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1734, 3dy3P, 0.8901, 1.98, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1735, 5nifE, 0.8900, 1.60, 0.377, 233, 228, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1736, 3bdmP, 0.8900, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1737, 3bdmB, 0.8900, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1738, 4zzgQ, 0.8899, 2.11, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1739, 4hrdR, 0.8899, 2.01, 0.341, 238, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1740, 4hrcR, 0.8899, 1.99, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1741, 5l64R, 0.8898, 2.01, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1742, 5l61R, 0.8898, 2.09, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1743, 5l5wR, 0.8898, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1744, 4eu2E, 0.8898, 2.09, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1745, 3oeuR, 0.8898, 1.85, 0.343, 236, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1746, 2zcyB, 0.8898, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1747, 5l64D, 0.8897, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1748, 5l63R, 0.8897, 1.98, 0.307, 242, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1749, 5l62R, 0.8897, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1750, 5l61D, 0.8897, 2.02, 0.336, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1751, 5l5wD, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1752, 5cz6R, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1753, 4r17R, 0.8897, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1754, 3wxrC, 0.8897, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1755, 3mg4D, 0.8897, 2.07, 0.341, 236, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1756, 3gpjP, 0.8897, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1757, 3gpjB, 0.8897, 1.83, 0.343, 235, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1758, 3dy4P, 0.8897, 1.83, 0.343, 235, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1759, 3dy4B, 0.8897, 1.83, 0.343, 235, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1760, 2zcyP, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1761, 5lttR, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1762, 5lttD, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1763, 5laiR, 0.8896, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1764, 5l63D, 0.8896, 2.11, 0.306, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1765, 5l62D, 0.8896, 2.05, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1766, 5l5yR, 0.8896, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1767, 5l5yD, 0.8896, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1768, 5l5rR, 0.8896, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1769, 5l5pR, 0.8896, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1770, 5l5pD, 0.8896, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1771, 5cz6D, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1772, 4zzgC, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1773, 4ya1R, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1774, 4y8mR, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1775, 4r17D, 0.8896, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1776, 4gk7R, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1777, 5nifC, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1778, 5mp9b, 0.8895, 1.83, 0.343, 235, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1779, 5m2bR, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1780, 5laiD, 0.8895, 1.84, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1781, 5l60R, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1782, 5l5zR, 0.8895, 2.11, 0.306, 241, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1783, 5l5zD, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1784, 5l5xR, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1785, 5l5xD, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1786, 5l5vR, 0.8895, 1.98, 0.341, 242, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1787, 5l5vD, 0.8895, 2.12, 0.306, 241, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1788, 5l5tR, 0.8895, 1.69, 0.362, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1789, 5l5tD, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1790, 5l5rD, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1791, 5l5qR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1792, 5l5oR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1793, 5l5hR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1794, 5l5hD, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1795, 5l5bR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1796, 5l5aR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1797, 5fg9R, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1798, 5fg9D, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1799, 5fg7R, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1800, 5bouR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1801, 4zzgE, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1802, 4ya1D, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1803, 4y8mD, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1804, 4y6vR, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1805, 4y6vD, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1806, 4r02R, 0.8895, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1807, 4quxR, 0.8895, 1.83, 0.343, 235, 230, YCP BETA5-A49T-MUTANT
1808, 4gk7D, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1809, 5m2bD, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1810, 5l6cR, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1811, 5l6cD, 0.8894, 1.86, 0.343, 236, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1812, 5l6aR, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1813, 5l6aD, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1814, 5l66R, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1815, 5l66D, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1816, 5l60D, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1817, 5l5uR, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1818, 5l5uD, 0.8894, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1819, 5l5sR, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1820, 5l5sD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1821, 5l5qD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1822, 5l5oD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1823, 5l5fR, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1824, 5l5fD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1825, 5l5bD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1826, 5l5aD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1827, 5fg7D, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1828, 5d0wR, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1829, 5d0wD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1830, 5bouD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1831, 4y9yR, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1832, 4y9yD, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1833, 4rurR, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1834, 4qvyR, 0.8894, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1835, 4qvyD, 0.8894, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1836, 4quxD, 0.8894, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT
1837, 4no9R, 0.8894, 1.83, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1838, 4no9D, 0.8894, 1.83, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1839, 3oevR, 0.8894, 1.84, 0.343, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1840, 3mg7D, 0.8894, 1.83, 0.343, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1841, 5l67R, 0.8893, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1842, 5l67D, 0.8893, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1843, 5l5jR, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1844, 5l5jD, 0.8893, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1845, 5l5dR, 0.8893, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1846, 5l5dD, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1847, 5czaR, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1848, 5czaD, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1849, 5cz7R, 0.8893, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1850, 5cz7D, 0.8893, 2.03, 0.341, 242, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1851, 5bxlR, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1852, 5bxlD, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1853, 4ya5R, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1854, 4y8sR, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1855, 4y8sD, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1856, 4y8nR, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1857, 4y8nD, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1858, 4y75R, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1859, 4y75D, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1860, 4y74R, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1861, 4y6aR, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1862, 4rurD, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1863, 4qv0R, 0.8893, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1864, 4no1R, 0.8893, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1865, 4no1D, 0.8893, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1866, 4ltcD, 0.8893, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1867, 5l6bR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1868, 5l6bD, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1869, 5l69R, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1870, 5l68R, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1871, 5l5iR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1872, 5l5iD, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1873, 5fgaR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1874, 5fgaD, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1875, 4ya5D, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1876, 4ya4R, 0.8892, 2.00, 0.341, 242, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1877, 4ya4D, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1878, 4y8uR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1879, 4y8tR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1880, 4y8tD, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1881, 4y8rR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1882, 4y8pR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1883, 4y8pD, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1884, 4y7wR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1885, 4y77R, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1886, 4y77D, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1887, 4y74D, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1888, 4y70R, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1889, 4y6zR, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1890, 4y6aD, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1891, 4y69R, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1892, 4y69D, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1893, 4qvvR, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1894, 4qvlR, 0.8892, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH BORTEZOMIB
1895, 4qvlD, 0.8892, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH BORTEZOMIB
1896, 4qv5R, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45I MUTANT
1897, 4qv4R, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45T MUTANT
1898, 4qv4D, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45T MUTANT
1899, 4qv1R, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45A MUTANT
1900, 4qv0D, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1901, 1g65D, 0.8892, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1902, 5l69D, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1903, 5l68D, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1904, 5l5eR, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1905, 5cz4R, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1906, 5cz4D, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1907, 5cgfR, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1908, 5cgfD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1909, 5bxnR, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1910, 5bxnD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1911, 4ya7R, 0.8891, 2.00, 0.336, 242, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1912, 4ya7D, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1913, 4y9zR, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1914, 4y9zD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1915, 4y8uD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1916, 4y8rD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1917, 4y82R, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1918, 4y82D, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1919, 4y80R, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1920, 4y7wD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1921, 4y70D, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1922, 4y6zD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1923, 4r00R, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1924, 4r00D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1925, 4qwjR, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1926, 4qw0R, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1927, 4qw0D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1928, 4qvwR, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1929, 4qvwD, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1930, 4qvvD, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1931, 4qv8R, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT
1932, 4qv8D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT
1933, 4qv7R, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT
1934, 4qv7D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT
1935, 4qv5D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45I MUTANT
1936, 4qv3R, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45V MUTANT
1937, 4qv3D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45V MUTANT
1938, 4qv1D, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45A MUTANT
1939, 4quyR, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT
1940, 4q1sD, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1941, 4nnnR, 0.8891, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH MG132
1942, 4nnnD, 0.8891, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH MG132
1943, 4hrdD, 0.8891, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1944, 1jd2W, 0.8891, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1945, 1jd2B, 0.8891, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1946, 1j2pF, 0.8891, 1.84, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1947, 5l65R, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1948, 5l65D, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1949, 5l5eD, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1950, 4z1lR, 0.8890, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1951, 4z1lD, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1952, 4ya9R, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1953, 4ya3R, 0.8890, 2.03, 0.341, 242, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1954, 4ya3D, 0.8890, 2.11, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1955, 4y8oR, 0.8890, 2.11, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1956, 4y8oD, 0.8890, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1957, 4y8kR, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1958, 4y8kD, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1959, 4y8jR, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1960, 4y80D, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1961, 4qz5R, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1962, 4qz5D, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1963, 4qz3R, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1964, 4qz3D, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1965, 4qwrR, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1966, 4qwrD, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1967, 4qwkR, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1968, 4qwjD, 0.8890, 1.85, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1969, 4qwiR, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1970, 4qwiD, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1971, 4quyD, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT
1972, 4qlqR, 0.8890, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1973, 3wxrQ, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1974, 5jhrR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1975, 5jhrD, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1976, 5fghR, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1977, 5fghD, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1978, 5dkjR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1979, 5dkjD, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1980, 5d0xR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1981, 5d0xD, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1982, 5cghR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1983, 5cghD, 0.8889, 2.15, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1984, 4ya9D, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1985, 4y8qR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1986, 4y8qD, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1987, 4y8lR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1988, 4y8jD, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1989, 4y81R, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1990, 4y81D, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1991, 4y7xR, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1992, 4y7xD, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1993, 4x6zS, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1994, 4x6zQ, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1995, 4qzzR, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH OMURALIDE
1996, 4qzzD, 0.8889, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH OMURALIDE
1997, 4qwkD, 0.8889, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1998, 4qw1R, 0.8889, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1999, 4qvnR, 0.8889, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2000, 4qvnD, 0.8889, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2001, 4qlsR, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2002, 4qlsD, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2003, 4qlqD, 0.8889, 2.07, 0.336, 242, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2004, 4nnwR, 0.8889, 2.11, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2005, 4nnwD, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2006, 4hrcD, 0.8889, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2007, 3mg6D, 0.8889, 1.85, 0.343, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2008, 1j2pG, 0.8889, 1.84, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2009, 1j2pE, 0.8889, 1.85, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2010, 1j2pC, 0.8889, 1.85, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2011, 1j2pA, 0.8889, 1.84, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2012, 1g65R, 0.8889, 1.84, 0.343, 235, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2013, 5mpab, 0.8888, 1.84, 0.343, 235, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2014, 5fgeR, 0.8888, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2015, 5d0tR, 0.8888, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2016, 5d0tD, 0.8888, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2017, 5cggR, 0.8888, 2.03, 0.341, 242, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2018, 5cggD, 0.8888, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2019, 4ya0R, 0.8888, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2020, 4ya0D, 0.8888, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2021, 4y8lD, 0.8888, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2022, 4y8iR, 0.8888, 2.00, 0.336, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2023, 4y7yR, 0.8888, 1.69, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2024, 4y7yD, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2025, 4qz6D, 0.8888, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2026, 4qz4R, 0.8888, 1.84, 0.343, 235, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2027, 4qz4D, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2028, 4qwxR, 0.8888, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2029, 4qwxD, 0.8888, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2030, 4qwgR, 0.8888, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2031, 4qw1D, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2032, 4qvmR, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2033, 4qvmD, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2034, 4no6R, 0.8888, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2035, 1j2pD, 0.8888, 1.85, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2036, 1j2pB, 0.8888, 1.85, 0.343, 235, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2037, 5l55R, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2038, 5fgeD, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2039, 5d0zR, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2040, 5d0zD, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2041, 5cz9R, 0.8887, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2042, 5cz9D, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2043, 4y8iD, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2044, 4y8gR, 0.8887, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2045, 4y8gD, 0.8887, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2046, 4y78R, 0.8887, 1.92, 0.430, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2047, 4y78D, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2048, 4qzwR, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2049, 4qzwD, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2050, 4qz7R, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2051, 4qz7D, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2052, 4qz6R, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2053, 4qwlR, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2054, 4qwlD, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2055, 4qwgD, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2056, 4qvqR, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2057, 4qvqD, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2058, 4qvpR, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2059, 4qvpD, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2060, 4qv9R, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT
2061, 4qv9D, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT
2062, 4no6D, 0.8887, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2063, 5l55D, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2064, 5jhsR, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2065, 5jhsD, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2066, 5fgiR, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2067, 5fgiD, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2068, 5fggR, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2069, 5fggD, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2070, 5fgfR, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2071, 5fgfD, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2072, 5fgdR, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2073, 5fgdD, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2074, 4y8hR, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2075, 4y84R, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2076, 4y84D, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2077, 4x6zE, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2078, 4qw6R, 0.8886, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2079, 4qw4R, 0.8886, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH CARFILZOMIB
2080, 4no8R, 0.8886, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2081, 5l52R, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2082, 5l52D, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2083, 5fhsR, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2084, 5fhsD, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2085, 5dkiR, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2086, 5d0sR, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2087, 5d0sD, 0.8885, 2.04, 0.341, 242, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2088, 5cz5R, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2089, 5cgiR, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2090, 5cgiD, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2091, 5ahjR, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2092, 5ahjD, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2093, 4y8hD, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2094, 4qwfR, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2095, 4qwfD, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2096, 4qw6D, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2097, 4qw5R, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2098, 4qw5D, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2099, 4qw4D, 0.8885, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH CARFILZOMIB
2100, 4no8D, 0.8885, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2101, 5dkiD, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2102, 5d0vR, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2103, 5d0vD, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2104, 5cz5D, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2105, 4r18R, 0.8884, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2106, 4r18D, 0.8884, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2107, 4qxjR, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2108, 4qxjD, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2109, 4qwsR, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2110, 4qwsD, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2111, 4qw7R, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2112, 4qw7D, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2113, 4qv6R, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT
2114, 4qv6D, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT
2115, 3oeuD, 0.8884, 1.85, 0.343, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2116, 6gopR, 0.8883, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2117, 5lajR, 0.8883, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2118, 5lajD, 0.8883, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2119, 4ya2R, 0.8883, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2120, 4ya2D, 0.8883, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2121, 4qzxR, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2122, 4qzxD, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2123, 4qwuR, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2124, 4qwuD, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2125, 4qw3R, 0.8883, 2.03, 0.341, 242, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2126, 4qw3D, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2127, 4qluR, 0.8883, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2128, 4qluD, 0.8883, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2129, 3oevD, 0.8883, 1.85, 0.343, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2130, 6gopD, 0.8882, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2131, 4qz1R, 0.8882, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2132, 4qz1D, 0.8882, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2133, 4qz0R, 0.8882, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2134, 4qz0D, 0.8882, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2135, 4qz2R, 0.8881, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2136, 4qz2D, 0.8881, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2137, 3mg8D, 0.8881, 1.85, 0.343, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2138, 5cz8R, 0.8880, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2139, 5cz8D, 0.8880, 2.03, 0.341, 242, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2140, 4qlvR, 0.8880, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2141, 4qlvD, 0.8880, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2142, 5mpaC, 0.8878, 1.86, 0.343, 235, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2143, 5l54R, 0.8877, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2144, 5l54D, 0.8876, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2145, 4qltR, 0.8875, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2146, 4qltD, 0.8875, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2147, 4qbyR, 0.8873, 2.04, 0.341, 242, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2148, 4qbyD, 0.8873, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2149, 4r3oO, 0.8870, 1.86, 0.343, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2150, 3jcoKA, 0.8870, 1.86, 0.343, 235, 230, 
2151, 3jcoK, 0.8870, 1.86, 0.343, 235, 230, 
2152, 5mpaB, 0.8868, 2.19, 0.306, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2153, 4r3oA, 0.8868, 1.86, 0.343, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2154, 4r02D, 0.8868, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2155, 5ln3C, 0.8867, 1.86, 0.343, 235, 230, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2156, 1iruO, 0.8866, 1.86, 0.343, 235, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2157, 1iruA, 0.8866, 1.87, 0.343, 235, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2158, 1jd2D, 0.8865, 1.87, 0.343, 235, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2159, 5mp9e, 0.8864, 1.87, 0.296, 244, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2160, 1jd2Y, 0.8864, 1.72, 0.358, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2161, 5wvkW, 0.8861, 1.72, 0.358, 250, 229, 
2162, 3uneG, 0.8861, 1.72, 0.358, 250, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2163, 3uneU, 0.8860, 1.72, 0.362, 250, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2164, 4r67q, 0.8859, 1.88, 0.287, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2165, 4r67O, 0.8859, 1.87, 0.343, 235, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2166, 4r67c, 0.8859, 2.28, 0.322, 261, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2167, 4r67A, 0.8859, 1.89, 0.291, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2168, 4cr2B, 0.8858, 1.89, 0.291, 244, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2169, 3jcpNA, 0.8857, 2.05, 0.336, 242, 232, 
2170, 3jcpN, 0.8857, 2.08, 0.341, 242, 232, 
2171, 5gjqh, 0.8856, 2.05, 0.336, 242, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2172, 3wxrE, 0.8856, 1.71, 0.367, 250, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2173, 5mp9c, 0.8855, 1.88, 0.291, 244, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2174, 5gjrGA, 0.8854, 1.88, 0.291, 244, 230, 
2175, 3jcpLA, 0.8854, 1.89, 0.296, 244, 230, 
2176, 3jcpL, 0.8854, 1.89, 0.296, 244, 230, 
2177, 4g4sC, 0.8851, 1.89, 0.296, 244, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2178, 5gjrS, 0.8850, 1.89, 0.296, 244, 230, 
2179, 5mpaE, 0.8846, 1.76, 0.362, 250, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2180, 5gjqB, 0.8846, 2.04, 0.341, 242, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2181, 5mp9C, 0.8843, 2.04, 0.341, 242, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2182, 5l4gG, 0.8843, 2.04, 0.341, 242, 232, 
2183, 5mp9E, 0.8842, 1.87, 0.296, 244, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2184, 3mg7U, 0.8842, 2.08, 0.341, 239, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2185, 5t0jI, 0.8841, 2.17, 0.306, 244, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2186, 5l4gU, 0.8840, 1.89, 0.300, 244, 230, 
2187, 6epfB, 0.8838, 2.14, 0.306, 244, 232, GROUND STATE 26S PROTEASOME (GS1)
2188, 5mpac, 0.8837, 2.14, 0.306, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2189, 1rypO, 0.8836, 2.14, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2190, 3unei, 0.8835, 2.04, 0.309, 237, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2191, 3sdkU, 0.8835, 1.89, 0.300, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2192, 3unbU, 0.8832, 1.98, 0.346, 242, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2193, 5l4gO, 0.8831, 1.90, 0.300, 244, 230, 
2194, 3unbG, 0.8830, 2.16, 0.306, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2195, 5t0iH, 0.8829, 2.16, 0.284, 242, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2196, 3unbi, 0.8829, 2.12, 0.341, 242, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2197, 3mg6U, 0.8829, 2.04, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2198, 3mg7P, 0.8828, 2.10, 0.329, 250, 234, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2199, 5mpae, 0.8827, 2.16, 0.284, 241, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2200, 3unew, 0.8827, 1.66, 0.390, 234, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2201, 3sdiU, 0.8826, 2.19, 0.310, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2202, 3oevU, 0.8826, 2.05, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2203, 3oeuP, 0.8826, 1.93, 0.291, 244, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2204, 3oeuB, 0.8825, 2.05, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2205, 1g0uU, 0.8825, 1.87, 0.306, 243, 229, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2206, 5gjqn, 0.8824, 1.89, 0.300, 244, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2207, 3unbw, 0.8824, 1.87, 0.306, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2208, 3un8U, 0.8824, 1.71, 0.377, 233, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2209, 3mg8U, 0.8824, 1.87, 0.306, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2210, 3mg8B, 0.8824, 2.06, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2211, 3mg6P, 0.8824, 1.84, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2212, 1z7qQ, 0.8824, 1.98, 0.339, 242, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2213, 1z7qC, 0.8824, 1.91, 0.296, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2214, 5t0iI, 0.8823, 2.08, 0.263, 240, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2215, 3sdkP, 0.8823, 2.06, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2216, 3mg0U, 0.8823, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2217, 1g65U, 0.8823, 1.83, 0.313, 235, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2218, 3sdiP, 0.8822, 2.07, 0.263, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2219, 3mg8P, 0.8822, 2.20, 0.280, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2220, 1jd22, 0.8822, 1.88, 0.301, 243, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2221, 3oeuU, 0.8820, 2.07, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2222, 3mg6B, 0.8820, 2.07, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2223, 3sdkB, 0.8819, 1.83, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2224, 4hnpF, 0.8818, 1.85, 0.313, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2225, 3sdkR, 0.8818, 1.95, 0.310, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2226, 3sdiF, 0.8818, 1.96, 0.310, 243, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2227, 3sdiB, 0.8818, 2.19, 0.323, 250, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2228, 3mg7B, 0.8818, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2229, 3mg4U, 0.8818, 2.06, 0.259, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2230, 3bdmU, 0.8818, 2.05, 0.259, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2231, 1g0uP, 0.8818, 1.85, 0.313, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2232, 5l4gA, 0.8817, 1.84, 0.313, 235, 227, 
2233, 3bdmG, 0.8817, 2.08, 0.263, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2234, 1rypA, 0.8817, 2.07, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2235, 1g0uB, 0.8817, 1.84, 0.313, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2236, 5wvkZ, 0.8816, 1.84, 0.313, 235, 227, 
2237, 4q1sU, 0.8815, 2.23, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2238, 3wxrO, 0.8815, 1.86, 0.346, 232, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2239, 3gpjU, 0.8815, 2.21, 0.297, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2240, 1g0uG, 0.8815, 1.84, 0.313, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2241, 5wvkS, 0.8814, 1.83, 0.313, 235, 227, 
2242, 4zzgU, 0.8814, 2.09, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2243, 4g4sE, 0.8814, 2.07, 0.259, 243, 232, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2244, 3tddU, 0.8814, 1.84, 0.313, 235, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2245, 3gpjG, 0.8814, 1.92, 0.296, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2246, 3tddG, 0.8813, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2247, 3gptU, 0.8813, 2.07, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2248, 4hrdF, 0.8812, 1.84, 0.313, 235, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2249, 3oevP, 0.8812, 2.13, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2250, 3nzjU, 0.8812, 2.10, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2251, 4j70U, 0.8811, 2.09, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2252, 3oevB, 0.8811, 2.08, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2253, 3gpwU, 0.8811, 2.08, 0.263, 240, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2254, 3gptG, 0.8811, 2.00, 0.342, 242, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2255, 5m32B, 0.8810, 2.25, 0.297, 244, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2256, 5laiT, 0.8810, 2.02, 0.333, 249, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2257, 5laiF, 0.8810, 2.08, 0.259, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2258, 4r17T, 0.8810, 2.08, 0.259, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2259, 4r17F, 0.8810, 2.08, 0.259, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2260, 4jsuU, 0.8810, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2261, 4hnpU, 0.8810, 2.23, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2262, 3un4U, 0.8810, 1.70, 0.314, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2263, 3mg7G, 0.8810, 2.08, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2264, 3hyeU, 0.8810, 2.10, 0.263, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2265, 5mpbE, 0.8809, 1.85, 0.313, 235, 227, 
2266, 5mpbB, 0.8809, 2.08, 0.259, 243, 232, 
2267, 5gjrY, 0.8809, 2.08, 0.259, 243, 232, 
2268, 5gjrMA, 0.8809, 2.00, 0.325, 234, 228, 
2269, 4jsuG, 0.8809, 2.25, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2270, 3un4G, 0.8809, 2.25, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2271, 3nzjG, 0.8809, 2.25, 0.297, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2272, 3gpwG, 0.8809, 2.25, 0.297, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2273, 1g0uD, 0.8809, 2.08, 0.259, 243, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2274, 4rurT, 0.8808, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2275, 4rurF, 0.8808, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2276, 4jsqU, 0.8808, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2277, 3nzwU, 0.8808, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2278, 3mg6G, 0.8808, 2.17, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2279, 3jcoNA, 0.8808, 1.83, 0.367, 250, 229, 
2280, 3jcoN, 0.8808, 2.23, 0.280, 243, 232, 
2281, 3hyeG, 0.8808, 2.23, 0.280, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2282, 5wvkP, 0.8807, 2.08, 0.259, 243, 232, 
2283, 4zzgA, 0.8807, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2284, 4ya5T, 0.8807, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2285, 4ya5F, 0.8807, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2286, 4y8nT, 0.8807, 1.75, 0.339, 230, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2287, 4y8nF, 0.8807, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2288, 4x6zG, 0.8807, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2289, 4jt0U, 0.8807, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2290, 4jt0G, 0.8807, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2291, 4jsqG, 0.8807, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2292, 3un8G, 0.8807, 2.09, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2293, 3oevG, 0.8807, 2.09, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2294, 3nzxU, 0.8807, 2.09, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2295, 5nifA, 0.8806, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2296, 5gjqX, 0.8806, 1.78, 0.367, 250, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2297, 4r02F, 0.8806, 2.07, 0.264, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2298, 4q1sF, 0.8806, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2299, 3nzwG, 0.8806, 2.26, 0.297, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2300, 3jcoLA, 0.8806, 2.26, 0.297, 243, 232, 
2301, 3jcoL, 0.8806, 2.26, 0.297, 243, 232, 
2302, 1g0uR, 0.8806, 2.24, 0.297, 244, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2303, 5mp9g, 0.8805, 2.09, 0.259, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2304, 5l5eT, 0.8805, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2305, 5l5eF, 0.8805, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2306, 4y69F, 0.8805, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2307, 4qvwT, 0.8805, 2.08, 0.259, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2308, 4ltcU, 0.8805, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2309, 4intU, 0.8805, 2.07, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2310, 3sdkG, 0.8805, 2.23, 0.276, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2311, 3sdkD, 0.8805, 2.12, 0.299, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2312, 3nzxG, 0.8805, 2.25, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2313, 3d29U, 0.8805, 2.09, 0.259, 243, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2314, 2fakU, 0.8805, 2.20, 0.306, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2315, 5m2bT, 0.8804, 2.20, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2316, 5m2bF, 0.8804, 2.20, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2317, 5lajT, 0.8804, 1.75, 0.339, 230, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2318, 4zzgG, 0.8804, 2.23, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2319, 4y8uF, 0.8804, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2320, 4y69T, 0.8804, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2321, 4qvwF, 0.8804, 2.26, 0.297, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2322, 4eu2G, 0.8804, 2.26, 0.297, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2323, 3shjU, 0.8804, 2.11, 0.263, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2324, 3e47U, 0.8804, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2325, 3d29G, 0.8804, 2.09, 0.259, 243, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2326, 5nifU, 0.8803, 1.97, 0.341, 233, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2327, 5l64F, 0.8803, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2328, 5l63T, 0.8803, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2329, 5l63F, 0.8803, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2330, 5fg9T, 0.8803, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2331, 5fg9F, 0.8803, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2332, 4ya1T, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2333, 4ya1F, 0.8803, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2334, 4y9yT, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2335, 4y9yF, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2336, 4y8uT, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2337, 4qvmT, 0.8803, 2.11, 0.299, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2338, 4qvmF, 0.8803, 2.09, 0.259, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2339, 4inrU, 0.8803, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2340, 3un8F, 0.8803, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2341, 2fakG, 0.8803, 2.13, 0.299, 244, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2342, 1g65G, 0.8803, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2343, 5l64T, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2344, 5l5tF, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2345, 5l5dT, 0.8802, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2346, 5l5dF, 0.8802, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2347, 5cz4T, 0.8802, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2348, 5cz4F, 0.8802, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2349, 5bouT, 0.8802, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2350, 5bouF, 0.8802, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2351, 4qw0T, 0.8802, 2.26, 0.297, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2352, 4qw0F, 0.8802, 2.26, 0.297, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2353, 4hrcF, 0.8802, 2.26, 0.297, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2354, 3shjG, 0.8802, 2.09, 0.259, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2355, 3okjU, 0.8802, 2.26, 0.297, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2356, 3dy3U, 0.8802, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2357, 3d29T, 0.8802, 2.07, 0.259, 243, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2358, 3d29F, 0.8802, 2.13, 0.299, 243, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
2359, 2zcyU, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2360, 5lezT, 0.8801, 2.13, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2361, 5l6cF, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2362, 5l69T, 0.8801, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2363, 5l69F, 0.8801, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2364, 5l62T, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2365, 5l62F, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2366, 5l61T, 0.8801, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2367, 5l61F, 0.8801, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2368, 5l60T, 0.8801, 2.25, 0.297, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2369, 5l60F, 0.8801, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2370, 5l5yT, 0.8801, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2371, 5l5yF, 0.8801, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2372, 5l5wT, 0.8801, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2373, 5l5wF, 0.8801, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2374, 5l5tT, 0.8801, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2375, 5l5pT, 0.8801, 2.17, 0.277, 240, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2376, 5l5pF, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2377, 5l5oT, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2378, 5l5oF, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2379, 5l5jT, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2380, 5l5jF, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2381, 4r18T, 0.8801, 2.13, 0.299, 243, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2382, 4r18F, 0.8801, 2.13, 0.299, 243, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2383, 4j70G, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2384, 4hrdU, 0.8801, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2385, 3oeuG, 0.8801, 2.13, 0.299, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2386, 3e47G, 0.8801, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2387, 3dy4U, 0.8801, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2388, 3dy3G, 0.8801, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2389, 2zcyG, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2390, 2gplU, 0.8801, 2.13, 0.299, 243, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2391, 5l6cT, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2392, 5l68F, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2393, 5l66T, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2394, 5l66F, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2395, 5l65F, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2396, 5l5vT, 0.8800, 2.13, 0.299, 243, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2397, 5l5vF, 0.8800, 2.13, 0.299, 243, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2398, 5l5sF, 0.8800, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2399, 5l5qT, 0.8800, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2400, 5l5qF, 0.8800, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2401, 5l5iT, 0.8800, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2402, 5l5iF, 0.8800, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2403, 5l5hT, 0.8800, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2404, 5l5hF, 0.8800, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2405, 5fgaT, 0.8800, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2406, 5fgaF, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2407, 5fg7T, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2408, 5fg7F, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2409, 5d0xT, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2410, 5d0xF, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2411, 4ya3T, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2412, 4ya3F, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2413, 4ya0F, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2414, 4y8rF, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2415, 4y6vT, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2416, 4y6vF, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2417, 4qlvT, 0.8800, 2.13, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2418, 4qlvF, 0.8800, 2.13, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2419, 4lqiU, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2420, 3wxrA, 0.8800, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2421, 3gptF, 0.8800, 2.27, 0.297, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2422, 3dy4G, 0.8800, 2.27, 0.297, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2423, 5mp9G, 0.8799, 2.27, 0.297, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2424, 5l6aT, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2425, 5l6aF, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2426, 5l68T, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2427, 5l65T, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2428, 5l5zT, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2429, 5l5zF, 0.8799, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2430, 5l5sT, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2431, 5l5rT, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2432, 5l5rF, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2433, 5d0tT, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2434, 5d0tF, 0.8799, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2435, 4ya0T, 0.8799, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2436, 4y8rT, 0.8799, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2437, 4y6aT, 0.8799, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2438, 4y6aF, 0.8799, 2.22, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2439, 4qvyT, 0.8799, 2.14, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2440, 4qvyF, 0.8799, 2.14, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2441, 4inuU, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2442, 4hrcU, 0.8799, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2443, 4cr2C, 0.8799, 2.13, 0.299, 243, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2444, 3sdiT, 0.8799, 2.13, 0.299, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2445, 3okjG, 0.8799, 2.13, 0.299, 243, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2446, 3nzwT, 0.8799, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2447, 3nzwF, 0.8799, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2448, 3gptT, 0.8799, 2.26, 0.297, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2449, 2gplG, 0.8799, 2.26, 0.297, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2450, 5nifG, 0.8798, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2451, 5l6bF, 0.8798, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2452, 5l67T, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2453, 5l67F, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2454, 5l5xT, 0.8798, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2455, 5l5xF, 0.8798, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2456, 5l5fT, 0.8798, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2457, 5l5fF, 0.8798, 2.12, 0.263, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2458, 5l5aT, 0.8798, 2.19, 0.310, 245, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2459, 5l5aF, 0.8798, 2.11, 0.299, 242, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2460, 5l54T, 0.8798, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2461, 5l54F, 0.8798, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2462, 5dkiT, 0.8798, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2463, 5dkiF, 0.8798, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2464, 5cz6T, 0.8798, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2465, 5cz6F, 0.8798, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2466, 4y8mF, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2467, 4x6zU, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2468, 4quxF, 0.8798, 2.14, 0.299, 243, 231, YCP BETA5-A49T-MUTANT
2469, 4qltT, 0.8798, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2470, 4qltF, 0.8798, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2471, 4lqiG, 0.8798, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2472, 4fzgU, 0.8798, 2.13, 0.299, 243, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2473, 4fzgF, 0.8798, 2.14, 0.299, 243, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2474, 3hyeF, 0.8798, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2475, 5lf1T, 0.8797, 2.27, 0.297, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2476, 5lezF, 0.8797, 2.27, 0.297, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2477, 5l6bT, 0.8797, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2478, 5l5bF, 0.8797, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2479, 5cgfT, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2480, 5cgfF, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2481, 5bxnT, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2482, 5bxnF, 0.8797, 2.13, 0.299, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2483, 5bxlT, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2484, 5bxlF, 0.8797, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2485, 4y8mT, 0.8797, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2486, 4quxT, 0.8797, 2.10, 0.259, 243, 232, YCP BETA5-A49T-MUTANT
2487, 4intT, 0.8797, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2488, 4inrG, 0.8797, 2.25, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2489, 4fzcU, 0.8797, 2.28, 0.297, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2490, 3hyeT, 0.8797, 2.19, 0.277, 240, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2491, 2f16U, 0.8797, 2.18, 0.277, 239, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2492, 5lajF, 0.8796, 2.14, 0.299, 243, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2493, 5l5uT, 0.8796, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2494, 5l5uF, 0.8796, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2495, 5l5bT, 0.8796, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2496, 5dsvG, 0.8796, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2497, 5dsvE, 0.8796, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2498, 5dsvD, 0.8796, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2499, 4z1lF, 0.8796, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2500, 4qvlT, 0.8796, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH BORTEZOMIB
2501, 4qvlF, 0.8796, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH BORTEZOMIB
2502, 4intF, 0.8796, 2.29, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2503, 4inrT, 0.8796, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2504, 4inrF, 0.8796, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2505, 4fzgT, 0.8796, 2.28, 0.297, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2506, 4fzgG, 0.8796, 2.10, 0.259, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2507, 4cr2G, 0.8796, 2.14, 0.299, 243, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2508, 3tddT, 0.8796, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2509, 3tddF, 0.8796, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2510, 3mg4F, 0.8796, 2.15, 0.299, 243, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2511, 5lttT, 0.8795, 2.28, 0.280, 242, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2512, 5lttF, 0.8795, 2.27, 0.280, 245, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2513, 5fghT, 0.8795, 2.27, 0.280, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2514, 5fghF, 0.8795, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2515, 5cz7T, 0.8795, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2516, 5cz7F, 0.8795, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2517, 4z1lT, 0.8795, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2518, 4ya4T, 0.8795, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2519, 4ya4F, 0.8795, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2520, 4v7oIA, 0.8795, 2.28, 0.297, 244, 232, 
2521, 4qvvT, 0.8795, 2.12, 0.263, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2522, 4qvvF, 0.8795, 2.17, 0.293, 245, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2523, 4qvnT, 0.8795, 2.26, 0.297, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2524, 4qvnF, 0.8795, 2.26, 0.297, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2525, 4inuG, 0.8795, 2.12, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2526, 4fzcG, 0.8795, 2.14, 0.299, 243, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2527, 3nzjT, 0.8795, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2528, 3nzjF, 0.8795, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2529, 2f16G, 0.8795, 2.13, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2530, 5mpbS, 0.8794, 2.14, 0.299, 243, 231, 
2531, 5lexT, 0.8794, 2.14, 0.299, 243, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2532, 5lexF, 0.8794, 2.27, 0.297, 243, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2533, 5le5T, 0.8794, 2.15, 0.299, 243, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2534, 5dsvA, 0.8794, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2535, 5czaT, 0.8794, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2536, 5czaF, 0.8794, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2537, 5cghT, 0.8794, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2538, 5cghF, 0.8794, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2539, 4y8tF, 0.8794, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2540, 4y8gT, 0.8794, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2541, 4y8gF, 0.8794, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2542, 4v7oWA, 0.8794, 2.14, 0.299, 244, 231, 
2543, 4v7oO, 0.8794, 2.14, 0.299, 244, 231, 
2544, 4v7oA, 0.8794, 2.10, 0.259, 243, 232, 
2545, 4qlsF, 0.8794, 2.16, 0.332, 242, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2546, 4inuF, 0.8794, 2.18, 0.277, 240, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2547, 3sdiG, 0.8794, 2.19, 0.277, 239, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2548, 3gpwF, 0.8794, 2.19, 0.277, 240, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2549, 1jd2G, 0.8794, 2.27, 0.280, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2550, 5lf7T, 0.8793, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2551, 5dsvL, 0.8793, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2552, 5dkjT, 0.8793, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2553, 5dkjF, 0.8793, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2554, 5d0wT, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2555, 5d0wF, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2556, 4ya9T, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2557, 4ya9F, 0.8793, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2558, 4y8tT, 0.8793, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2559, 4y8kT, 0.8793, 2.20, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2560, 4y84T, 0.8793, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2561, 4y84F, 0.8793, 2.17, 0.338, 250, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2562, 4qw3T, 0.8793, 2.14, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2563, 4qw3F, 0.8793, 2.27, 0.297, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2564, 4qlsT, 0.8793, 2.11, 0.263, 240, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2565, 4ltcF, 0.8793, 2.27, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2566, 4j70F, 0.8793, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2567, 4inuT, 0.8793, 2.19, 0.277, 240, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2568, 4intG, 0.8793, 2.27, 0.280, 245, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2569, 3nzxT, 0.8793, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2570, 3nzxF, 0.8793, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2571, 3gpwT, 0.8793, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2572, 3dy3T, 0.8793, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2573, 3dy3F, 0.8793, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2574, 3bdmT, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2575, 3bdmF, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2576, 2zcyT, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2577, 2zcyF, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2578, 5lf6T, 0.8792, 2.14, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2579, 4y8kF, 0.8792, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2580, 4y81T, 0.8792, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2581, 4y81F, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2582, 4y75T, 0.8792, 2.13, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2583, 4y75F, 0.8792, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2584, 4y6zT, 0.8792, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2585, 4y6zF, 0.8792, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2586, 4qwgT, 0.8792, 2.26, 0.297, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2587, 4qwgF, 0.8792, 2.26, 0.297, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2588, 4qw1T, 0.8792, 2.27, 0.297, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2589, 4qw1F, 0.8792, 2.14, 0.299, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2590, 4qvqT, 0.8792, 2.14, 0.299, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2591, 4qvqF, 0.8792, 2.14, 0.299, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2592, 4qvpT, 0.8792, 2.14, 0.299, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2593, 4qvpF, 0.8792, 2.14, 0.299, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2594, 4qv4T, 0.8792, 2.14, 0.299, 244, 231, YCP BETA5-M45T MUTANT
2595, 4qv4F, 0.8792, 2.19, 0.277, 240, 231, YCP BETA5-M45T MUTANT
2596, 4qv1T, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-M45A MUTANT
2597, 4qv1F, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-M45A MUTANT
2598, 4q1sT, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2599, 3mg8G, 0.8792, 2.14, 0.299, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2600, 3mg4T, 0.8792, 2.14, 0.299, 243, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2601, 2gplF, 0.8792, 2.14, 0.299, 243, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2602, 2fakT, 0.8792, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2603, 2fakF, 0.8792, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2604, 5lf4T, 0.8791, 2.14, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2605, 4y8oF, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2606, 4y7xT, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2607, 4y7xF, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2608, 4y77T, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2609, 4y77F, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2610, 4r3oU, 0.8791, 2.14, 0.299, 243, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
2611, 4r3oG, 0.8791, 2.15, 0.299, 243, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
2612, 4qzzT, 0.8791, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH OMURALIDE
2613, 4qzzF, 0.8791, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH OMURALIDE
2614, 4qv5F, 0.8791, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT
2615, 2gplT, 0.8791, 2.16, 0.299, 244, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2616, 6avoJ, 0.8790, 2.10, 0.259, 243, 232, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2617, 5lf3T, 0.8790, 2.29, 0.297, 244, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2618, 5fgiT, 0.8790, 2.28, 0.297, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2619, 5fgiF, 0.8790, 2.29, 0.297, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2620, 5fgeT, 0.8790, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2621, 5fgeF, 0.8790, 2.19, 0.277, 240, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2622, 5dsvB, 0.8790, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2623, 4y8pT, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2624, 4y8pF, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2625, 4y8oT, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2626, 4y74T, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2627, 4y74F, 0.8790, 2.27, 0.280, 245, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2628, 4qv8T, 0.8790, 2.27, 0.280, 245, 232, YCP BETA5-C52F MUTANT
2629, 4qv8F, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT
2630, 4qv7T, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT
2631, 4qv7F, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT
2632, 4qv6T, 0.8790, 2.28, 0.297, 244, 232, YCP BETA5-A49V MUTANT
2633, 4qv6F, 0.8790, 2.21, 0.277, 239, 231, YCP BETA5-A49V MUTANT
2634, 4qv5T, 0.8790, 2.19, 0.277, 240, 231, YCP BETA5-M45I MUTANT
2635, 4qv0F, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2636, 4quyT, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49S-MUTANT
2637, 4quyF, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49S-MUTANT
2638, 4nnwT, 0.8790, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2639, 4nnwF, 0.8790, 2.27, 0.280, 245, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2640, 4hrdT, 0.8790, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2641, 4hnpT, 0.8790, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2642, 3un8T, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2643, 1rypG, 0.8790, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2644, 6avoQ, 0.8789, 2.14, 0.299, 243, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2645, 5l5bU, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2646, 5fggT, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2647, 5fggF, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2648, 5cz9T, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2649, 5cz9F, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2650, 4y8sT, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2651, 4y8sF, 0.8789, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2652, 4y82T, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2653, 4y82F, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2654, 4qz7T, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2655, 4qz7F, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2656, 4qz1T, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2657, 4qz1F, 0.8789, 2.29, 0.297, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2658, 4qwxT, 0.8789, 2.14, 0.299, 244, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2659, 4qwxF, 0.8789, 2.14, 0.299, 244, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2660, 4qwfT, 0.8789, 2.26, 0.297, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2661, 4qwfF, 0.8789, 2.21, 0.277, 239, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2662, 4qv0T, 0.8789, 2.09, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2663, 4no1T, 0.8789, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2664, 4no1F, 0.8789, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2665, 4ltcT, 0.8789, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2666, 4j70T, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2667, 3mg4G, 0.8789, 2.14, 0.299, 243, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2668, 3gpjT, 0.8789, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2669, 3gpjF, 0.8789, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2670, 3dy4T, 0.8789, 2.14, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2671, 3dy4F, 0.8789, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2672, 5lf0T, 0.8788, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2673, 5l5bG, 0.8788, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2674, 5jhrF, 0.8788, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2675, 5fgdT, 0.8788, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2676, 5fgdF, 0.8788, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2677, 4ya2T, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2678, 4ya2F, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2679, 4y8hT, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2680, 4y8hF, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2681, 4r67i, 0.8788, 2.15, 0.299, 243, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2682, 4r00T, 0.8788, 2.14, 0.299, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2683, 4r00F, 0.8788, 2.14, 0.299, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2684, 4qw6T, 0.8788, 2.12, 0.263, 243, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2685, 4qw6F, 0.8788, 2.14, 0.299, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2686, 4qw4T, 0.8788, 2.14, 0.299, 244, 231, YCP IN COMPLEX WITH CARFILZOMIB
2687, 4qw4F, 0.8788, 2.15, 0.299, 244, 231, YCP IN COMPLEX WITH CARFILZOMIB
2688, 4qluF, 0.8788, 2.15, 0.299, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2689, 4qlqF, 0.8788, 2.19, 0.277, 240, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2690, 4qbyF, 0.8788, 2.09, 0.264, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2691, 4no9T, 0.8788, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2692, 4no6F, 0.8788, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2693, 4jt0T, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2694, 4jt0F, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2695, 4jsqT, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2696, 4jsqF, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2697, 4cr2E, 0.8788, 2.15, 0.299, 243, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2698, 3okjF, 0.8788, 2.27, 0.280, 245, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2699, 1g65F, 0.8788, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2700, 1g0uF, 0.8788, 2.15, 0.299, 243, 231, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2701, 5jhrT, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2702, 5cggF, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2703, 5ahjT, 0.8787, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2704, 5ahjF, 0.8787, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2705, 4ya7T, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2706, 4ya7F, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2707, 4y8qT, 0.8787, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2708, 4y8qF, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2709, 4y8iT, 0.8787, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2710, 4y8iF, 0.8787, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2711, 4qz4T, 0.8787, 2.27, 0.297, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2712, 4qz4F, 0.8787, 2.27, 0.297, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2713, 4qwrF, 0.8787, 2.27, 0.297, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2714, 4qwkT, 0.8787, 2.14, 0.341, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2715, 4qwkF, 0.8787, 2.27, 0.297, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2716, 4qw7T, 0.8787, 2.26, 0.297, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2717, 4qw7F, 0.8787, 2.26, 0.297, 242, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2718, 4qluT, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2719, 4qlqT, 0.8787, 2.16, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2720, 4qbyT, 0.8787, 2.16, 0.299, 243, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2721, 4no9F, 0.8787, 2.16, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2722, 4no8T, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2723, 4no8F, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2724, 4no6T, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2725, 3unbh, 0.8787, 2.15, 0.299, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2726, 3shjF, 0.8787, 2.14, 0.299, 243, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2727, 3okjT, 0.8787, 2.14, 0.299, 243, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2728, 1rypU, 0.8787, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2729, 1iruU, 0.8787, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2730, 1iruG, 0.8787, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2731, 6gopT, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2732, 6gopF, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2733, 5ln3B, 0.8786, 2.15, 0.299, 243, 231, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2734, 5leyT, 0.8786, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2735, 5jhsT, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2736, 5jhsF, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2737, 5cggT, 0.8786, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2738, 4y8lT, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2739, 4y80F, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2740, 4r67w, 0.8786, 2.15, 0.299, 243, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2741, 4r67U, 0.8786, 2.14, 0.299, 243, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2742, 4qz0T, 0.8786, 2.08, 0.278, 244, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2743, 4qz0F, 0.8786, 2.27, 0.297, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2744, 4qwuT, 0.8786, 2.27, 0.297, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2745, 4qwuF, 0.8786, 2.27, 0.297, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2746, 4qwrT, 0.8786, 2.27, 0.280, 245, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2747, 4gk7U, 0.8786, 2.27, 0.280, 245, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2748, 3shjT, 0.8786, 2.15, 0.299, 243, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2749, 3e47T, 0.8786, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2750, 3e47F, 0.8786, 1.73, 0.382, 234, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2751, 1g65T, 0.8786, 2.20, 0.277, 240, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2752, 5fgfT, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2753, 5fgfF, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2754, 5dsvN, 0.8785, 2.16, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2755, 5dsvF, 0.8785, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2756, 5d0wU, 0.8785, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2757, 5d0vT, 0.8785, 2.28, 0.280, 245, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2758, 5d0vF, 0.8785, 2.28, 0.280, 245, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2759, 5d0sT, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2760, 5d0sF, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2761, 4y9zT, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2762, 4y9zF, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2763, 4y8lF, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2764, 4y80T, 0.8785, 2.13, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2765, 4y70F, 0.8785, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2766, 4r02T, 0.8785, 2.28, 0.297, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2767, 4qzwT, 0.8785, 2.28, 0.297, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2768, 4qzwF, 0.8785, 2.26, 0.297, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2769, 4qz6T, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2770, 4qz6F, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2771, 4qwiT, 0.8785, 2.28, 0.280, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2772, 4qwiF, 0.8785, 2.28, 0.280, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2773, 4qw5T, 0.8785, 2.09, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2774, 4qw5F, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2775, 4qv3T, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-M45V MUTANT
2776, 4qv3F, 0.8785, 2.16, 0.299, 243, 231, YCP BETA5-M45V MUTANT
2777, 3unbF, 0.8785, 2.15, 0.299, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2778, 3sdiR, 0.8785, 2.15, 0.299, 243, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2779, 5lf1F, 0.8784, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2780, 5l5rU, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2781, 5d0zT, 0.8784, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2782, 5d0zF, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2783, 5d0wG, 0.8784, 2.18, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2784, 4ya4U, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2785, 4y7wT, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2786, 4y7wF, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2787, 4y70T, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2788, 4qz3T, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2789, 4qz3F, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2790, 4qz2T, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2791, 4qz2F, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2792, 4qwsT, 0.8784, 2.16, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2793, 4qwsF, 0.8784, 2.16, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2794, 4qwlT, 0.8784, 2.22, 0.277, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2795, 4qwlF, 0.8784, 1.72, 0.345, 229, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2796, 4nnnT, 0.8784, 2.21, 0.277, 239, 231, YCP IN COMPLEX WITH MG132
2797, 4nnnF, 0.8784, 2.09, 0.264, 241, 231, YCP IN COMPLEX WITH MG132
2798, 4lqiF, 0.8784, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2799, 4gk7G, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2800, 4fzcF, 0.8784, 2.10, 0.264, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2801, 4eu2O, 0.8784, 2.09, 0.264, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2802, 5l5rG, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2803, 5l55T, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2804, 5l55F, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2805, 5czaU, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2806, 4ya4G, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2807, 4y8jT, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2808, 4y8jF, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2809, 4y78F, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2810, 4r67G, 0.8783, 2.15, 0.299, 243, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2811, 4qv9U, 0.8783, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT
2812, 4qv9T, 0.8783, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT
2813, 4qv9F, 0.8783, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT
2814, 4lqiT, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2815, 4fzcT, 0.8783, 2.15, 0.299, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2816, 3mg0F, 0.8783, 2.13, 0.263, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2817, 2f16F, 0.8783, 2.29, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2818, 5fhsT, 0.8782, 2.03, 0.265, 241, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2819, 5fhsF, 0.8782, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2820, 5czaG, 0.8782, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2821, 5cz5T, 0.8782, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2822, 5cz5F, 0.8782, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2823, 5cgiT, 0.8782, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2824, 5cgiF, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2825, 4y78T, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2826, 4qz5T, 0.8782, 2.15, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2827, 4qz5F, 0.8782, 2.28, 0.280, 245, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2828, 4qxjT, 0.8782, 2.10, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2829, 4qxjF, 0.8782, 2.16, 0.299, 243, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2830, 4ltcG, 0.8782, 2.16, 0.299, 243, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2831, 4eu2U, 0.8782, 2.15, 0.299, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2832, 3unbv, 0.8782, 2.29, 0.297, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2833, 5le5F, 0.8781, 2.14, 0.299, 244, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2834, 5l52T, 0.8781, 2.28, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2835, 5l52F, 0.8781, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2836, 4ya1U, 0.8781, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2837, 4y8rU, 0.8781, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2838, 4y7yF, 0.8781, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2839, 4qv9G, 0.8781, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT
2840, 2f16T, 0.8781, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2841, 5lf7F, 0.8780, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2842, 5fg7U, 0.8780, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2843, 4zzgO, 0.8780, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2844, 4ya1G, 0.8780, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2845, 4y8rG, 0.8780, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2846, 4y7yT, 0.8780, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2847, 4qzxT, 0.8780, 2.14, 0.263, 243, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2848, 4qzxF, 0.8780, 2.16, 0.299, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2849, 4no9U, 0.8780, 2.21, 0.273, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2850, 4hrcT, 0.8780, 2.21, 0.277, 239, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2851, 3unbT, 0.8780, 2.16, 0.299, 243, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2852, 3un4F, 0.8780, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2853, 3mg0T, 0.8780, 2.10, 0.264, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2854, 1g0uT, 0.8780, 2.10, 0.264, 241, 231, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2855, 5lf0F, 0.8779, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2856, 5fg7G, 0.8779, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2857, 5bxlU, 0.8779, 2.28, 0.297, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2858, 4qwjF, 0.8779, 2.21, 0.277, 239, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2859, 4no9G, 0.8779, 2.10, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2860, 3unhT, 0.8779, 2.10, 0.264, 242, 231, MOUSE 20S IMMUNOPROTEASOME
2861, 3unhF, 0.8779, 2.10, 0.264, 241, 231, MOUSE 20S IMMUNOPROTEASOME
2862, 3un4T, 0.8779, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2863, 5nifO, 0.8778, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2864, 5l6aU, 0.8778, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2865, 5dsvI, 0.8778, 2.15, 0.299, 243, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2866, 5bxlG, 0.8778, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2867, 4qwjT, 0.8778, 2.15, 0.299, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2868, 4quyU, 0.8778, 2.22, 0.277, 244, 231, YCP BETA5-A49S-MUTANT
2869, 4no1U, 0.8778, 2.28, 0.297, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2870, 4hnpG, 0.8778, 2.15, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2871, 4gk7F, 0.8778, 2.28, 0.297, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2872, 3unfT, 0.8778, 2.21, 0.277, 239, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2873, 3unfF, 0.8778, 2.10, 0.264, 241, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2874, 5lf6F, 0.8777, 2.10, 0.264, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2875, 5lf4F, 0.8777, 2.15, 0.299, 243, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2876, 5l6aG, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2877, 5l5uU, 0.8777, 2.10, 0.274, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2878, 5fgaU, 0.8777, 2.10, 0.274, 244, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2879, 5cz8T, 0.8777, 2.28, 0.297, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2880, 5cz8F, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2881, 5cgfU, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2882, 5bxnU, 0.8777, 2.24, 0.277, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2883, 4y8tU, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2884, 4qv7U, 0.8777, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT
2885, 4quyG, 0.8777, 2.10, 0.264, 241, 231, YCP BETA5-A49S-MUTANT
2886, 4no1G, 0.8777, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2887, 4jsuF, 0.8777, 2.14, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2888, 4gk7T, 0.8777, 2.15, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2889, 5lf3F, 0.8776, 2.10, 0.274, 244, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2890, 5l5uG, 0.8776, 2.10, 0.274, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2891, 5fgaG, 0.8776, 2.21, 0.277, 239, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2892, 5cgfG, 0.8776, 2.21, 0.277, 239, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2893, 5bxnG, 0.8776, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2894, 4y8tG, 0.8776, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2895, 4qv7G, 0.8776, 2.10, 0.264, 241, 231, YCP BETA5-A50V MUTANT
2896, 4q1sG, 0.8776, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2897, 4jsuT, 0.8776, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2898, 3unhU, 0.8776, 2.10, 0.264, 241, 231, MOUSE 20S IMMUNOPROTEASOME
2899, 3unhG, 0.8776, 2.10, 0.264, 241, 231, MOUSE 20S IMMUNOPROTEASOME
2900, 5wviOA, 0.8775, 2.10, 0.264, 241, 231, 
2901, 4y8mU, 0.8775, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2902, 4y8mG, 0.8775, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2903, 4r17U, 0.8775, 2.11, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2904, 4qv3U, 0.8775, 2.15, 0.299, 244, 231, YCP BETA5-M45V MUTANT
2905, 4qv3G, 0.8775, 2.16, 0.299, 244, 231, YCP BETA5-M45V MUTANT
2906, 4qv1U, 0.8775, 2.21, 0.277, 239, 231, YCP BETA5-M45A MUTANT
2907, 3mg0G, 0.8775, 2.10, 0.264, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2908, 5l5aU, 0.8774, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2909, 5fggU, 0.8774, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2910, 5fg9U, 0.8774, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2911, 4r17G, 0.8774, 2.10, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2912, 4qv1G, 0.8774, 2.11, 0.264, 241, 231, YCP BETA5-M45A MUTANT
2913, 1fntQ, 0.8774, 2.12, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2914, 1fntC, 0.8774, 2.16, 0.299, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2915, 5l5aG, 0.8773, 1.94, 0.301, 243, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2916, 5fggG, 0.8773, 1.94, 0.301, 243, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2917, 5ahjU, 0.8773, 1.82, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2918, 4y9yU, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2919, 4y9yG, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2920, 4x6zA, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2921, 4qv8U, 0.8773, 2.10, 0.264, 241, 231, YCP BETA5-C52F MUTANT
2922, 4qv5U, 0.8773, 2.10, 0.264, 241, 231, YCP BETA5-M45I MUTANT
2923, 4qv4U, 0.8773, 2.11, 0.264, 241, 231, YCP BETA5-M45T MUTANT
2924, 3jcpJA, 0.8773, 2.13, 0.259, 243, 232, 
2925, 3jcpJ, 0.8773, 2.11, 0.264, 241, 231, 
2926, 2ku2A, 0.8773, 2.11, 0.264, 241, 231, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2927, 5t0hH, 0.8772, 2.11, 0.264, 241, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2928, 5l6bU, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2929, 5l5dU, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2930, 5jhrU, 0.8772, 2.01, 0.310, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2931, 5fg9G, 0.8772, 2.01, 0.310, 241, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2932, 5dsvK, 0.8772, 2.11, 0.264, 241, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2933, 5cz6U, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2934, 5ahjG, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2935, 4z1lU, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2936, 4qwuU, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2937, 4qvnU, 0.8772, 2.15, 0.263, 242, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2938, 4qv8G, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT
2939, 4qv5G, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-M45I MUTANT
2940, 4qv4G, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-M45T MUTANT
2941, 4nnnU, 0.8772, 2.11, 0.259, 243, 232, YCP IN COMPLEX WITH MG132
2942, 4g4sA, 0.8772, 2.11, 0.259, 243, 232, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2943, 2ku1A, 0.8772, 2.11, 0.259, 243, 232, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2944, 6epfC, 0.8771, 1.57, 0.357, 237, 224, GROUND STATE 26S PROTEASOME (GS1)
2945, 5wviDA, 0.8771, 1.78, 0.377, 232, 228, 
2946, 5leyF, 0.8771, 2.11, 0.264, 241, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2947, 5l6bG, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2948, 5l5oU, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2949, 5l5hU, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2950, 5l5dG, 0.8771, 2.24, 0.277, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2951, 5l55U, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2952, 5jhrG, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2953, 5cz6G, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2954, 4x6zO, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2955, 4qzzU, 0.8771, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH OMURALIDE
2956, 4qwuG, 0.8771, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2957, 4qvnG, 0.8771, 2.11, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2958, 4nnnG, 0.8771, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH MG132
2959, 5lttU, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2960, 5l63U, 0.8770, 2.23, 0.263, 241, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2961, 5l5oG, 0.8770, 1.57, 0.366, 237, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2962, 5l5hG, 0.8770, 2.29, 0.306, 249, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2963, 5l55G, 0.8770, 1.82, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2964, 5cz7U, 0.8770, 2.22, 0.277, 239, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2965, 5cggU, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2966, 4z1lG, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2967, 4y8sU, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2968, 4qzzG, 0.8770, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH OMURALIDE
2969, 4qvlU, 0.8770, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
2970, 4qv0U, 0.8770, 2.11, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2971, 4qv0G, 0.8770, 2.11, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2972, 4qbyU, 0.8770, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2973, 3unfU, 0.8770, 2.11, 0.264, 241, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2974, 3unfG, 0.8770, 2.11, 0.264, 241, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2975, 6gopU, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2976, 5lttG, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2977, 5l67U, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2978, 5l64U, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2979, 5l5pU, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2980, 5cz7G, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2981, 5cggG, 0.8769, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2982, 4ya2U, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2983, 4y8sG, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2984, 4r00U, 0.8769, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2985, 4qvlG, 0.8769, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
2986, 4quxU, 0.8769, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT
2987, 4qbyG, 0.8769, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2988, 3unev, 0.8769, 2.11, 0.264, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
2989, 2ku2B, 0.8769, 2.11, 0.264, 241, 231, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2990, 5mpag, 0.8768, 2.10, 0.264, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2991, 5l67G, 0.8768, 1.95, 0.301, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2992, 5l66U, 0.8768, 1.95, 0.301, 243, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2993, 5l64G, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2994, 5l63G, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2995, 5l61U, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2996, 5l5pG, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2997, 4ya7U, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2998, 4ya7G, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2999, 4ya2G, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3000, 4r00G, 0.8768, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3001, 4qwlU, 0.8768, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3002, 4qvyU, 0.8768, 2.12, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3003, 4quxG, 0.8768, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT
3004, 1z7qU, 0.8768, 2.11, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3005, 1jd21, 0.8768, 2.10, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3006, 6gopG, 0.8767, 2.11, 0.278, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3007, 5m2bU, 0.8767, 1.61, 0.366, 237, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3008, 5l6cU, 0.8767, 2.29, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3009, 5l66G, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3010, 5l65U, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3011, 5l61G, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3012, 5l5wU, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3013, 4y8pU, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3014, 4y8pG, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3015, 4r02U, 0.8767, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3016, 4qwlG, 0.8767, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3017, 4qvyG, 0.8767, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3018, 4qv6U, 0.8767, 2.12, 0.264, 241, 231, YCP BETA5-A49V MUTANT
3019, 4no8U, 0.8767, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3020, 1z7qG, 0.8767, 2.11, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3021, 5m2bG, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3022, 5l6cG, 0.8766, 2.28, 0.297, 243, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3023, 5l65G, 0.8766, 2.29, 0.297, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3024, 5l62U, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3025, 5l5wG, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3026, 5l5fU, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3027, 5d0sU, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3028, 4y8kU, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3029, 4y8kG, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3030, 4qw1U, 0.8766, 2.11, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3031, 4qw1G, 0.8766, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3032, 4qv6G, 0.8766, 2.12, 0.264, 241, 231, YCP BETA5-A49V MUTANT
3033, 4no8G, 0.8766, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3034, 3uneh, 0.8766, 2.12, 0.264, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
3035, 5mpcS, 0.8765, 2.11, 0.264, 241, 231, 
3036, 5l62G, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3037, 5l5tU, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3038, 5l5qU, 0.8765, 2.28, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3039, 5l5fG, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3040, 5d0sG, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3041, 4y8uU, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3042, 4y8hU, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3043, 4y75U, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3044, 4y75G, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3045, 4y6vU, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3046, 4y6vG, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3047, 4qvpU, 0.8765, 2.12, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3048, 5l5tG, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3049, 5l5qG, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3050, 5l5eU, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3051, 5l52U, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3052, 5l52G, 0.8764, 2.10, 0.278, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3053, 5fgfU, 0.8764, 2.05, 0.338, 242, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3054, 5bouU, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3055, 4y9zU, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3056, 4y8uG, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3057, 4y8hG, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3058, 4y6aU, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3059, 4y6aG, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3060, 4qz6U, 0.8764, 2.12, 0.264, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3061, 4qvpG, 0.8764, 2.12, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3062, 4nnwU, 0.8764, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3063, 4hrdG, 0.8764, 2.11, 0.264, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3064, 3uneF, 0.8764, 2.11, 0.264, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
3065, 5l5xU, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3066, 5l5vU, 0.8763, 2.11, 0.264, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3067, 5l5vG, 0.8763, 2.12, 0.264, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3068, 5l5eG, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3069, 5fgfG, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3070, 5cz9U, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3071, 5bouG, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3072, 4y9zG, 0.8763, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3073, 4qz6G, 0.8763, 2.12, 0.264, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3074, 4qvwU, 0.8763, 2.12, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3075, 4qvwG, 0.8763, 2.12, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3076, 4nnwG, 0.8763, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3077, 4hrcG, 0.8763, 2.12, 0.264, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3078, 5l68U, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3079, 5l68G, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3080, 5l5sU, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3081, 5l5sG, 0.8762, 2.16, 0.263, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3082, 5l5jU, 0.8762, 2.11, 0.278, 244, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3083, 5l5jG, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3084, 5d0zU, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3085, 5cz9G, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3086, 4ya9U, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3087, 4ya9G, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3088, 4y8nU, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3089, 4y77U, 0.8762, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3090, 4rurU, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3091, 4rurG, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3092, 4qz0U, 0.8762, 2.12, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3093, 1jd2F, 0.8762, 2.12, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3094, 5l5zU, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3095, 5l5xG, 0.8761, 2.16, 0.263, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3096, 5l5iU, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3097, 5d0zG, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3098, 5d0vU, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3099, 4y8nG, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3100, 4y8gU, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3101, 4y77G, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3102, 4y69U, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3103, 4qz0G, 0.8761, 2.12, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3104, 3mg8T, 0.8761, 2.12, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3105, 5l5zG, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3106, 5l5iG, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3107, 5d0vG, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3108, 5cghU, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3109, 4y8gG, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3110, 4y69G, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3111, 4qz7U, 0.8760, 2.17, 0.299, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3112, 5fhsU, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3113, 5fgeU, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3114, 5d0tU, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3115, 5cghG, 0.8759, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3116, 4ya5U, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3117, 4y74U, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3118, 4y70U, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3119, 4y70G, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3120, 4qz7G, 0.8759, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3121, 4qz4U, 0.8759, 2.12, 0.264, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3122, 4qz3U, 0.8759, 2.02, 0.301, 237, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3123, 4qw5U, 0.8759, 2.12, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3124, 4qlqU, 0.8759, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3125, 3uneT, 0.8759, 2.12, 0.264, 241, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
3126, 5vfoH, 0.8758, 2.12, 0.264, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3127, 5fhsG, 0.8758, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3128, 5fgeG, 0.8758, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3129, 5d0tG, 0.8758, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3130, 4ya5G, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3131, 4y7wU, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3132, 4y74G, 0.8758, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3133, 4qz4G, 0.8758, 2.12, 0.264, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3134, 4qz3G, 0.8758, 2.12, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3135, 4qw7U, 0.8758, 2.13, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3136, 4qw5G, 0.8758, 2.13, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3137, 4qlsU, 0.8758, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3138, 4qlqG, 0.8758, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3139, 5mpbP, 0.8757, 2.12, 0.264, 241, 231, 
3140, 5jhsU, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3141, 4y8lU, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3142, 4y8lG, 0.8757, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3143, 4y82U, 0.8757, 2.13, 0.278, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3144, 4y82G, 0.8757, 1.77, 0.373, 230, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3145, 4y7wG, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3146, 4r18U, 0.8757, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3147, 4qz5U, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3148, 4qz5G, 0.8757, 2.12, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3149, 4qwrU, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3150, 4qwrG, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3151, 4qw7G, 0.8757, 2.12, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3152, 4qw6U, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3153, 4qw0U, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3154, 4qluU, 0.8757, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3155, 4qlsG, 0.8757, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3156, 5laiU, 0.8756, 2.12, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3157, 5laiG, 0.8756, 1.87, 0.358, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3158, 5l5yU, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3159, 5jhsG, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3160, 5dkjU, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3161, 4y8qU, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3162, 4y7xU, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3163, 4y7xG, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3164, 4r18G, 0.8756, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3165, 4qzwU, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3166, 4qzwG, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3167, 4qw6G, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3168, 4qw0G, 0.8756, 2.14, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3169, 4qvqU, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3170, 4qluG, 0.8756, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3171, 4cr4E, 0.8756, 2.13, 0.264, 241, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3172, 5l60U, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3173, 5l60G, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3174, 5l5yG, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3175, 5dkjG, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3176, 5cz8U, 0.8755, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3177, 5cgiU, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3178, 4y8qG, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3179, 4y7yU, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3180, 4qwxU, 0.8755, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3181, 4qvqG, 0.8755, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3182, 3oevF, 0.8755, 2.13, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3183, 2ku2C, 0.8755, 2.13, 0.264, 241, 231, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3184, 5lajU, 0.8754, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3185, 5l69U, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3186, 5l69G, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3187, 5d0xU, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3188, 5cgiG, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3189, 4y8jU, 0.8754, 2.16, 0.341, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3190, 4y8jG, 0.8754, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3191, 4y80U, 0.8754, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3192, 4y80G, 0.8754, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3193, 4y7yG, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3194, 4y6zU, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3195, 4qwxG, 0.8754, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3196, 4qwjU, 0.8754, 2.13, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3197, 4no6U, 0.8754, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3198, 3mg7F, 0.8754, 2.13, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3199, 5lajG, 0.8753, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3200, 5cz8G, 0.8753, 2.02, 0.301, 237, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3201, 4ya3U, 0.8753, 1.70, 0.366, 237, 224, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3202, 4y6zG, 0.8753, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3203, 4qwjG, 0.8753, 2.12, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3204, 4qltU, 0.8753, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3205, 4no6G, 0.8753, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3206, 3jcpPA, 0.8753, 2.13, 0.264, 241, 231, 
3207, 5vfrH, 0.8752, 2.13, 0.264, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3208, 5d0xG, 0.8752, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3209, 5cz4U, 0.8752, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3210, 4ya3G, 0.8752, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3211, 4qltG, 0.8752, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3212, 3mg6T, 0.8752, 2.13, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3213, 5mpbU, 0.8751, 2.13, 0.264, 241, 231, 
3214, 5fgiU, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3215, 5fgdU, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3216, 5fgdG, 0.8751, 2.03, 0.301, 237, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3217, 5cz4G, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3218, 4y84U, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3219, 4qzxU, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3220, 4qwkU, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3221, 4qwiU, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3222, 4qvvU, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3223, 4qvmU, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3224, 3mg7T, 0.8751, 2.27, 0.297, 244, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3225, 5vfqB, 0.8750, 1.76, 0.373, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3226, 5l54U, 0.8750, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3227, 5fgiG, 0.8750, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3228, 5cz5U, 0.8750, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3229, 4y84G, 0.8750, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3230, 4v7oU, 0.8750, 2.03, 0.301, 237, 229, 
3231, 4v7oG, 0.8750, 2.28, 0.297, 243, 232, 
3232, 4qzxG, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3233, 4qwkG, 0.8750, 2.13, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3234, 4qwiG, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3235, 4qwfU, 0.8750, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3236, 4qvvG, 0.8750, 2.13, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3237, 4qvmG, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3238, 3mg8F, 0.8750, 2.13, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3239, 3mg6F, 0.8750, 2.14, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3240, 5l54G, 0.8749, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3241, 4v7oOA, 0.8749, 2.13, 0.264, 241, 231, 
3242, 4qz2U, 0.8749, 2.03, 0.301, 237, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3243, 4qwfG, 0.8749, 2.01, 0.335, 250, 236, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3244, 4qlvU, 0.8749, 1.77, 0.373, 230, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3245, 4eu2A, 0.8749, 2.14, 0.264, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3246, 3wxrG, 0.8749, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3247, 3oevT, 0.8749, 2.14, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3248, 3jcpP, 0.8749, 2.13, 0.264, 241, 231, 
3249, 5fghU, 0.8748, 2.19, 0.299, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3250, 5cz5G, 0.8748, 2.19, 0.299, 244, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3251, 5a5bG, 0.8748, 2.14, 0.264, 241, 231, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3252, 4v7oCB, 0.8748, 2.14, 0.264, 241, 231, 
3253, 4qz2G, 0.8748, 2.14, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3254, 4qlvG, 0.8748, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3255, 4cr3G, 0.8748, 2.14, 0.264, 241, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3256, 3oeuT, 0.8748, 2.13, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3257, 5vfpB, 0.8747, 2.03, 0.301, 237, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3258, 5fghG, 0.8747, 2.03, 0.301, 237, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3259, 4y81U, 0.8747, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3260, 4y81G, 0.8747, 2.20, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3261, 4y78U, 0.8747, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3262, 3oeuF, 0.8747, 2.13, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3263, 4ya0U, 0.8746, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3264, 4ya0G, 0.8746, 2.08, 0.270, 241, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3265, 4y8iU, 0.8746, 2.17, 0.300, 237, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3266, 4y8iG, 0.8746, 2.05, 0.301, 237, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3267, 4y78G, 0.8746, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3268, 4g4sG, 0.8746, 2.30, 0.297, 244, 232, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3269, 4qz1U, 0.8745, 2.13, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3270, 4qw4U, 0.8745, 2.14, 0.264, 241, 231, YCP IN COMPLEX WITH CARFILZOMIB
3271, 4qw4G, 0.8745, 2.40, 0.288, 245, 233, YCP IN COMPLEX WITH CARFILZOMIB
3272, 4qz1G, 0.8744, 2.20, 0.299, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3273, 4y8oU, 0.8743, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3274, 4qxjU, 0.8743, 2.14, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3275, 4qxjG, 0.8743, 2.40, 0.288, 245, 233, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3276, 4y8oG, 0.8742, 2.04, 0.301, 237, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3277, 4qw3U, 0.8742, 1.72, 0.595, 239, 237, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3278, 4qw3G, 0.8742, 1.78, 0.373, 230, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3279, 5wvkU, 0.8740, 2.13, 0.264, 241, 231, 
3280, 4qwsU, 0.8740, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3281, 1z7qP, 0.8740, 2.14, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3282, 1z7qB, 0.8740, 2.14, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3283, 5vfuX, 0.8739, 2.03, 0.301, 237, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3284, 5vftM, 0.8739, 2.14, 0.264, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3285, 4qwsG, 0.8739, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3286, 5vfsZ, 0.8738, 2.14, 0.264, 241, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3287, 5dkiU, 0.8738, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3288, 5dkiG, 0.8738, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3289, 4r02G, 0.8738, 2.22, 0.296, 246, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3290, 5vfqG, 0.8737, 2.14, 0.264, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3291, 5vfsA, 0.8736, 2.14, 0.264, 241, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3292, 4qwgU, 0.8735, 2.14, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3293, 4cr4B, 0.8735, 2.14, 0.264, 241, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3294, 1fntU, 0.8735, 2.14, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3295, 1fntG, 0.8735, 2.14, 0.264, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3296, 5vfqFA, 0.8734, 2.14, 0.264, 241, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3297, 4qwgG, 0.8734, 2.14, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3298, 5vfoM, 0.8732, 2.14, 0.264, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3299, 5vfom, 0.8732, 2.14, 0.264, 241, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3300, 4cr2A, 0.8731, 2.19, 0.299, 244, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3301, 6avoR, 0.8730, 2.15, 0.264, 241, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3302, 6avoK, 0.8730, 1.83, 0.358, 249, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3303, 5vfoG, 0.8729, 1.83, 0.358, 249, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3304, 5t0cYA, 0.8728, 2.24, 0.277, 240, 231, 
3305, 5t0cS, 0.8728, 2.24, 0.277, 240, 231, 
3306, 5a5bC, 0.8728, 2.15, 0.264, 241, 231, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3307, 4cr3C, 0.8728, 1.97, 0.301, 240, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3308, 3sdiD, 0.8728, 2.14, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3309, 5dsvH, 0.8727, 2.14, 0.264, 241, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3310, 4v7oE, 0.8727, 2.15, 0.264, 241, 231, 
3311, 4v7oAB, 0.8727, 2.24, 0.277, 240, 231, 
3312, 2ku1B, 0.8727, 1.46, 0.386, 232, 228, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3313, 5m32T, 0.8726, 1.96, 0.301, 240, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3314, 4v7oMA, 0.8726, 2.16, 0.264, 241, 231, 
3315, 3sdkT, 0.8726, 1.91, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3316, 3jcoJA, 0.8726, 2.33, 0.297, 240, 232, 
3317, 3jcoJ, 0.8726, 2.33, 0.297, 240, 232, 
3318, 4v7oS, 0.8725, 2.26, 0.277, 240, 231, 
3319, 3sdkF, 0.8724, 2.16, 0.264, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3320, 5wvkBA, 0.8723, 2.26, 0.277, 240, 231, 
3321, 5vfrG, 0.8722, 2.25, 0.277, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3322, 5vfsG, 0.8721, 2.25, 0.258, 243, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3323, 5vfpG, 0.8721, 1.86, 0.288, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3324, 5wvkV, 0.8719, 1.86, 0.288, 240, 226, 
3325, 5vfog, 0.8719, 1.96, 0.301, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3326, 5mpcE, 0.8719, 1.98, 0.306, 240, 229, 
3327, 5gjqm, 0.8719, 1.98, 0.306, 240, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3328, 3wxrU, 0.8719, 2.41, 0.313, 245, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3329, 5vfsFA, 0.8717, 2.41, 0.313, 245, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3330, 5vfuR, 0.8716, 1.75, 0.347, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3331, 5vfpA, 0.8716, 2.04, 0.276, 239, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3332, 5mpaG, 0.8716, 2.17, 0.338, 250, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3333, 5vfrM, 0.8715, 2.17, 0.338, 250, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3334, 5vftG, 0.8714, 1.79, 0.375, 237, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3335, 5vfqA, 0.8713, 2.28, 0.283, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3336, 5vfuLA, 0.8712, 2.17, 0.338, 250, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3337, 5vftm, 0.8712, 2.02, 0.303, 236, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3338, 5vfpEA, 0.8712, 2.18, 0.259, 243, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3339, 6epeD, 0.8711, 2.18, 0.259, 243, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3340, 5mpbQ, 0.8709, 2.18, 0.259, 243, 232, 
3341, 5mp9a, 0.8709, 2.17, 0.338, 250, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3342, 6epfA, 0.8708, 2.02, 0.303, 236, 228, GROUND STATE 26S PROTEASOME (GS1)
3343, 5a5bB, 0.8708, 2.31, 0.297, 244, 232, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3344, 4cr3B, 0.8708, 1.97, 0.301, 239, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3345, 1fntP, 0.8707, 2.25, 0.277, 240, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3346, 1fntB, 0.8707, 2.27, 0.277, 240, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3347, 5vfrm, 0.8706, 2.18, 0.254, 243, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3348, 5vfqZ, 0.8704, 1.98, 0.301, 240, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3349, 5mp9A, 0.8704, 2.10, 0.346, 242, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3350, 5dsvJ, 0.8704, 2.25, 0.335, 238, 230, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3351, 5vfrg, 0.8702, 2.09, 0.301, 237, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3352, 5wvkQ, 0.8701, 2.25, 0.277, 240, 231, 
3353, 5vfuFA, 0.8701, 1.99, 0.301, 240, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3354, 5vftg, 0.8701, 2.03, 0.335, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3355, 5mpcU, 0.8699, 1.97, 0.306, 239, 229, 
3356, 6epcD, 0.8698, 2.35, 0.297, 243, 232, GROUND STATE 26S PROTEASOME (GS2)
3357, 5t0jJ, 0.8698, 2.27, 0.277, 240, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3358, 5t0gG, 0.8698, 1.99, 0.301, 240, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3359, 5gjrX, 0.8698, 1.53, 0.377, 232, 228, 
3360, 5gjqG, 0.8697, 1.97, 0.306, 239, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3361, 5vfpY, 0.8696, 2.23, 0.273, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3362, 5t0cY, 0.8696, 2.23, 0.273, 240, 231, 
3363, 5t0cEB, 0.8696, 2.26, 0.277, 240, 231, 
3364, 5lexR, 0.8694, 2.32, 0.564, 246, 234, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3365, 5wvkX, 0.8693, 2.21, 0.312, 244, 231, 
3366, 5mpbG, 0.8693, 2.17, 0.264, 241, 231, 
3367, 5lf6R, 0.8693, 2.10, 0.283, 246, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3368, 5lezR, 0.8693, 1.95, 0.367, 250, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3369, 5le5R, 0.8692, 1.95, 0.367, 250, 229, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3370, 5vfrl, 0.8690, 1.79, 0.364, 247, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3371, 5mpcC, 0.8689, 1.79, 0.364, 247, 225, 
3372, 1iruS, 0.8689, 2.28, 0.277, 240, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3373, 1iruE, 0.8689, 1.99, 0.301, 240, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3374, 5l4gT, 0.8688, 2.16, 0.260, 241, 231, 
3375, 5m32U, 0.8687, 2.09, 0.281, 239, 228, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3376, 5lf0R, 0.8687, 1.99, 0.301, 240, 229, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3377, 3unbD, 0.8687, 2.31, 0.306, 244, 232, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3378, 5lf7R, 0.8686, 2.05, 0.301, 240, 229, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3379, 5lf1R, 0.8686, 2.05, 0.301, 240, 229, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3380, 5lf3R, 0.8684, 2.28, 0.297, 243, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3381, 5lezD, 0.8684, 2.32, 0.559, 246, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3382, 5leyR, 0.8684, 2.12, 0.575, 239, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3383, 5gjrLA, 0.8684, 1.99, 0.293, 240, 229, 
3384, 4r67u, 0.8684, 2.26, 0.335, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3385, 6epcA, 0.8683, 2.26, 0.335, 238, 230, GROUND STATE 26S PROTEASOME (GS2)
3386, 5lexD, 0.8683, 2.00, 0.306, 240, 229, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3387, 4r67S, 0.8683, 1.98, 0.306, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3388, 4r67h, 0.8683, 2.27, 0.277, 240, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3389, 4r67E, 0.8683, 2.27, 0.277, 240, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3390, 5mpcQ, 0.8682, 1.95, 0.347, 233, 225, 
3391, 5m32F, 0.8682, 2.32, 0.306, 244, 232, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3392, 5ln3G, 0.8682, 2.35, 0.297, 243, 232, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3393, 5lf4R, 0.8682, 1.97, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3394, 5gjrW, 0.8682, 1.96, 0.347, 233, 225, 
3395, 4r67g, 0.8682, 1.96, 0.347, 233, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3396, 4cr4G, 0.8682, 2.23, 0.335, 238, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3397, 3unbR, 0.8682, 2.16, 0.313, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3398, 3unbf, 0.8682, 1.98, 0.342, 234, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3399, 5mpaa, 0.8681, 1.98, 0.342, 234, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3400, 5lf6D, 0.8681, 2.22, 0.335, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3401, 4r3oF, 0.8679, 1.86, 0.283, 241, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
3402, 5vfoL, 0.8678, 1.97, 0.347, 233, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3403, 5gjrKA, 0.8678, 2.00, 0.347, 233, 225, 
3404, 3jcoP, 0.8678, 1.98, 0.347, 233, 225, 
3405, 1iruT, 0.8678, 1.97, 0.347, 233, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3406, 4r67T, 0.8677, 1.98, 0.347, 233, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3407, 3jcoPA, 0.8677, 1.97, 0.347, 233, 225, 
3408, 6epdC, 0.8676, 1.97, 0.347, 233, 225, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3409, 6avoM, 0.8676, 2.28, 0.335, 238, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3410, 5lf1D, 0.8676, 1.99, 0.347, 234, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3411, 5gjql, 0.8676, 2.36, 0.280, 246, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3412, 4r67v, 0.8676, 1.98, 0.347, 233, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3413, 6avoH, 0.8675, 1.99, 0.347, 234, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3414, 5lf7D, 0.8675, 2.25, 0.335, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3415, 5lf0D, 0.8675, 1.99, 0.347, 234, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3416, 5leyD, 0.8675, 2.20, 0.304, 244, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3417, 5le5D, 0.8675, 2.06, 0.286, 232, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3418, 5vfqEA, 0.8674, 2.24, 0.281, 242, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3419, 5lf4D, 0.8674, 1.98, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3420, 1z7qO, 0.8674, 2.00, 0.347, 234, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3421, 1z7qA, 0.8674, 1.99, 0.347, 234, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3422, 5vfrL, 0.8673, 2.51, 0.291, 245, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3423, 5vfol, 0.8673, 1.99, 0.342, 233, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3424, 5lf3D, 0.8673, 2.00, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3425, 5gjqF, 0.8673, 2.22, 0.264, 241, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3426, 4r67F, 0.8673, 1.99, 0.347, 233, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3427, 5l4gS, 0.8672, 2.26, 0.335, 238, 230, 
3428, 5l4gF, 0.8672, 2.24, 0.335, 238, 230, 
3429, 5vfpDA, 0.8671, 2.01, 0.347, 234, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3430, 5vfsF, 0.8670, 2.38, 0.297, 244, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3431, 5vfsEA, 0.8670, 2.38, 0.297, 244, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3432, 5mpcG, 0.8670, 2.30, 0.335, 238, 230, 
3433, 4r3oT, 0.8668, 2.25, 0.335, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
3434, 4cr4C, 0.8667, 2.38, 0.297, 244, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3435, 3unbt, 0.8667, 2.52, 0.319, 249, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3436, 1iruF, 0.8667, 1.97, 0.347, 233, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3437, 4r3oS, 0.8666, 2.00, 0.347, 233, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
3438, 4r3oE, 0.8666, 2.00, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
3439, 1ya7F, 0.8666, 2.26, 0.335, 238, 230, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3440, 3uneR, 0.8663, 1.97, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3441, 3j9iU, 0.8663, 2.00, 0.347, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3442, 3j9iT, 0.8663, 2.00, 0.347, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3443, 3j9iS, 0.8663, 1.99, 0.347, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3444, 3j9iR, 0.8663, 2.00, 0.347, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3445, 3j9iQ, 0.8663, 2.26, 0.335, 238, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3446, 3j9iP, 0.8663, 2.00, 0.347, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3447, 3j9iO, 0.8663, 2.18, 0.263, 243, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3448, 3j9iG, 0.8663, 2.18, 0.263, 243, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3449, 3j9iF, 0.8663, 2.24, 0.335, 238, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3450, 3j9iE, 0.8663, 2.26, 0.335, 238, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3451, 3j9iD, 0.8663, 2.00, 0.347, 233, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3452, 3j9iC, 0.8663, 2.02, 0.347, 234, 225, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3453, 3j9iB, 0.8663, 2.15, 0.336, 238, 229, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3454, 3j9iA, 0.8663, 1.85, 0.348, 234, 224, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3455, 5vftL, 0.8662, 2.25, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3456, 3uneD, 0.8662, 2.25, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3457, 1yauF, 0.8662, 2.25, 0.277, 240, 231, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3458, 5wviH, 0.8661, 2.25, 0.335, 238, 230, 
3459, 5vfuW, 0.8660, 2.25, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3460, 5vftl, 0.8659, 2.33, 0.297, 243, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3461, 5lexG, 0.8659, 2.28, 0.335, 238, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3462, 5vfuKA, 0.8658, 2.41, 0.315, 245, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3463, 5l4gE, 0.8658, 2.01, 0.342, 233, 225, 
3464, 3unhS, 0.8658, 2.27, 0.339, 238, 230, MOUSE 20S IMMUNOPROTEASOME
3465, 3unhE, 0.8658, 2.02, 0.347, 234, 225, MOUSE 20S IMMUNOPROTEASOME
3466, 3unfS, 0.8658, 2.02, 0.347, 234, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3467, 3unfE, 0.8658, 1.67, 0.371, 227, 221, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3468, 3unbS, 0.8658, 2.03, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3469, 2ku2G, 0.8658, 1.55, 0.364, 224, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3470, 2ku1D, 0.8658, 1.55, 0.364, 224, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3471, 5vfqF, 0.8657, 1.55, 0.364, 224, 220, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3472, 5lezG, 0.8656, 1.55, 0.364, 224, 220, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3473, 3unbu, 0.8656, 1.55, 0.364, 224, 220, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3474, 2ku2D, 0.8656, 1.55, 0.364, 224, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3475, 3unhR, 0.8655, 1.55, 0.364, 224, 220, MOUSE 20S IMMUNOPROTEASOME
3476, 3unhD, 0.8655, 1.55, 0.364, 224, 220, MOUSE 20S IMMUNOPROTEASOME
3477, 3unfR, 0.8655, 1.55, 0.364, 224, 220, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3478, 3unfD, 0.8655, 1.55, 0.364, 224, 220, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3479, 1fntO, 0.8655, 1.55, 0.364, 224, 220, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3480, 6epcB, 0.8654, 1.55, 0.364, 224, 220, GROUND STATE 26S PROTEASOME (GS2)
3481, 3unet, 0.8654, 1.55, 0.364, 224, 220, MOUSE CONSTITUTIVE 20S PROTEASOME
3482, 2ku2F, 0.8654, 1.55, 0.364, 224, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3483, 1ya7G, 0.8654, 2.27, 0.335, 238, 230, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3484, 1fntA, 0.8654, 2.03, 0.347, 233, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3485, 6epeA, 0.8653, 1.42, 0.365, 222, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3486, 5mpbA, 0.8653, 2.20, 0.332, 243, 232, 
3487, 2ku1F, 0.8653, 2.27, 0.335, 238, 230, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3488, 5vfpF, 0.8651, 2.29, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3489, 5lf0G, 0.8650, 1.86, 0.284, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3490, 3unef, 0.8650, 2.29, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3491, 5t0gM, 0.8649, 2.04, 0.347, 234, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3492, 5wviBA, 0.8648, 2.30, 0.335, 238, 230, 
3493, 3unbg, 0.8648, 2.30, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3494, 1ya7C, 0.8648, 2.29, 0.335, 238, 230, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3495, 2ku2E, 0.8647, 2.29, 0.335, 238, 230, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3496, 5lf3G, 0.8646, 2.31, 0.335, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3497, 5leyG, 0.8645, 1.60, 0.371, 237, 221, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3498, 5le5G, 0.8645, 1.75, 0.374, 237, 222, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3499, 1yauG, 0.8644, 2.26, 0.277, 240, 231, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3500, 3unbE, 0.8643, 2.27, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3501, 5wvkO, 0.8642, 1.87, 0.284, 241, 225, 
3502, 5lf7G, 0.8641, 2.32, 0.335, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3503, 3uneE, 0.8641, 1.61, 0.371, 237, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
3504, 5lf6G, 0.8640, 2.03, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3505, 3jrmG, 0.8640, 2.03, 0.347, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3506, 2ku1C, 0.8640, 2.03, 0.347, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3507, 5lf1G, 0.8639, 2.03, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3508, 5lf0S, 0.8639, 2.18, 0.260, 238, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3509, 3jrmA, 0.8639, 1.96, 0.377, 234, 228, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3510, 1yauC, 0.8639, 2.03, 0.342, 233, 225, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3511, 5lf7S, 0.8638, 1.63, 0.371, 237, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3512, 5lf4G, 0.8638, 1.69, 0.371, 227, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3513, 3jseG, 0.8638, 2.19, 0.260, 238, 231, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3514, 3jrmF, 0.8638, 2.18, 0.289, 246, 232, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3515, 3jrmB, 0.8638, 2.17, 0.260, 241, 231, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3516, 2ku1E, 0.8638, 1.63, 0.371, 237, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3517, 3jrmE, 0.8637, 2.28, 0.335, 238, 230, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3518, 3jrmD, 0.8637, 1.88, 0.280, 241, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3519, 3jrmC, 0.8637, 2.05, 0.347, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3520, 1ya7B, 0.8637, 2.33, 0.273, 240, 231, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3521, 3jseF, 0.8636, 2.24, 0.332, 243, 232, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3522, 1yauB, 0.8636, 2.34, 0.335, 238, 230, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3523, 5m32G, 0.8635, 1.70, 0.371, 227, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3524, 1yauD, 0.8635, 1.66, 0.371, 237, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3525, 6epcC, 0.8634, 1.88, 0.284, 241, 225, GROUND STATE 26S PROTEASOME (GS2)
3526, 5lf6S, 0.8634, 1.88, 0.284, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3527, 5lf1S, 0.8634, 1.88, 0.284, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3528, 3uneu, 0.8634, 1.46, 0.365, 222, 219, MOUSE CONSTITUTIVE 20S PROTEASOME
3529, 3jseE, 0.8634, 2.34, 0.335, 238, 230, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3530, 3jseB, 0.8634, 2.28, 0.263, 243, 232, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3531, 5lf4S, 0.8633, 1.89, 0.280, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3532, 5lf3S, 0.8633, 2.33, 0.335, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3533, 3uneg, 0.8633, 1.90, 0.280, 241, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3534, 3jseD, 0.8633, 1.71, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3535, 3jseA, 0.8633, 1.69, 0.371, 237, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3536, 3jseC, 0.8632, 1.89, 0.284, 241, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3537, 1yarF, 0.8632, 2.08, 0.339, 237, 227, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3538, 1yauA, 0.8631, 1.71, 0.371, 227, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3539, 1yarG, 0.8630, 1.47, 0.365, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3540, 5leyS, 0.8629, 2.09, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3541, 5le5S, 0.8629, 1.90, 0.280, 241, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3542, 1ya7D, 0.8628, 1.72, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3543, 6avoL, 0.8627, 1.71, 0.371, 227, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3544, 3uneS, 0.8627, 1.71, 0.371, 227, 221, MOUSE CONSTITUTIVE 20S PROTEASOME
3545, 1yauE, 0.8627, 1.74, 0.371, 237, 221, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3546, 5t0jG, 0.8626, 1.72, 0.371, 227, 221, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3547, 2ku1G, 0.8626, 1.71, 0.371, 227, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3548, 6avoG, 0.8625, 1.72, 0.371, 227, 221, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3549, 5m32S, 0.8625, 1.71, 0.371, 227, 221, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3550, 3jtlG, 0.8625, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3551, 3jtlF, 0.8624, 1.47, 0.365, 222, 219, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3552, 3jtlB, 0.8624, 1.90, 0.289, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3553, 5ln3A, 0.8623, 1.48, 0.365, 222, 219, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3554, 3jtlD, 0.8623, 2.70, 0.316, 249, 237, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3555, 3jtlC, 0.8623, 2.09, 0.339, 237, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3556, 3jtlA, 0.8623, 2.09, 0.339, 237, 227, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3557, 1ya7E, 0.8623, 2.35, 0.339, 238, 230, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3558, 5lexS, 0.8622, 1.72, 0.371, 227, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3559, 3jtlE, 0.8622, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3560, 3c92U, 0.8622, 2.09, 0.339, 237, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3561, 3c92T, 0.8622, 2.09, 0.339, 237, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3562, 3c92S, 0.8622, 2.32, 0.335, 238, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3563, 3c92R, 0.8622, 1.72, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3564, 3c92Q, 0.8622, 1.72, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3565, 3c92P, 0.8622, 1.73, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3566, 3c92O, 0.8622, 1.41, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3567, 3c92G, 0.8622, 1.48, 0.361, 222, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3568, 3c92F, 0.8622, 1.42, 0.362, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3569, 3c92E, 0.8622, 2.10, 0.339, 235, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3570, 3c92D, 0.8622, 2.11, 0.339, 237, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3571, 3c92C, 0.8622, 1.73, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3572, 3c92B, 0.8622, 2.06, 0.341, 234, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3573, 3c92A, 0.8622, 2.33, 0.339, 238, 230, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3574, 1yarC, 0.8621, 1.49, 0.361, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3575, 1ya7A, 0.8621, 2.03, 0.301, 240, 229, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3576, 5mpbC, 0.8617, 1.58, 0.368, 237, 220, 
3577, 3c91U, 0.8616, 2.07, 0.341, 234, 226, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3578, 3c91T, 0.8616, 2.07, 0.335, 238, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3579, 3c91S, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3580, 3c91R, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3581, 3c91Q, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3582, 3c91P, 0.8616, 2.20, 0.286, 239, 231, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3583, 3c91O, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3584, 3c91G, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3585, 3c91F, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3586, 3c91E, 0.8616, 1.75, 0.367, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3587, 3c91D, 0.8616, 2.11, 0.339, 235, 227, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3588, 3c91C, 0.8616, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3589, 3c91B, 0.8616, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3590, 3c91A, 0.8616, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3591, 5vy4Y, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3592, 5vy4W, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3593, 5vy4U, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3594, 5vy4S, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3595, 5vy4Q, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3596, 5vy4O, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3597, 5vy4M, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3598, 5vy4K, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3599, 5vy4I, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3600, 5vy4G, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3601, 5vy4E, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3602, 5vy4C, 0.8614, 1.61, 0.368, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3603, 5vy4AA, 0.8614, 1.43, 0.362, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3604, 5vy4A, 0.8614, 1.74, 0.371, 227, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3605, 5vy40, 0.8614, 2.44, 0.310, 244, 232, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3606, 5vy3Y, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3607, 5vy3W, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3608, 5vy3U, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3609, 5vy3S, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3610, 5vy3Q, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3611, 5vy3O, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3612, 5vy3M, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3613, 5vy3K, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3614, 5vy3I, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3615, 5vy3G, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3616, 5vy3C, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3617, 5vy3A, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3618, 5vy30, 0.8614, 1.61, 0.368, 227, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3619, 4v7oYA, 0.8614, 1.61, 0.368, 227, 220, 
3620, 1yarD, 0.8614, 1.44, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3621, 5vy3E, 0.8613, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3622, 5t0cX, 0.8613, 1.44, 0.367, 221, 218, 
3623, 5t0cDB, 0.8613, 1.44, 0.367, 221, 218, 
3624, 5lezS, 0.8613, 1.44, 0.367, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3625, 4v7oQ, 0.8613, 1.44, 0.367, 221, 218, 
3626, 4v7oC, 0.8613, 1.44, 0.367, 221, 218, 
3627, 4v7oKA, 0.8612, 1.44, 0.367, 221, 218, 
3628, 5mpaA, 0.8611, 1.44, 0.367, 221, 218, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3629, 5dsvM, 0.8608, 1.44, 0.367, 221, 218, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3630, 6bdfY, 0.8607, 1.44, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3631, 6bdfW, 0.8607, 1.44, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3632, 6bdfU, 0.8607, 1.44, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3633, 6bdfS, 0.8607, 1.44, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3634, 6bdfQ, 0.8607, 1.44, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3635, 6bdfO, 0.8607, 1.44, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3636, 6bdfM, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3637, 6bdfK, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3638, 6bdfI, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3639, 6bdfG, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3640, 6bdfE, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3641, 6bdfC, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3642, 6bdfA, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3643, 6bdf0, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3644, 1yarB, 0.8607, 1.45, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3645, 5t0hM, 0.8606, 1.45, 0.367, 221, 218, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3646, 5m32E, 0.8605, 1.45, 0.367, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3647, 1yarA, 0.8605, 1.45, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3648, 1yarE, 0.8604, 1.45, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3649, 5mpcO, 0.8598, 1.84, 0.305, 232, 223, 
3650, 5wviX, 0.8597, 1.45, 0.367, 221, 218, 
3651, 5mpcB, 0.8595, 1.45, 0.367, 221, 218, 
3652, 5t0hG, 0.8594, 2.32, 0.335, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3653, 5mpcP, 0.8590, 2.32, 0.335, 238, 230, 
3654, 5vfrK, 0.8589, 2.12, 0.339, 237, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3655, 1pmaO, 0.8587, 1.85, 0.305, 232, 223, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3656, 1pmaK, 0.8586, 2.20, 0.299, 244, 231, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3657, 1pmaC, 0.8586, 1.85, 0.305, 232, 223, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3658, 1pmaM, 0.8585, 1.85, 0.305, 232, 223, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3659, 1pmaE, 0.8585, 2.28, 0.260, 241, 231, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3660, 1pmaD, 0.8585, 2.22, 0.283, 239, 226, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3661, 1pmaG, 0.8584, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3662, 5t0gL, 0.8583, 1.45, 0.367, 221, 218, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3663, 1pmaN, 0.8583, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3664, 1pmaL, 0.8583, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3665, 1pmaH, 0.8583, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3666, 5vfoK, 0.8582, 1.45, 0.367, 221, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3667, 4cr4A, 0.8582, 1.45, 0.367, 221, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3668, 1pmaJ, 0.8582, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3669, 1pmaF, 0.8582, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3670, 5t0jM, 0.8581, 1.45, 0.367, 221, 218, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3671, 5lf0E, 0.8581, 1.45, 0.367, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3672, 5le5E, 0.8581, 1.45, 0.367, 221, 218, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3673, 1pmaI, 0.8581, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3674, 1pmaA, 0.8580, 1.45, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3675, 5lf7E, 0.8578, 1.46, 0.362, 221, 218, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3676, 5lf4E, 0.8578, 2.38, 0.268, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3677, 5lf1E, 0.8578, 2.02, 0.332, 234, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3678, 5m32R, 0.8575, 1.46, 0.362, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3679, 5m32D, 0.8575, 1.47, 0.367, 221, 218, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3680, 5lf6E, 0.8575, 2.24, 0.257, 241, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3681, 5vfqE, 0.8574, 2.46, 0.292, 245, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3682, 5leyE, 0.8574, 1.97, 0.367, 250, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3683, 5vfsDA, 0.8573, 2.23, 0.300, 240, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3684, 6epeC, 0.8572, 2.05, 0.363, 250, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3685, 5lf3E, 0.8572, 1.85, 0.351, 228, 222, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3686, 5vfpE, 0.8571, 1.49, 0.367, 221, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3687, 5a5bE, 0.8571, 1.49, 0.367, 221, 218, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3688, 4cr3E, 0.8571, 1.49, 0.367, 221, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3689, 5vfok, 0.8569, 1.49, 0.367, 221, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3690, 5vfsE, 0.8567, 1.49, 0.367, 221, 218, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3691, 5vfpCA, 0.8566, 1.49, 0.367, 221, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3692, 5vfqDA, 0.8565, 1.49, 0.367, 221, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3693, 5lexE, 0.8564, 2.33, 0.330, 238, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3694, 5a0qR, 0.8564, 1.49, 0.367, 221, 218, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3695, 5a0qD, 0.8564, 1.49, 0.367, 221, 218, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3696, 6epdB, 0.8560, 1.49, 0.367, 221, 218, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3697, 5lezE, 0.8560, 1.85, 0.351, 228, 222, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3698, 5vfrk, 0.8559, 2.29, 0.263, 243, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3699, 5vftk, 0.8550, 1.49, 0.367, 221, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3700, 6epfG, 0.8549, 1.50, 0.367, 221, 218, GROUND STATE 26S PROTEASOME (GS1)
3701, 4g4sF, 0.8545, 2.28, 0.284, 240, 229, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3702, 5wviCA, 0.8540, 2.05, 0.342, 233, 225, 
3703, 3ipmG, 0.8540, 2.06, 0.342, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3704, 5wviNA, 0.8539, 1.50, 0.367, 221, 218, 
3705, 5vfuJA, 0.8539, 1.50, 0.367, 221, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3706, 3sdkE, 0.8539, 2.06, 0.342, 233, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3707, 3ipmF, 0.8539, 2.06, 0.342, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3708, 3ipmE, 0.8539, 2.06, 0.342, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3709, 3ipmD, 0.8539, 2.05, 0.344, 233, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3710, 3ipmC, 0.8539, 2.05, 0.344, 233, 224, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3711, 3ipmB, 0.8539, 2.06, 0.342, 233, 225, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3712, 3ipmA, 0.8539, 2.26, 0.335, 238, 230, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3713, 5wviF, 0.8537, 1.87, 0.351, 228, 222, 
3714, 4hrdE, 0.8537, 2.07, 0.342, 233, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3715, 5t0iJ, 0.8536, 1.87, 0.351, 228, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3716, 5mpaf, 0.8536, 2.35, 0.313, 249, 233, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3717, 5lajS, 0.8536, 2.07, 0.342, 233, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3718, 5lajE, 0.8536, 2.26, 0.277, 240, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3719, 5dsvC, 0.8535, 1.87, 0.351, 228, 222, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3720, 3sdkS, 0.8535, 2.49, 0.345, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3721, 3sdiE, 0.8535, 2.49, 0.345, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3722, 3mg6S, 0.8535, 1.72, 0.348, 228, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3723, 3mg6E, 0.8535, 2.25, 0.335, 238, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3724, 4hrdS, 0.8534, 1.88, 0.351, 228, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3725, 5vftK, 0.8533, 1.72, 0.348, 228, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3726, 5fgfS, 0.8533, 1.72, 0.348, 228, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3727, 5fgfE, 0.8533, 2.09, 0.342, 233, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3728, 4intS, 0.8533, 1.24, 0.593, 214, 214, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3729, 4intE, 0.8533, 1.24, 0.593, 214, 214, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3730, 5dkjS, 0.8532, 2.13, 0.382, 234, 228, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3731, 5dkjE, 0.8532, 2.09, 0.342, 233, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3732, 4r18S, 0.8532, 1.73, 0.348, 228, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3733, 4r18E, 0.8532, 1.98, 0.350, 228, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3734, 4qvvS, 0.8532, 2.40, 0.270, 245, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3735, 4qvvE, 0.8532, 2.02, 0.305, 234, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3736, 4hnpS, 0.8532, 2.51, 0.310, 245, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3737, 5d0tS, 0.8531, 1.84, 0.362, 227, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3738, 5d0tE, 0.8531, 2.50, 0.310, 245, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3739, 5cz7S, 0.8531, 2.00, 0.350, 228, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3740, 5cz7E, 0.8531, 2.02, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3741, 4r00S, 0.8531, 1.84, 0.362, 227, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3742, 4r00E, 0.8531, 1.84, 0.362, 227, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3743, 4qwjS, 0.8531, 1.84, 0.362, 227, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3744, 4fzgS, 0.8531, 1.84, 0.362, 227, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3745, 4fzgE, 0.8531, 1.84, 0.362, 227, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3746, 3oevE, 0.8531, 1.84, 0.362, 227, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3747, 3oeuE, 0.8531, 2.52, 0.292, 245, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3748, 5vfuV, 0.8530, 2.03, 0.305, 233, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3749, 5mp9F, 0.8530, 2.35, 0.588, 239, 233, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3750, 5lttS, 0.8530, 2.01, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3751, 5lttE, 0.8530, 2.03, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3752, 5l61S, 0.8530, 2.03, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3753, 5l61E, 0.8530, 2.12, 0.290, 234, 224, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3754, 5fhsS, 0.8530, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3755, 5fhsE, 0.8530, 2.02, 0.305, 230, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3756, 5fgeS, 0.8530, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3757, 5fgeE, 0.8530, 2.03, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3758, 5d0xS, 0.8530, 2.03, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3759, 5d0xE, 0.8530, 1.92, 0.351, 228, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3760, 5cgfS, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3761, 5cgfE, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3762, 4z1lE, 0.8530, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3763, 4qwjE, 0.8530, 2.04, 0.305, 233, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3764, 4qw0S, 0.8530, 2.04, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3765, 4qw0E, 0.8530, 2.04, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3766, 3mg8E, 0.8530, 2.04, 0.305, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3767, 5l62S, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3768, 5l62E, 0.8529, 2.03, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3769, 5l5vS, 0.8529, 2.03, 0.305, 231, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3770, 5l5vE, 0.8529, 2.04, 0.305, 233, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3771, 5l5tS, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3772, 5l5tE, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3773, 5jhsS, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3774, 5jhsE, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3775, 5fgdS, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3776, 5fgdE, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3777, 5cz9S, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3778, 5cz9E, 0.8529, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3779, 5cz8S, 0.8529, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3780, 5cz8E, 0.8529, 2.03, 0.305, 233, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3781, 4z1lS, 0.8529, 2.02, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3782, 4y8uS, 0.8529, 1.93, 0.351, 228, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3783, 4y8uE, 0.8529, 2.00, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3784, 4y69E, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3785, 2fakE, 0.8529, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3786, 5t0gK, 0.8528, 2.04, 0.305, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3787, 5l6cS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3788, 5l6cE, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3789, 5l67S, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3790, 5l67E, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3791, 5l60S, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3792, 5l60E, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3793, 5l5xS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3794, 5l5xE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3795, 5l5qS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3796, 5l5qE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3797, 5l5pS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3798, 5l5pE, 0.8528, 2.03, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3799, 5l5oS, 0.8528, 2.03, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3800, 5l5oE, 0.8528, 2.02, 0.305, 233, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3801, 5l5jS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3802, 5l5jE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3803, 5l5eS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3804, 5l5eE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3805, 5fgiS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3806, 5fgiE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3807, 5fgaS, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3808, 5fgaE, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3809, 5fg9S, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3810, 5fg9E, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3811, 5fg7S, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3812, 5fg7E, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3813, 5d0zS, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3814, 5d0sS, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3815, 5d0sE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3816, 5cz5S, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3817, 4y8kE, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3818, 4y6aS, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3819, 4y6aE, 0.8528, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3820, 4y69S, 0.8528, 1.90, 0.351, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3821, 4qzzS, 0.8528, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH OMURALIDE
3822, 4qzzE, 0.8528, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH OMURALIDE
3823, 4qzxS, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3824, 4qzxE, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3825, 4qwrS, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3826, 4qwrE, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3827, 4qwiS, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3828, 4qwiE, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3829, 4qvyS, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3830, 4qvyE, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3831, 4qvpS, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3832, 4qvpE, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3833, 4jt0S, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3834, 4jt0E, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3835, 3sdiS, 0.8528, 2.04, 0.305, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3836, 3mg0S, 0.8528, 2.04, 0.305, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3837, 2fakS, 0.8528, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3838, 5t0iG, 0.8527, 2.04, 0.305, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3839, 5l6bS, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3840, 5l6bE, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3841, 5l64S, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3842, 5l64E, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3843, 5l5zS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3844, 5l5zE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3845, 5l5uS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3846, 5l5uE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3847, 5l5fS, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3848, 5l5fE, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3849, 5l52S, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3850, 5l52E, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3851, 5fghS, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3852, 5fghE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3853, 5dkiS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3854, 5dkiE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3855, 5d0zE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3856, 5czaS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3857, 5czaE, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3858, 5cz5E, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3859, 5cgiS, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3860, 5cggS, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3861, 4zzgF, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3862, 4ya5S, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3863, 4ya5E, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3864, 4y8mS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3865, 4y8mE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3866, 4y8lS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3867, 4y8lE, 0.8527, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3868, 4y8kS, 0.8527, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3869, 4y7yS, 0.8527, 2.04, 0.305, 230, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3870, 4y7yE, 0.8527, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3871, 4r02S, 0.8527, 2.05, 0.305, 233, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3872, 4qz3S, 0.8527, 2.17, 0.297, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3873, 4qz3E, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3874, 4qwlS, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3875, 4qwlE, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3876, 4qvwS, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3877, 4qvwE, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3878, 4qvqS, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3879, 4qvqE, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3880, 4qv8S, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT
3881, 4qv8E, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-C52F MUTANT
3882, 4qv7S, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A50V MUTANT
3883, 4qv7E, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT
3884, 4quxS, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A49T-MUTANT
3885, 4quxE, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT
3886, 4jsqS, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3887, 4jsqE, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3888, 3mg8S, 0.8527, 2.04, 0.305, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3889, 3dy3S, 0.8527, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3890, 3dy3E, 0.8527, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3891, 5l68S, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3892, 5l68E, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3893, 5l66S, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3894, 5l66E, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3895, 5l65S, 0.8526, 2.03, 0.305, 232, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3896, 5l65E, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3897, 5l5sS, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3898, 5l5sE, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3899, 5l5iE, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3900, 5cz6S, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3901, 5cz6E, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3902, 5cgiE, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3903, 5cggE, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3904, 4ya3S, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3905, 4ya3E, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3906, 4ya1S, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3907, 4ya1E, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3908, 4y9yS, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3909, 4y9yE, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3910, 4y8nS, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3911, 4y8nE, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3912, 4y80S, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3913, 4y80E, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3914, 4y6vS, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3915, 4y6vE, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3916, 4r02E, 0.8526, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3917, 4qzwS, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3918, 4qzwE, 0.8526, 2.04, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3919, 4qz7S, 0.8526, 2.04, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3920, 4qz7E, 0.8526, 2.04, 0.305, 233, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3921, 4qwkS, 0.8526, 2.04, 0.305, 233, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3922, 4qwkE, 0.8526, 2.04, 0.305, 233, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3923, 4qw5S, 0.8526, 2.04, 0.305, 233, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3924, 4qvmS, 0.8526, 2.04, 0.305, 233, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3925, 4qvmE, 0.8526, 2.04, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3926, 4qvlS, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3927, 4qvlE, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3928, 4no8S, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3929, 4no8E, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3930, 4ltcS, 0.8526, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3931, 4inrE, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3932, 4eu2F, 0.8526, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3933, 3bdmS, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3934, 1rypF, 0.8526, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3935, 1g0uE, 0.8526, 2.04, 0.305, 231, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3936, 5mpbO, 0.8525, 2.05, 0.305, 231, 223, 
3937, 5l63S, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3938, 5l63E, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3939, 5l5yS, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3940, 5l5yE, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3941, 5l5iS, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3942, 5l5hS, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3943, 5l5hE, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3944, 5l5aS, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3945, 5l5aE, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3946, 5cz4S, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3947, 5cz4E, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3948, 4zzgT, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3949, 4ya0S, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3950, 4ya0E, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3951, 4y8rS, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3952, 4y8rE, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3953, 4y8qS, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3954, 4y8qE, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3955, 4y78S, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3956, 4y78E, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3957, 4rurS, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3958, 4rurE, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3959, 4qz6S, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3960, 4qz6E, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3961, 4qz5S, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3962, 4qz0S, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3963, 4qz0E, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3964, 4qxjS, 0.8525, 2.05, 0.305, 233, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3965, 4qxjE, 0.8525, 2.05, 0.305, 233, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3966, 4qw7S, 0.8525, 2.05, 0.305, 232, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3967, 4qw7E, 0.8525, 2.04, 0.305, 233, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3968, 4qw6S, 0.8525, 2.04, 0.305, 233, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3969, 4qw6E, 0.8525, 2.05, 0.305, 230, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3970, 4qw5E, 0.8525, 2.40, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3971, 4qw1S, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3972, 4qw1E, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3973, 4qvnS, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3974, 4qvnE, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3975, 4qv9S, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-C63F MUTANT
3976, 4qv9E, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT
3977, 4qv3E, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT
3978, 4qv0S, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3979, 4qv0E, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3980, 4quyS, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT
3981, 4quyE, 0.8525, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT
3982, 4ltcE, 0.8525, 2.03, 0.305, 232, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3983, 4inrS, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3984, 4hnpE, 0.8525, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3985, 3oevS, 0.8525, 2.05, 0.305, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3986, 3oeuS, 0.8525, 2.05, 0.305, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3987, 3nzjS, 0.8525, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3988, 3bdmE, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3989, 1g65E, 0.8525, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3990, 5t0cW, 0.8524, 2.05, 0.305, 231, 223, 
3991, 5t0cCB, 0.8524, 2.04, 0.305, 231, 223, 
3992, 5l5bS, 0.8524, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3993, 5l5bE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3994, 5l55E, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3995, 5jhrS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3996, 5jhrE, 0.8524, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3997, 5fggS, 0.8524, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3998, 5fggE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3999, 5d0vS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4000, 5d0vE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4001, 5bxlS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4002, 5bxlE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4003, 5bouS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4004, 5bouE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4005, 4y8jS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4006, 4y8jE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4007, 4y8iS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4008, 4y8iE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4009, 4y82S, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4010, 4y82E, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4011, 4y7xS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4012, 4y7xE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4013, 4y7wS, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4014, 4y7wE, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4015, 4y70S, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4016, 4y70E, 0.8524, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4017, 4qz5E, 0.8524, 2.05, 0.305, 233, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4018, 4qz2S, 0.8524, 2.04, 0.305, 233, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4019, 4qz2E, 0.8524, 2.05, 0.305, 233, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4020, 4qwuS, 0.8524, 2.05, 0.305, 233, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4021, 4qwuE, 0.8524, 2.04, 0.305, 233, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4022, 4qw3S, 0.8524, 2.04, 0.305, 233, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4023, 4qw3E, 0.8524, 2.05, 0.305, 233, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4024, 4qv3S, 0.8524, 1.90, 0.351, 228, 222, YCP BETA5-M45V MUTANT
4025, 4q1sE, 0.8524, 1.90, 0.351, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4026, 3un4S, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4027, 3un4E, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4028, 3nzjE, 0.8524, 2.06, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4029, 3mg0E, 0.8524, 2.05, 0.305, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4030, 2gplS, 0.8524, 2.05, 0.305, 231, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4031, 2gplE, 0.8524, 2.06, 0.305, 231, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4032, 1rypT, 0.8524, 2.06, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4033, 5wviD, 0.8523, 2.05, 0.305, 231, 223, 
4034, 5nifT, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4035, 5m2bS, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4036, 5l6aS, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4037, 5l6aE, 0.8523, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4038, 5l5wS, 0.8523, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4039, 5l5wE, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4040, 5l5dE, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4041, 5l55S, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4042, 5l54S, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4043, 5l54E, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4044, 5d0wS, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4045, 5d0wE, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4046, 5cghS, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4047, 5cghE, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4048, 4y9zS, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4049, 4y9zE, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4050, 4y8pS, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4051, 4y8pE, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4052, 4qwsS, 0.8523, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4053, 4qwsE, 0.8523, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4054, 4qw4S, 0.8523, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
4055, 4qw4E, 0.8523, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
4056, 4qv1S, 0.8523, 2.04, 0.305, 231, 223, YCP BETA5-M45A MUTANT
4057, 4qv1E, 0.8523, 2.04, 0.305, 231, 223, YCP BETA5-M45A MUTANT
4058, 4qlvE, 0.8523, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4059, 4inuE, 0.8523, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4060, 4eu2T, 0.8523, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4061, 3un8S, 0.8523, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4062, 3un8E, 0.8523, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4063, 3okjS, 0.8523, 2.04, 0.305, 233, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4064, 3dy4S, 0.8523, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4065, 3dy4E, 0.8523, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4066, 3d29S, 0.8523, 2.04, 0.305, 233, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
4067, 3d29E, 0.8523, 1.82, 0.362, 250, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
4068, 2zcyS, 0.8523, 2.34, 0.263, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4069, 2zcyE, 0.8523, 2.04, 0.305, 232, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4070, 5nifF, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4071, 5m2bE, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4072, 5l5dS, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4073, 5bxnS, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4074, 5bxnE, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4075, 4ya4S, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4076, 4ya4E, 0.8522, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4077, 4y77S, 0.8522, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4078, 4y77E, 0.8522, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4079, 4y6zS, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4080, 4y6zE, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4081, 4qwfS, 0.8522, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4082, 4qwfE, 0.8522, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4083, 4qlvS, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4084, 4qlsS, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4085, 4qlsE, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4086, 4no1S, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4087, 4no1E, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4088, 4nnwS, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4089, 4nnwE, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4090, 4j70S, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4091, 4fzcS, 0.8522, 2.05, 0.305, 231, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4092, 3okjE, 0.8522, 2.05, 0.305, 231, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4093, 3nzxS, 0.8522, 2.04, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4094, 3nzxE, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4095, 3nzwS, 0.8522, 2.05, 0.305, 232, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4096, 3nzwE, 0.8522, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4097, 3mg7S, 0.8522, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4098, 3gptS, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4099, 3gptE, 0.8522, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4100, 5laiS, 0.8521, 2.04, 0.305, 233, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4101, 5laiE, 0.8521, 2.04, 0.305, 233, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4102, 5l69S, 0.8521, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4103, 5l69E, 0.8521, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4104, 5l5rS, 0.8521, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4105, 5l5rE, 0.8521, 2.04, 0.305, 232, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4106, 4ya7S, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4107, 4ya7E, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4108, 4qz4S, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4109, 4qz4E, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4110, 4qwxS, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4111, 4qwxE, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4112, 4qv4S, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT
4113, 4qv4E, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT
4114, 4qluS, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4115, 4qluE, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4116, 4qlqS, 0.8521, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4117, 4qlqE, 0.8521, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4118, 4lqiS, 0.8521, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4119, 4lqiE, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4120, 4jsuS, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4121, 4jsuE, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4122, 4inuS, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4123, 4fzcE, 0.8521, 2.05, 0.305, 231, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4124, 2f16E, 0.8521, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4125, 5ahjS, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4126, 5ahjE, 0.8520, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4127, 4y8tS, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4128, 4y8tE, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4129, 4y8sS, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4130, 4y8sE, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4131, 4y8oS, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4132, 4y81S, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4133, 4y81E, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4134, 4y74S, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4135, 4y74E, 0.8520, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4136, 4q1sS, 0.8520, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4137, 4no9S, 0.8520, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4138, 4no9E, 0.8520, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4139, 4j70E, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4140, 3wxrF, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4141, 3tddS, 0.8520, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4142, 3tddE, 0.8520, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4143, 3mg7E, 0.8520, 2.05, 0.305, 231, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4144, 3gpjS, 0.8520, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4145, 3gpjE, 0.8520, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4146, 2f16S, 0.8520, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4147, 6gopS, 0.8519, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4148, 6gopE, 0.8519, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4149, 5lezU, 0.8519, 2.04, 0.305, 231, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4150, 4y8oE, 0.8519, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4151, 4r17S, 0.8519, 2.05, 0.305, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4152, 4r17E, 0.8519, 2.05, 0.305, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4153, 4qz1S, 0.8519, 2.05, 0.305, 233, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4154, 4qz1E, 0.8519, 2.05, 0.305, 233, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4155, 4qwgS, 0.8519, 2.05, 0.305, 233, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4156, 4qwgE, 0.8519, 2.05, 0.305, 233, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4157, 4qltS, 0.8519, 2.06, 0.305, 233, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4158, 4qltE, 0.8519, 2.04, 0.305, 233, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4159, 4nnnS, 0.8519, 2.06, 0.305, 233, 223, YCP IN COMPLEX WITH MG132
4160, 4nnnE, 0.8519, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH MG132
4161, 4hrcE, 0.8519, 2.06, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4162, 3shjE, 0.8519, 2.05, 0.305, 231, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4163, 3gpwS, 0.8519, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4164, 3gpwE, 0.8519, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4165, 1g0uS, 0.8519, 2.06, 0.305, 231, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4166, 4ya9S, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4167, 4ya9E, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4168, 4y8hS, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4169, 4y8hE, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4170, 4y75S, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4171, 4y75E, 0.8518, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4172, 4qv5S, 0.8518, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT
4173, 4qv5E, 0.8518, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT
4174, 4gk7S, 0.8518, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4175, 4gk7E, 0.8518, 2.05, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4176, 3shjS, 0.8518, 2.05, 0.305, 233, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4177, 3hyeE, 0.8518, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4178, 4ya2S, 0.8517, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4179, 4ya2E, 0.8517, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4180, 3wxrT, 0.8517, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4181, 3hyeS, 0.8517, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4182, 1g65S, 0.8517, 2.06, 0.305, 231, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4183, 4qv6S, 0.8516, 2.05, 0.305, 231, 223, YCP BETA5-A49V MUTANT
4184, 4qv6E, 0.8516, 1.85, 0.294, 235, 221, YCP BETA5-A49V MUTANT
4185, 4hrcS, 0.8516, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4186, 3mg4S, 0.8516, 2.05, 0.305, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4187, 3mg4E, 0.8516, 2.05, 0.305, 231, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4188, 5lexU, 0.8515, 2.05, 0.305, 231, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4189, 4y84S, 0.8515, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4190, 4y84E, 0.8515, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4191, 4y8gS, 0.8514, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4192, 4y8gE, 0.8514, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4193, 4qbyS, 0.8514, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4194, 4qbyE, 0.8514, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4195, 4no6S, 0.8514, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4196, 4no6E, 0.8514, 2.05, 0.305, 233, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4197, 6epeG, 0.8513, 2.04, 0.305, 233, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4198, 5lf0U, 0.8512, 2.06, 0.305, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4199, 3e47S, 0.8512, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4200, 3e47E, 0.8512, 2.06, 0.305, 230, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4201, 5lf3U, 0.8507, 2.06, 0.305, 231, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4202, 5a0qP, 0.8507, 2.06, 0.305, 231, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4203, 5a0qB, 0.8507, 2.05, 0.305, 231, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4204, 5t0iL, 0.8504, 2.05, 0.305, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4205, 5mpcA, 0.8504, 2.06, 0.305, 231, 223, 
4206, 5t0jL, 0.8503, 2.06, 0.305, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4207, 5lf7U, 0.8503, 2.06, 0.305, 231, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4208, 5lf6U, 0.8502, 2.06, 0.305, 231, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4209, 4x6zT, 0.8502, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4210, 5lf4U, 0.8499, 2.06, 0.305, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4211, 5lf1U, 0.8499, 2.05, 0.305, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4212, 6epfF, 0.8498, 2.06, 0.305, 233, 223, GROUND STATE 26S PROTEASOME (GS1)
4213, 5leyU, 0.8498, 2.06, 0.305, 231, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4214, 5wviY, 0.8497, 2.06, 0.305, 231, 223, 
4215, 1z7qF, 0.8497, 2.05, 0.305, 232, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4216, 4x6zF, 0.8496, 2.06, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4217, 1z7qT, 0.8496, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4218, 3jcpOA, 0.8494, 2.06, 0.305, 231, 223, 
4219, 3jcpO, 0.8494, 2.06, 0.305, 231, 223, 
4220, 5mp9f, 0.8493, 2.07, 0.305, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4221, 6epdD, 0.8491, 2.08, 0.305, 233, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4222, 1jd2E, 0.8491, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4223, 5wvkT, 0.8490, 1.86, 0.294, 235, 221, 
4224, 5ln3E, 0.8490, 2.05, 0.305, 231, 223, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4225, 1fntF, 0.8489, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4226, 4v7oT, 0.8488, 2.05, 0.305, 231, 223, 
4227, 4v7oF, 0.8488, 2.05, 0.305, 231, 223, 
4228, 4v7oBB, 0.8487, 2.05, 0.305, 231, 223, 
4229, 1fntT, 0.8487, 2.05, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4230, 5t0hK, 0.8486, 2.06, 0.305, 231, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4231, 4v7oNA, 0.8486, 2.06, 0.305, 231, 223, 
4232, 1jd2Z, 0.8485, 2.43, 0.278, 245, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4233, 6epdA, 0.8479, 1.86, 0.294, 235, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4234, 5t0hL, 0.8476, 2.07, 0.305, 233, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4235, 5a5bA, 0.8474, 2.06, 0.305, 233, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4236, 4cr3A, 0.8474, 1.86, 0.294, 235, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4237, 5mpaF, 0.8465, 1.35, 0.393, 214, 214, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4238, 5a5bF, 0.8462, 1.35, 0.393, 214, 214, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4239, 4cr3F, 0.8462, 2.33, 0.332, 238, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4240, 5wvkAA, 0.8457, 2.54, 0.254, 241, 232, 
4241, 5fmgQ, 0.8457, 2.42, 0.335, 238, 230, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4242, 5fmgC, 0.8457, 1.88, 0.290, 235, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4243, 5mpbT, 0.8456, 1.88, 0.290, 235, 221, 
4244, 5fmgR, 0.8454, 2.08, 0.305, 232, 223, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4245, 5fmgD, 0.8454, 1.88, 0.290, 235, 221, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4246, 5a0qS, 0.8447, 1.87, 0.294, 235, 221, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4247, 5a0qE, 0.8447, 2.38, 0.338, 238, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4248, 6epeF, 0.8443, 1.88, 0.294, 235, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4249, 6epeB, 0.8437, 2.37, 0.263, 243, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4250, 5t0iM, 0.8432, 2.08, 0.305, 234, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4251, 5le5U, 0.8426, 2.08, 0.305, 232, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4252, 3jcoOA, 0.8423, 2.08, 0.305, 234, 223, 
4253, 3jcoO, 0.8423, 2.11, 0.305, 233, 223, 
4254, 5mpbF, 0.8418, 2.11, 0.305, 233, 223, 
4255, 5t0jK, 0.8401, 2.11, 0.305, 233, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4256, 6epfE, 0.8398, 2.06, 0.305, 231, 223, GROUND STATE 26S PROTEASOME (GS1)
4257, 6epcF, 0.8380, 2.58, 0.565, 246, 237, GROUND STATE 26S PROTEASOME (GS2)
4258, 5mpcT, 0.8373, 2.09, 0.305, 233, 223, 
4259, 5fmgT, 0.8373, 2.02, 0.305, 233, 223, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4260, 5fmgF, 0.8373, 2.15, 0.351, 232, 225, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4261, 4cr2F, 0.8364, 2.08, 0.305, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4262, 6epcE, 0.8352, 2.09, 0.305, 234, 223, GROUND STATE 26S PROTEASOME (GS2)
4263, 6epcG, 0.8345, 2.09, 0.305, 234, 223, GROUND STATE 26S PROTEASOME (GS2)
4264, 5fmgP, 0.8344, 2.09, 0.305, 234, 223, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4265, 5fmgB, 0.8344, 2.08, 0.305, 233, 223, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4266, 5mpcF, 0.8338, 2.02, 0.350, 228, 223, 
4267, 4cr4F, 0.8338, 2.09, 0.305, 234, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4268, 5fmgS, 0.8330, 2.09, 0.305, 233, 223, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4269, 5fmgE, 0.8330, 2.48, 0.280, 246, 232, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4270, 6epdG, 0.8329, 2.37, 0.336, 238, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4271, 5t0iK, 0.8324, 2.64, 0.248, 243, 234, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4272, 4v7oP, 0.8309, 2.64, 0.248, 243, 234, 
4273, 4v7oB, 0.8309, 2.08, 0.305, 233, 223, 
4274, 4v7oJA, 0.8307, 2.10, 0.305, 233, 223, 
4275, 4v7oXA, 0.8306, 2.10, 0.305, 233, 223, 
4276, 5fmgO, 0.8305, 2.10, 0.305, 233, 223, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4277, 5fmgA, 0.8305, 1.61, 0.343, 220, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4278, 6epdF, 0.8278, 1.61, 0.343, 220, 216, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4279, 5ln3F, 0.8249, 2.06, 0.305, 233, 223, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4280, 6epeE, 0.8223, 1.58, 0.479, 215, 215, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4281, 5t0jH, 0.8222, 1.58, 0.479, 215, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4282, 5wviG, 0.8185, 1.39, 0.362, 215, 213, 
4283, 5wviZ, 0.8179, 1.39, 0.362, 215, 213, 
4284, 6epdE, 0.8172, 2.53, 0.342, 238, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4285, 5fmgU, 0.8096, 2.15, 0.371, 234, 224, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4286, 5fmgG, 0.8096, 2.46, 0.289, 240, 228, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4287, 5a0qU, 0.7973, 1.79, 0.294, 232, 218, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4288, 5a0qG, 0.7973, 2.19, 0.305, 233, 223, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4289, 5ts0G, 0.7943, 2.19, 0.305, 233, 223, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4290, 5trgP, 0.7936, 2.19, 0.305, 233, 223, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4291, 2h6jB, 0.7919, 2.15, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4292, 5trsA, 0.7916, 2.12, 0.347, 228, 222, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4293, 5trrA, 0.7914, 2.22, 0.339, 233, 224, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4294, 2h6jA, 0.7912, 2.57, 0.342, 238, 228, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4295, 2h6jG, 0.7910, 2.20, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4296, 5thoG, 0.7909, 1.94, 0.321, 219, 218, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4297, 2h6jF, 0.7909, 1.94, 0.321, 219, 218, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4298, 2h6jE, 0.7909, 2.18, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4299, 2fhgW, 0.7909, 2.32, 0.342, 233, 225, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4300, 2fhgQ, 0.7909, 2.62, 0.281, 245, 231, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4301, 2fhgD, 0.7909, 1.54, 0.340, 212, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4302, 5trgA, 0.7908, 1.54, 0.340, 212, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4303, 2h6jD, 0.7908, 2.20, 0.305, 231, 223, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4304, 2h6jC, 0.7908, 2.29, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4305, 2fhgU, 0.7908, 1.70, 0.341, 217, 214, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4306, 2fhgM, 0.7908, 1.70, 0.341, 217, 214, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4307, 2fhgI, 0.7908, 2.68, 0.274, 245, 230, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4308, 2fhgF, 0.7908, 2.25, 0.354, 228, 223, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4309, 2fhgB, 0.7908, 1.64, 0.366, 231, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4310, 2fhgA, 0.7908, 2.09, 0.305, 234, 223, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4311, 2fhg1, 0.7908, 1.64, 0.366, 231, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4312, 1q5qD, 0.7908, 1.65, 0.366, 231, 213, THE RHODOCOCCUS 20S PROTEASOME
4313, 1q5qC, 0.7908, 1.65, 0.366, 231, 213, THE RHODOCOCCUS 20S PROTEASOME
4314, 1q5qB, 0.7908, 1.78, 0.313, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4315, 1q5qA, 0.7908, 1.78, 0.313, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4316, 2fhgY, 0.7907, 2.61, 0.333, 238, 228, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4317, 2fhgS, 0.7907, 2.25, 0.342, 233, 222, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4318, 2fhgK, 0.7907, 2.46, 0.350, 233, 223, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4319, 1q5qG, 0.7907, 2.48, 0.369, 232, 225, THE RHODOCOCCUS 20S PROTEASOME
4320, 1q5qF, 0.7907, 2.37, 0.305, 233, 223, THE RHODOCOCCUS 20S PROTEASOME
4321, 1q5qE, 0.7907, 2.38, 0.305, 233, 223, THE RHODOCOCCUS 20S PROTEASOME
4322, 2fhgO, 0.7906, 2.65, 0.345, 233, 226, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4323, 1q5rF, 0.7906, 2.27, 0.200, 219, 215, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4324, 1q5rG, 0.7905, 2.27, 0.200, 219, 215, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4325, 1q5rE, 0.7905, 1.88, 0.291, 209, 206, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4326, 1q5rD, 0.7905, 1.88, 0.291, 209, 206, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4327, 1q5rC, 0.7905, 2.16, 0.151, 220, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4328, 1q5rB, 0.7905, 2.17, 0.151, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4329, 1q5rA, 0.7904, 2.21, 0.175, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4330, 5tryA, 0.7903, 2.15, 0.152, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4331, 2fhhW, 0.7900, 2.13, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4332, 2fhhD, 0.7898, 2.20, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4333, 2fhhU, 0.7897, 2.20, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4334, 2fhhS, 0.7897, 2.16, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4335, 2fhhO, 0.7897, 2.20, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4336, 2fhhM, 0.7897, 2.22, 0.175, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4337, 5thoA, 0.7896, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4338, 2fhhY, 0.7896, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4339, 2fhhQ, 0.7896, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4340, 2fhhK, 0.7896, 2.15, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4341, 2fhhI, 0.7896, 2.22, 0.175, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4342, 2fhhB, 0.7896, 2.21, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4343, 2fhhA, 0.7896, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4344, 2fhhF, 0.7895, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4345, 2fhh1, 0.7895, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4346, 5ts0A, 0.7894, 2.30, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4347, 3mkaU, 0.7893, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4348, 3mkaF, 0.7890, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4349, 5ts0T, 0.7889, 2.31, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4350, 5trsP, 0.7888, 2.22, 0.179, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4351, 3mkaA, 0.7888, 2.22, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4352, 5tryF, 0.7887, 2.22, 0.179, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4353, 5trsC, 0.7887, 2.22, 0.179, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4354, 3mfeI, 0.7887, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4355, 5thoS, 0.7883, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4356, 3mkaM, 0.7883, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4357, 5ts0U, 0.7881, 2.22, 0.179, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4358, 5tryQ, 0.7881, 2.22, 0.179, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4359, 3mkaB, 0.7880, 2.22, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4360, 5trgU, 0.7879, 2.31, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4361, 3mkaW, 0.7877, 2.24, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4362, 5ts0E, 0.7875, 2.24, 0.179, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4363, 3h6iQ, 0.7875, 2.24, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4364, 3mkaS, 0.7873, 2.24, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4365, 3mkaQ, 0.7873, 2.24, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4366, 3mkaO, 0.7873, 2.24, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4367, 3mi0F, 0.7873, 2.24, 0.179, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4368, 5ts0C, 0.7872, 2.15, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4369, 5trgE, 0.7872, 2.32, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4370, 5tryU, 0.7870, 2.32, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4371, 5trsD, 0.7870, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4372, 5trrT, 0.7870, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4373, 5thoO, 0.7870, 2.32, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4374, 5trrP, 0.7869, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4375, 5thoE, 0.7869, 2.17, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4376, 5ts0P, 0.7868, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4377, 5tryS, 0.7868, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4378, 5trsT, 0.7868, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4379, 5thoT, 0.7867, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4380, 5ts0B, 0.7866, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4381, 5tryR, 0.7863, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4382, 5trsU, 0.7863, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4383, 5trgS, 0.7863, 2.33, 0.155, 220, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4384, 3mkaK, 0.7863, 2.17, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4385, 3mfeB, 0.7863, 2.44, 0.155, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4386, 5ts0Q, 0.7862, 2.45, 0.150, 221, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4387, 5trsO, 0.7862, 2.18, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4388, 5trrU, 0.7860, 2.25, 0.151, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4389, 3mkaD, 0.7860, 2.46, 0.155, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4390, 5tryD, 0.7858, 2.18, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4391, 5trrS, 0.7858, 2.21, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4392, 5trrO, 0.7857, 2.12, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4393, 5trsG, 0.7854, 2.26, 0.156, 221, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4394, 3h6iF, 0.7854, 2.51, 0.150, 224, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4395, 5thoC, 0.7853, 2.15, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4396, 5trsE, 0.7852, 2.19, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4397, 5trsB, 0.7852, 2.37, 0.151, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4398, 5trgT, 0.7852, 2.09, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4399, 3mkaY, 0.7852, 2.32, 0.152, 221, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4400, 3mfeK, 0.7852, 2.20, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4401, 5trgO, 0.7851, 2.27, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4402, 5ts0D, 0.7850, 2.37, 0.151, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4403, 5trrG, 0.7850, 2.42, 0.151, 222, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4404, 5trrC, 0.7849, 2.32, 0.156, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4405, 5tryE, 0.7848, 2.43, 0.156, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4406, 5trrE, 0.7848, 2.16, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4407, 5tryC, 0.7847, 2.21, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4408, 5ts0S, 0.7845, 2.10, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4409, 5thoR, 0.7845, 2.22, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4410, 5tryP, 0.7844, 2.15, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4411, 5lzpD, 0.7844, 2.22, 0.152, 218, 211, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4412, 3h6fQ, 0.7844, 2.30, 0.151, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4413, 5trsS, 0.7843, 2.21, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4414, 3h6iW, 0.7843, 2.23, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4415, 5thoF, 0.7842, 2.29, 0.151, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4416, 3mka1, 0.7841, 2.16, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4417, 3h6fW, 0.7841, 2.16, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4418, 5tryG, 0.7840, 2.11, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4419, 5trgG, 0.7840, 2.17, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4420, 5thoU, 0.7840, 2.12, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4421, 5ts0R, 0.7839, 2.24, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4422, 5tryT, 0.7833, 2.44, 0.156, 221, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4423, 3h6fF, 0.7833, 2.11, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4424, 5trrD, 0.7832, 2.23, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4425, 5thoP, 0.7832, 2.17, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4426, 3h6iA, 0.7832, 2.11, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4427, 5thoD, 0.7830, 2.44, 0.156, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4428, 5trsR, 0.7828, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4429, 5ts0O, 0.7825, 2.23, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4430, 5tryB, 0.7824, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4431, 3krdF, 0.7823, 2.13, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4432, 3hfaB, 0.7821, 2.23, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4433, 3h6fA, 0.7821, 2.19, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4434, 3h6iK, 0.7819, 2.18, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4435, 3h6iI, 0.7819, 2.13, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4436, 5trgD, 0.7818, 2.19, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4437, 3mi0U, 0.7818, 2.26, 0.152, 224, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4438, 3mfeS, 0.7818, 2.12, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4439, 3h6iU, 0.7815, 2.24, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4440, 5ts0F, 0.7814, 2.19, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4441, 5trsQ, 0.7814, 2.14, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4442, 5thoQ, 0.7814, 2.19, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4443, 3h6iM, 0.7814, 2.19, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4444, 5trsF, 0.7813, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4445, 5trgC, 0.7812, 2.12, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4446, 3krdY, 0.7812, 2.26, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4447, 3h6i1, 0.7812, 2.21, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4448, 3h6fO, 0.7809, 2.22, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4449, 3mi0S, 0.7808, 2.24, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4450, 3h6fK, 0.7808, 2.32, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4451, 5trgB, 0.7807, 2.26, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4452, 3h6f1, 0.7807, 2.24, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4453, 3mi0O, 0.7806, 2.20, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4454, 5thoB, 0.7803, 2.41, 0.152, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4455, 5tryO, 0.7802, 2.22, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4456, 5trrQ, 0.7802, 2.15, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4457, 3krdI, 0.7802, 2.16, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4458, 3h6iO, 0.7802, 2.14, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4459, 5trgQ, 0.7800, 2.21, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4460, 5trrR, 0.7797, 2.15, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4461, 3mi0M, 0.7796, 2.21, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4462, 3mi0K, 0.7796, 2.15, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4463, 5trrB, 0.7793, 2.21, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4464, 3krdW, 0.7791, 2.16, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4465, 3h6fS, 0.7790, 2.17, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4466, 3h6iS, 0.7789, 2.19, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4467, 3mi0Y, 0.7788, 2.17, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4468, 3mfeA, 0.7788, 2.12, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4469, 3hfaA, 0.7787, 2.22, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4470, 5trgR, 0.7786, 2.05, 0.155, 214, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4471, 3h6fD, 0.7785, 2.11, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4472, 3h6fI, 0.7784, 2.33, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4473, 3mi0W, 0.7783, 2.11, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4474, 3mfeY, 0.7783, 2.31, 0.148, 223, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4475, 3krdS, 0.7783, 2.27, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4476, 3hfaW, 0.7782, 2.13, 0.149, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4477, 3mi0I, 0.7781, 2.13, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4478, 3mi01, 0.7781, 2.14, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4479, 3krdO, 0.7781, 2.19, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4480, 5trrF, 0.7780, 2.19, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4481, 3krdK, 0.7780, 2.22, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4482, 5trgF, 0.7779, 2.20, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4483, 3h6iB, 0.7778, 2.19, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4484, 3krd1, 0.7777, 2.25, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4485, 3hfaS, 0.7777, 2.12, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4486, 3hfaQ, 0.7777, 2.19, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4487, 5lzpH, 0.7776, 2.30, 0.158, 216, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4488, 3hfaO, 0.7776, 2.12, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4489, 3hfa1, 0.7776, 2.14, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4490, 3mkaI, 0.7774, 2.13, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4491, 3mi0Q, 0.7773, 2.29, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4492, 3hfaK, 0.7773, 2.14, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4493, 3hfaF, 0.7773, 2.23, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4494, 5lzpJ, 0.7772, 2.15, 0.154, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4495, 3hfaM, 0.7772, 2.20, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4496, 3h6fM, 0.7772, 2.15, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4497, 3mi0A, 0.7770, 2.30, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4498, 3hfaI, 0.7770, 2.16, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4499, 3hf9I, 0.7770, 2.29, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4500, 3h6iD, 0.7770, 2.31, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4501, 3h6fB, 0.7767, 2.16, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4502, 5lzpS, 0.7766, 2.16, 0.154, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4503, 5lzp2, 0.7766, 2.22, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4504, 5lzp0, 0.7766, 2.16, 0.154, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4505, 3krdQ, 0.7766, 2.36, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4506, 5lzpY, 0.7764, 2.10, 0.150, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4507, 3mi0D, 0.7764, 2.11, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4508, 3hfaY, 0.7764, 2.17, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4509, 5lzp4, 0.7763, 2.10, 0.155, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4510, 5lzpW, 0.7762, 2.11, 0.155, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4511, 5lzp8, 0.7762, 2.40, 0.158, 216, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4512, 5lzp6, 0.7762, 2.06, 0.150, 213, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4513, 3hfaU, 0.7761, 2.23, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4514, 3hfaD, 0.7761, 2.12, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4515, 3krdA, 0.7760, 2.42, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4516, 6bgoN, 0.7755, 2.25, 0.159, 215, 208, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4517, 5lzpQ, 0.7754, 2.19, 0.155, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4518, 3h6fU, 0.7754, 2.18, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4519, 5lzpB, 0.7753, 2.23, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4520, 5lzpM, 0.7749, 2.18, 0.154, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4521, 3h6fY, 0.7747, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4522, 3krdB, 0.7746, 2.24, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, 6bgoJ, 0.7742, 2.13, 0.155, 214, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4524, 3krdM, 0.7742, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4525, 3mfeO, 0.7741, 2.23, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4526, 3krdU, 0.7740, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4527, 3hf9b, 0.7737, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4528, 3hf9y, 0.7736, 2.41, 0.148, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4529, 3hf9s, 0.7736, 2.31, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4530, 3hf9f, 0.7735, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4531, 3krdD, 0.7734, 2.14, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4532, 3hf9A, 0.7733, 2.24, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4533, 3mfe1, 0.7730, 2.14, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4534, 3h6iY, 0.7729, 2.22, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4535, 3mi0B, 0.7725, 2.25, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4536, 3hf9K, 0.7725, 2.14, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4537, 3mfeQ, 0.7724, 2.00, 0.151, 212, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4538, 3mfeD, 0.7724, 2.07, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4539, 3hf9i, 0.7723, 2.21, 0.159, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4540, 3hf9U, 0.7722, 2.26, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4541, 3hf9B, 0.7721, 2.25, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4542, 6bgoK, 0.7720, 2.25, 0.159, 215, 208, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4543, 6bgoM, 0.7718, 2.16, 0.150, 214, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4544, 3hf9Q, 0.7718, 2.25, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4545, 6bgoO, 0.7714, 2.21, 0.159, 214, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4546, 6bgoL, 0.7714, 2.16, 0.155, 214, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4547, 6bgoI, 0.7714, 2.25, 0.159, 215, 208, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4548, 6bgoH, 0.7714, 2.25, 0.159, 215, 208, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4549, 6bgoG, 0.7714, 2.25, 0.159, 215, 208, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4550, 6bgoF, 0.7714, 2.25, 0.159, 215, 208, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4551, 6bgoE, 0.7714, 2.16, 0.155, 214, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4552, 6bgoA, 0.7714, 2.10, 0.155, 213, 206, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4553, 6bglO, 0.7714, 2.22, 0.155, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4554, 6bglN, 0.7714, 2.37, 0.152, 219, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4555, 6bglM, 0.7714, 2.21, 0.159, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4556, 6bglL, 0.7714, 2.22, 0.159, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4557, 6bglK, 0.7714, 2.22, 0.159, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4558, 6bglJ, 0.7714, 2.23, 0.159, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4559, 6bglI, 0.7714, 2.11, 0.155, 213, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4560, 6bglH, 0.7714, 2.16, 0.155, 213, 206, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4561, 6bglG, 0.7714, 2.44, 0.152, 219, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4562, 6bglF, 0.7714, 2.23, 0.155, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4563, 6bglE, 0.7714, 2.18, 0.150, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4564, 6bglA, 0.7714, 2.25, 0.155, 214, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4565, 6bgoD, 0.7713, 2.01, 0.152, 211, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4566, 6bgoC, 0.7713, 2.00, 0.152, 211, 204, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4567, 6bglD, 0.7713, 2.02, 0.152, 211, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4568, 6bglC, 0.7713, 2.02, 0.152, 211, 204, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4569, 3hf9u, 0.7713, 2.20, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, 3hf9k, 0.7713, 2.00, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, 3hf9d, 0.7713, 2.13, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4572, 3hf9O, 0.7711, 2.15, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4573, 3hf9a, 0.7711, 2.27, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4574, 3hf91, 0.7706, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4575, 3hf9Y, 0.7702, 2.15, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4576, 3hf9o, 0.7698, 2.15, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4577, 3hf9S, 0.7696, 2.02, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4578, 3hf9q, 0.7694, 2.03, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4579, 3mfeU, 0.7693, 2.02, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4580, 3hf93, 0.7693, 2.29, 0.154, 219, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4581, 3hf9w, 0.7686, 2.29, 0.154, 219, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4582, 3hf9D, 0.7653, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4583, 3hf9m, 0.7639, 2.18, 0.155, 217, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4584, 3mfeW, 0.7637, 2.18, 0.155, 218, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4585, 5a0qO, 0.7563, 2.18, 0.155, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4586, 5a0qA, 0.7563, 2.18, 0.155, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4587, 3hf9M, 0.7558, 2.18, 0.155, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4588, 5a0qT, 0.7540, 2.18, 0.155, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4589, 5a0qF, 0.7539, 2.18, 0.155, 215, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4590, 6bdfZ, 0.7314, 2.18, 0.155, 218, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4591, 6bdfX, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4592, 6bdfV, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4593, 6bdfT, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4594, 6bdfR, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4595, 6bdfP, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4596, 6bdfN, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4597, 6bdfL, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4598, 6bdfJ, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4599, 6bdfH, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4600, 6bdfF, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4601, 6bdfD, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4602, 6bdfB, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4603, 6bdf1, 0.7314, 2.18, 0.155, 215, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4604, 3mkaV, 0.7308, 2.18, 0.155, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4605, 3mkaL, 0.7304, 2.18, 0.155, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4606, 5ts0K, 0.7303, 2.18, 0.155, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4607, 5trsV, 0.7302, 2.04, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4608, 3hfaV, 0.7300, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4609, 5ts0V, 0.7299, 2.03, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4610, 5trgV, 0.7299, 2.03, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4611, 3mkaJ, 0.7299, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4612, 5trsK, 0.7298, 2.04, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4613, 5trrV, 0.7297, 1.99, 0.153, 210, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4614, 5trgK, 0.7297, 2.05, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4615, 3h4pf, 0.7296, 2.07, 0.152, 211, 204, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4616, 5tryV, 0.7295, 2.06, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4617, 3mkaP, 0.7295, 2.14, 0.151, 212, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4618, 3mkaN, 0.7294, 2.00, 0.153, 210, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4619, 5trgL, 0.7293, 2.07, 0.152, 211, 204, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4620, 3hfaZ, 0.7293, 2.11, 0.153, 210, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4621, 3h4pc, 0.7293, 1.98, 0.154, 208, 201, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4622, 5trsL, 0.7292, 2.01, 0.153, 209, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4623, 5thoL, 0.7292, 1.31, 0.323, 195, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4624, 3h4pn, 0.7292, 1.31, 0.323, 195, 189, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4625, 5lzpN, 0.7291, 1.87, 0.157, 205, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4626, 5vy3Z, 0.7290, 1.79, 0.373, 195, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4627, 5vy3X, 0.7290, 1.79, 0.373, 195, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4628, 5vy3V, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4629, 5vy3T, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4630, 5vy3R, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4631, 5vy3P, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4632, 5vy3N, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4633, 5vy3L, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4634, 5vy3J, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4635, 5vy3H, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4636, 5vy3F, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4637, 5vy3D, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4638, 5vy3B, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4639, 5vy31, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4640, 3j9iZ, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4641, 3j9iY, 0.7290, 2.29, 0.233, 201, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4642, 3j9iX, 0.7290, 2.70, 0.163, 249, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4643, 3j9iW, 0.7290, 2.70, 0.163, 251, 203, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4644, 3j9iV, 0.7290, 2.37, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4645, 3j9iN, 0.7290, 2.38, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4646, 3j9iM, 0.7290, 2.38, 0.166, 226, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4647, 3j9iL, 0.7290, 2.38, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4648, 3j9iK, 0.7290, 2.38, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4649, 3j9iJ, 0.7290, 3.17, 0.159, 252, 208, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4650, 3j9iI, 0.7290, 2.38, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4651, 3j9iH, 0.7290, 2.38, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4652, 3j9i2, 0.7290, 2.38, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4653, 3j9i1, 0.7290, 2.16, 0.203, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4654, 3hfaX, 0.7290, 2.39, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4655, 3h4pm, 0.7290, 2.66, 0.163, 250, 202, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4656, 3h4pi, 0.7290, 2.71, 0.163, 252, 203, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4657, 3h4pe, 0.7290, 2.38, 0.166, 223, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4658, 3h4pd, 0.7290, 2.40, 0.166, 224, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4659, 5thoV, 0.7289, 2.15, 0.203, 202, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4660, 5lzpP, 0.7289, 2.38, 0.166, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4661, 5tryb, 0.7288, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4662, 5trrL, 0.7288, 2.14, 0.203, 202, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4663, 3mkaE, 0.7287, 2.37, 0.161, 234, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4664, 3hfaT, 0.7287, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4665, 3h4pl, 0.7287, 2.33, 0.223, 203, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4666, 5trsY, 0.7286, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4667, 3hfaE, 0.7286, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4668, 3h4ph, 0.7286, 2.33, 0.223, 203, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4669, 3h4pa, 0.7286, 2.33, 0.223, 203, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4670, 5tryK, 0.7285, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4671, 3mi0V, 0.7285, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4672, 5ts0b, 0.7284, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4673, 5trsb, 0.7284, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4674, 5trrb, 0.7284, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4675, 3h4pk, 0.7284, 2.33, 0.223, 203, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4676, 3h4pb, 0.7284, 2.33, 0.223, 203, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4677, 3hfaH, 0.7283, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4678, 3h4pg, 0.7283, 2.36, 0.223, 203, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4679, 5vy4Z, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4680, 5vy4X, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4681, 5vy4V, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4682, 5vy4T, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4683, 5vy4R, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4684, 5vy4P, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4685, 5vy4N, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4686, 5vy4L, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4687, 5vy4J, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4688, 5vy4H, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4689, 5vy4F, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4690, 5vy4D, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4691, 5vy4BA, 0.7282, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4692, 5vy4B, 0.7282, 2.42, 0.166, 224, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4693, 5vy41, 0.7282, 2.15, 0.203, 202, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4694, 3mkaT, 0.7282, 2.14, 0.203, 202, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4695, 3mi0R, 0.7282, 2.16, 0.203, 202, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4696, 5trgY, 0.7281, 2.16, 0.203, 202, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4697, 5ts0W, 0.7280, 2.39, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4698, 5lzpI, 0.7279, 2.39, 0.161, 234, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4699, 5trrY, 0.7278, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4700, 5trrK, 0.7278, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4701, 3mkaH, 0.7278, 2.71, 0.163, 248, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4702, 5tryY, 0.7277, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4703, 5tryL, 0.7277, 2.16, 0.203, 202, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4704, 3hfaN, 0.7277, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4705, 3h4pj, 0.7277, 2.42, 0.166, 223, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4706, 5ts0L, 0.7276, 2.16, 0.203, 202, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4707, 5trsa, 0.7275, 2.16, 0.203, 202, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4708, 3c92X, 0.7275, 2.40, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4709, 3c92J, 0.7275, 2.38, 0.166, 239, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4710, 3c91X, 0.7275, 2.40, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4711, 3c91J, 0.7275, 2.41, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4712, 1pmaQ, 0.7275, 2.41, 0.166, 223, 199, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4713, 5thoK, 0.7274, 2.15, 0.203, 202, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4714, 5thob, 0.7274, 2.16, 0.203, 202, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4715, 5lzpR, 0.7274, 2.41, 0.166, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4716, 3mkaC, 0.7274, 2.16, 0.203, 202, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4717, 3c92N, 0.7273, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4718, 3c922, 0.7273, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4719, 3c91N, 0.7273, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4720, 3c912, 0.7273, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4721, 2h6jN, 0.7273, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4722, 2h6jM, 0.7273, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4723, 1pmaU, 0.7273, 2.33, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4724, 5trra, 0.7272, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4725, 5trgI, 0.7272, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4726, 5lzpT, 0.7272, 2.33, 0.223, 203, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4727, 3mi0X, 0.7272, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4728, 3mi0L, 0.7272, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4729, 1pmaX, 0.7272, 2.33, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4730, 1pmaV, 0.7272, 2.33, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4731, 5trrW, 0.7271, 2.33, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4732, 5thoW, 0.7271, 2.33, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4733, 3c92M, 0.7271, 2.67, 0.163, 250, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4734, 3c921, 0.7271, 2.39, 0.166, 239, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4735, 3c91M, 0.7271, 2.40, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4736, 3c911, 0.7271, 2.40, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4737, 2h6jK, 0.7271, 2.40, 0.161, 223, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4738, 1pmaY, 0.7271, 2.40, 0.166, 223, 199, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4739, 1pmaT, 0.7271, 2.41, 0.166, 223, 199, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4740, 5ts0a, 0.7270, 2.68, 0.163, 249, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4741, 5trsW, 0.7270, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4742, 5trga, 0.7270, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4743, 3hfaG, 0.7270, 2.45, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4744, 2h6jJ, 0.7270, 2.17, 0.203, 202, 192, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4745, 1pmaZ, 0.7270, 2.41, 0.166, 223, 199, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4746, 5trya, 0.7269, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4747, 3mi0Z, 0.7269, 2.35, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4748, 3c92W, 0.7269, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4749, 3c92I, 0.7269, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4750, 3c91W, 0.7269, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4751, 3c91I, 0.7269, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4752, 2h6jL, 0.7269, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4753, 1pmaP, 0.7269, 2.42, 0.166, 223, 199, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4754, 5thoY, 0.7268, 2.41, 0.161, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4755, 5lzpU, 0.7268, 2.67, 0.163, 250, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4756, 5lzpO, 0.7268, 2.35, 0.223, 203, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4757, 3hfaR, 0.7268, 2.35, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4758, 2h6jI, 0.7268, 2.35, 0.223, 203, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4759, 5ts0Z, 0.7267, 2.35, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4760, 2h6jH, 0.7267, 2.56, 0.171, 242, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4761, 1yauI, 0.7267, 2.57, 0.171, 242, 199, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4762, 1pmaW, 0.7267, 2.35, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4763, 5ts0Y, 0.7266, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4764, 5lzpC, 0.7266, 2.35, 0.167, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4765, 3mi0N, 0.7266, 2.41, 0.161, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4766, 3mi02, 0.7266, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4767, 3hfaL, 0.7266, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4768, 3hfa2, 0.7266, 2.36, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4769, 1yauH, 0.7266, 2.35, 0.223, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4770, 5trsN, 0.7265, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4771, 5thoa, 0.7265, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4772, 3mka2, 0.7265, 2.35, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4773, 3hfaC, 0.7265, 2.35, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4774, 5trsI, 0.7264, 2.35, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4775, 5lzpK, 0.7264, 2.35, 0.223, 203, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4776, 3hfaP, 0.7264, 2.56, 0.171, 242, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4777, 1yarK, 0.7264, 2.35, 0.223, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4778, 5fgeY, 0.7263, 2.35, 0.223, 203, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4779, 3hfaJ, 0.7263, 2.44, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4780, 1yarL, 0.7263, 2.42, 0.166, 223, 199, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4781, 1ya7I, 0.7263, 2.42, 0.166, 223, 199, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4782, 5trgb, 0.7262, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4783, 5fgdY, 0.7262, 2.57, 0.171, 242, 199, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4784, 3mkaG, 0.7262, 2.36, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4785, 3krdV, 0.7262, 2.43, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4786, 5trrI, 0.7261, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4787, 5trgX, 0.7261, 2.36, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4788, 5fgeK, 0.7261, 2.36, 0.223, 203, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4789, 3mi0T, 0.7261, 2.36, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4790, 3krdR, 0.7261, 2.36, 0.223, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4791, 1yauK, 0.7261, 2.57, 0.171, 242, 199, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4792, 5ts0I, 0.7260, 2.36, 0.223, 203, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4793, 5trrZ, 0.7260, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4794, 5trgN, 0.7260, 2.43, 0.161, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4795, 3mi0J, 0.7260, 2.43, 0.161, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4796, 1ya7N, 0.7260, 2.37, 0.167, 222, 198, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4797, 1ya7K, 0.7260, 2.58, 0.171, 242, 199, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4798, 1ya7H, 0.7260, 2.37, 0.167, 222, 198, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4799, 5trgW, 0.7259, 2.58, 0.171, 242, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4800, 1yarH, 0.7259, 2.36, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4801, 1pma2, 0.7259, 2.36, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4802, 5tryZ, 0.7258, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4803, 5trsH, 0.7258, 2.43, 0.161, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4804, 5thoM, 0.7258, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4805, 5thoI, 0.7258, 2.42, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4806, 5lzpG, 0.7258, 2.37, 0.167, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4807, 3jrmH, 0.7258, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4808, 1pma1, 0.7258, 2.23, 0.234, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4809, 5ts0H, 0.7257, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4810, 5tryI, 0.7257, 2.43, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4811, 3mkaR, 0.7257, 2.70, 0.163, 246, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4812, 3c92Z, 0.7257, 2.38, 0.167, 222, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4813, 3c92V, 0.7257, 2.37, 0.167, 222, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4814, 3c92L, 0.7257, 2.37, 0.162, 222, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4815, 3c92H, 0.7257, 2.38, 0.167, 222, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4816, 3c91Z, 0.7257, 2.36, 0.233, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4817, 3c91V, 0.7257, 2.94, 0.178, 218, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4818, 3c91L, 0.7257, 2.38, 0.167, 222, 198, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4819, 3c91H, 0.7257, 2.37, 0.233, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4820, 1yauM, 0.7257, 2.37, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4821, 1q5rN, 0.7257, 2.44, 0.166, 223, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4822, 1q5rM, 0.7257, 2.97, 0.183, 216, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4823, 1q5rL, 0.7257, 3.00, 0.161, 251, 205, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4824, 1q5rK, 0.7257, 2.42, 0.166, 229, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4825, 1q5rJ, 0.7257, 2.37, 0.167, 222, 198, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4826, 1pmaS, 0.7257, 2.37, 0.167, 222, 198, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4827, 1pmaB, 0.7257, 2.95, 0.178, 218, 202, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4828, 5ts0N, 0.7256, 2.43, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4829, 5tryW, 0.7256, 2.43, 0.166, 229, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4830, 5lzpE, 0.7256, 2.37, 0.233, 203, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4831, 3jrmM, 0.7256, 2.38, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4832, 3jrmK, 0.7256, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4833, 3jrmJ, 0.7256, 2.43, 0.166, 223, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4834, 3jrmI, 0.7256, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4835, 3c92Y, 0.7256, 2.38, 0.233, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4836, 3c92K, 0.7256, 2.37, 0.233, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4837, 3c91Y, 0.7256, 2.24, 0.234, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4838, 3c91K, 0.7256, 2.43, 0.166, 223, 199, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4839, 1ya7L, 0.7256, 2.24, 0.234, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4840, 1q5rI, 0.7256, 2.23, 0.224, 203, 192, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4841, 1q5rH, 0.7256, 2.37, 0.167, 222, 198, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4842, 1pmaR, 0.7256, 2.38, 0.167, 222, 198, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4843, 5trsZ, 0.7255, 2.46, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4844, 3jrmN, 0.7255, 2.38, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4845, 3jrmL, 0.7255, 2.39, 0.162, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4846, 5trrN, 0.7254, 2.24, 0.234, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4847, 5trgH, 0.7254, 2.24, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4848, 1yauJ, 0.7254, 2.38, 0.167, 222, 198, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4849, 1yarJ, 0.7254, 2.38, 0.167, 222, 198, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4850, 1yarI, 0.7254, 2.80, 0.163, 246, 203, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4851, 5trrM, 0.7253, 2.24, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4852, 5cz7Y, 0.7253, 2.24, 0.224, 203, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4853, 1yarM, 0.7253, 2.24, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4854, 5lzpA, 0.7252, 2.24, 0.224, 203, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4855, 5cz7K, 0.7252, 2.24, 0.224, 203, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4856, 3mi0E, 0.7252, 2.24, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4857, 3mi0C, 0.7252, 2.24, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4858, 3jseH, 0.7252, 2.24, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4859, 1yauN, 0.7252, 2.37, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4860, 3mi0G, 0.7251, 2.57, 0.166, 251, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4861, 3jseM, 0.7251, 2.58, 0.166, 251, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4862, 3jseK, 0.7251, 2.58, 0.166, 251, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4863, 1yauL, 0.7251, 2.58, 0.166, 251, 199, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4864, 1ya7M, 0.7251, 2.57, 0.166, 251, 199, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4865, 5tryH, 0.7250, 2.24, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4866, 5trrH, 0.7250, 2.24, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4867, 5thoZ, 0.7250, 2.44, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4868, 3jseL, 0.7250, 2.43, 0.166, 223, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4869, 3jseJ, 0.7250, 2.38, 0.162, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4870, 5lzpF, 0.7249, 2.25, 0.234, 203, 192, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4871, 3mi0H, 0.7249, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4872, 3jseN, 0.7249, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4873, 3jseI, 0.7249, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4874, 1yarN, 0.7249, 2.24, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4875, 1ya7J, 0.7249, 2.24, 0.224, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4876, 5ts0M, 0.7247, 2.24, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4877, 5tryN, 0.7247, 2.24, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4878, 5thoH, 0.7247, 2.37, 0.233, 203, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4879, 5fgdK, 0.7247, 2.58, 0.166, 251, 199, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4880, 6bgoX, 0.7246, 2.58, 0.166, 251, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4881, 6bgoW, 0.7246, 2.24, 0.224, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4882, 6bgoV, 0.7246, 2.38, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4883, 6bgoU, 0.7246, 2.25, 0.234, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4884, 6bgoT, 0.7246, 2.25, 0.234, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4885, 6bgoS, 0.7246, 2.44, 0.166, 223, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4886, 6bgoR, 0.7246, 2.38, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4887, 6bgoQ, 0.7246, 2.25, 0.234, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4888, 6bgoP, 0.7246, 2.24, 0.234, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4889, 6bgoc, 0.7246, 2.25, 0.234, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4890, 6bglZ, 0.7246, 2.39, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4891, 6bglY, 0.7246, 3.02, 0.183, 217, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4892, 6bglX, 0.7246, 2.37, 0.233, 203, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4893, 6bglW, 0.7246, 2.40, 0.162, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4894, 6bglV, 0.7246, 3.03, 0.183, 217, 202, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4895, 6bglU, 0.7246, 2.45, 0.166, 223, 199, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4896, 6bglT, 0.7246, 2.39, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4897, 6bglS, 0.7246, 2.24, 0.234, 203, 192, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4898, 6bglQ, 0.7246, 2.26, 0.234, 203, 192, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4899, 6bglP, 0.7246, 2.39, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4900, 6bglc, 0.7246, 2.24, 0.234, 203, 192, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4901, 6bgla, 0.7246, 2.24, 0.234, 203, 192, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4902, 6bgoZ, 0.7245, 2.25, 0.234, 203, 192, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4903, 6bgoY, 0.7245, 2.37, 0.233, 203, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4904, 6bgob, 0.7245, 2.39, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4905, 6bgoa, 0.7245, 2.39, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4906, 6bglR, 0.7245, 2.39, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4907, 6bglb, 0.7245, 2.24, 0.234, 203, 192, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4908, 5trgM, 0.7245, 2.24, 0.234, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4909, 5lzpL, 0.7245, 2.40, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4910, 5ts0J, 0.7244, 2.39, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4911, 3krdN, 0.7244, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4912, 3jtlN, 0.7243, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4913, 3jtlH, 0.7243, 2.26, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4914, 5ts0X, 0.7242, 2.25, 0.234, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4915, 5thoN, 0.7242, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4916, 3krdJ, 0.7242, 2.45, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4917, 3jtlJ, 0.7242, 2.39, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4918, 3jtlI, 0.7242, 2.90, 0.184, 215, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4919, 5trsX, 0.7241, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4920, 5trsM, 0.7241, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4921, 5trsJ, 0.7241, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4922, 3jtlM, 0.7241, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4923, 3jtlL, 0.7241, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4924, 3jtlK, 0.7241, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4925, 5trrX, 0.7240, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4926, 5trrJ, 0.7240, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4927, 3mi0P, 0.7240, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4928, 5tryM, 0.7239, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4929, 5tryX, 0.7237, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4930, 5trgZ, 0.7237, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4931, 3krdC, 0.7237, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4932, 5thoX, 0.7235, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4933, 5thoJ, 0.7235, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4934, 3krdX, 0.7234, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4935, 3krdL, 0.7233, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4936, 3krdG, 0.7233, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4937, 5d0vK, 0.7232, 2.41, 0.167, 222, 198, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4938, 3krdH, 0.7230, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4939, 5fgfK, 0.7229, 2.41, 0.167, 222, 198, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4940, 3krdZ, 0.7228, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4941, 3krdT, 0.7227, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4942, 5trgJ, 0.7226, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4943, 5fgfY, 0.7226, 2.41, 0.167, 222, 198, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4944, 1j2qN, 0.7226, 2.41, 0.167, 222, 198, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4945, 3krd2, 0.7225, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4946, 1j2qM, 0.7225, 2.41, 0.167, 222, 198, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4947, 1j2qJ, 0.7225, 2.40, 0.167, 222, 198, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4948, 1j2qI, 0.7225, 2.41, 0.162, 222, 198, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4949, 1j2qL, 0.7224, 2.41, 0.167, 222, 198, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4950, 1j2qH, 0.7224, 2.41, 0.167, 222, 198, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4951, 5tryJ, 0.7223, 2.26, 0.224, 203, 192, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4952, 1j2qK, 0.7223, 2.25, 0.224, 203, 192, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4953, 5fgiN, 0.7221, 2.41, 0.167, 222, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4954, 3mkaX, 0.7221, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4955, 5fgib, 0.7220, 2.41, 0.167, 222, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4956, 3krdE, 0.7220, 2.25, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4957, 3mfeP, 0.7219, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4958, 3krdP, 0.7216, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4959, 4cr45, 0.7204, 2.41, 0.167, 222, 198, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4960, 2fhhZ, 0.7202, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4961, 2fhhX, 0.7202, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4962, 2fhhG, 0.7202, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4963, 2fhhC, 0.7202, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4964, 3mfeC, 0.7201, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4965, 2fhhR, 0.7201, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4966, 2fhhP, 0.7200, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4967, 2fhhN, 0.7200, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4968, 2fhhJ, 0.7200, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4969, 2fhhH, 0.7200, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4970, 2fhhE, 0.7200, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4971, 2fhhT, 0.7199, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4972, 2fhhL, 0.7199, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4973, 2fhh2, 0.7199, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4974, 2fhgJ, 0.7199, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4975, 2fhhV, 0.7198, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4976, 2fhgX, 0.7198, 3.11, 0.178, 218, 202, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4977, 2fhgV, 0.7198, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4978, 2fhgP, 0.7198, 2.88, 0.185, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4979, 2fhgH, 0.7198, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4980, 2fhgG, 0.7198, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4981, 2fhgC, 0.7198, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4982, 2fhgZ, 0.7197, 2.88, 0.185, 214, 200, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4983, 2fhgT, 0.7197, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4984, 2fhgN, 0.7197, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4985, 2fhgL, 0.7197, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4986, 2fhg2, 0.7197, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4987, 2fhgR, 0.7196, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4988, 2fhgE, 0.7195, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4989, 3mkaZ, 0.7194, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4990, 3ipmM, 0.7193, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4991, 3ipmJ, 0.7193, 2.46, 0.238, 202, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4992, 5l5rK, 0.7192, 3.00, 0.151, 213, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4993, 5l5rY, 0.7191, 2.85, 0.163, 249, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4994, 5l5bY, 0.7190, 3.00, 0.151, 213, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4995, 5l5bK, 0.7190, 2.44, 0.167, 222, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4996, 5l5eY, 0.7189, 2.38, 0.162, 221, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4997, 5l5eK, 0.7189, 2.45, 0.167, 222, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4998, 2z5cF, 0.7189, 2.76, 0.165, 212, 200, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4999, 2z5cC, 0.7189, 2.46, 0.167, 222, 198, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
5000, 1q5qM, 0.7189, 2.47, 0.167, 222, 198, THE RHODOCOCCUS 20S PROTEASOME
